BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 038766
(299 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 150 bits (379), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 96/297 (32%), Positives = 153/297 (51%), Gaps = 12/297 (4%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF E++ A+ +FS NI+G VYKGRL DG +VAVK+L + + F E
Sbjct: 27 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQG-GELQFQTE 85
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ + HRNL+++ G+ + + L+ YM NGS+ S + PKR +
Sbjct: 86 VEMISMAVHRNLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ A GL YLH D I+H D+K +NILLD +FEA V DFG ++++D +D +
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY--KD-XHVXX 201
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
A +GTIG++APE+ + K DVF +G++++E +T +R L + L V+
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 241 KALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
L + + D L + ++AL+CT S+P +RP M+E++
Sbjct: 262 GLLKE--KKLEALVDVDLQGNY-----KDEEVEQLIQVALLCTQSSPMERPKMSEVV 311
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 147 bits (371), Expect = 8e-36, Method: Compositional matrix adjust.
Identities = 94/297 (31%), Positives = 151/297 (50%), Gaps = 12/297 (4%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF E++ A+ +F NI+G VYKGRL DG +VAVK+L + + + F E
Sbjct: 19 RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLK-EERTQGGELQFQTE 77
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ + HRNL+++ G+ + + L+ YM NGS+ S + PKR +
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ A GL YLH D I+H D+K +NILLD +FEA V DFG ++++D +D +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY--KD-XHVXX 193
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
A +G IG++APE+ + K DVF +G++++E +T +R L + L V+
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 241 KALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
L ++ LV ++AL+CT S+P +RP M+E++
Sbjct: 254 GLL-------KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 130 bits (327), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 98/298 (32%), Positives = 153/298 (51%), Gaps = 19/298 (6%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
R ++E AT +F +IG+ VYKG L DG VA+K+ S++ + F E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETE 85
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+TL +H +LV ++G+ E ++ LI +YMENG+L+ ++G + + +R+++
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEM-ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
I A GL YLH+ I+H D+K NILLD +F ++DFG S+ L D + L
Sbjct: 145 CIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK-GTEL-DQTHLXX 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
+GT+GY+ PE+ +T K DV+SFG+V+ E L R P + L E
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS-----LPREMVNLAE 254
Query: 241 KALANGING-VRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
A+ + NG + QI DP L I A+ C + + EDRP+M ++L
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDT-----AVKCLALSSEDRPSMGDVL 307
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 129 bits (323), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 97/298 (32%), Positives = 152/298 (51%), Gaps = 19/298 (6%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
R ++E AT +F +IG+ VYKG L DG VA+K+ S++ + F E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETE 85
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+TL +H +LV ++G+ E ++ LI +YMENG+L+ ++G + + +R+++
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEM-ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
I A GL YLH+ I+H D+K NILLD +F ++DFG S+ Q + L
Sbjct: 145 CIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQ--THLXX 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
+GT+GY+ PE+ +T K DV+SFG+V+ E L R P + L E
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS-----LPREMVNLAE 254
Query: 241 KALANGING-VRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
A+ + NG + QI DP L I A+ C + + EDRP+M ++L
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDT-----AVKCLALSSEDRPSMGDVL 307
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG + TV++ G VAVK L F AE F RE +K L+H N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 80 WESGKLKALILEYMENGSLESVIHGPG----VDHSRWTLPKRIDVLISVANGLDYLHSGY 135
+ L +++ EY+ GSL ++H G +D R R+ + VA G++YLH+
Sbjct: 104 TQPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDERR-----RLSMAYDVAKGMNYLHN-R 156
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+ PIVH ++K N+L+D+ + V DFG SR+ LSS S A GT ++APE
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAA--GTPEWMAPEVLR 212
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTG 223
K DV+SFG+++ E T ++P G
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWG 240
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 77/225 (34%), Positives = 119/225 (52%), Gaps = 19/225 (8%)
Query: 2 FDRTEIENATGSFSE------NNIIGNSNLSTVYKGRLEDGEIVAVKKLN--FHQFSAES 53
F E++N T +F E N +G VYKG + + VAVKKL + E
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 54 DKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRW 112
+ F +E K + + +H NLV++LG++ + L L+ YM NGSL + + G W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
+ R + ANG+++LH + I H D+K +NILLD F A +SDFG +R +
Sbjct: 133 HM--RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
Q + + + GT Y+APE A +T K D++SFG+V++E +T
Sbjct: 188 QTV--MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 77/225 (34%), Positives = 118/225 (52%), Gaps = 19/225 (8%)
Query: 2 FDRTEIENATGSFSE------NNIIGNSNLSTVYKGRLEDGEIVAVKKLN--FHQFSAES 53
F E++N T +F E N +G VYKG + + VAVKKL + E
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 54 DKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRW 112
+ F +E K + + +H NLV++LG++ + L L+ YM NGSL + + G W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
+ R + ANG+++LH + I H D+K +NILLD F A +SDFG +R +
Sbjct: 133 HM--RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
Q + + GT Y+APE A +T K D++SFG+V++E +T
Sbjct: 188 QTV--MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 105 bits (263), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 77/225 (34%), Positives = 117/225 (52%), Gaps = 19/225 (8%)
Query: 2 FDRTEIENATGSFSE------NNIIGNSNLSTVYKGRLEDGEIVAVKKLN--FHQFSAES 53
F E++N T +F E N +G VYKG + + VAVKKL + E
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 54 DKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG-PGVDHSRW 112
+ F +E K + + +H NLV++LG++ + L L+ YM NGSL + G W
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
+ R + ANG+++LH + I H D+K +NILLD F A +SDFG +R +
Sbjct: 127 HM--RCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
Q + + GT Y+APE A +T K D++SFG+V++E +T
Sbjct: 182 QXV--MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 223
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 72/208 (34%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG + TV++ G VAVK L F AE F RE +K L+H N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 80 WESGKLKALILEYMENGSLESVIHGPG----VDHSRWTLPKRIDVLISVANGLDYLHSGY 135
+ L +++ EY+ GSL ++H G +D R R+ + VA G++YLH+
Sbjct: 104 TQPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDERR-----RLSMAYDVAKGMNYLHN-R 156
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+ PIVH D+K N+L+D+ + V DFG SR+ L S A GT ++APE
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXF--LXSKXAA--GTPEWMAPEVLR 212
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTG 223
K DV+SFG+++ E T ++P G
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWG 240
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 76/225 (33%), Positives = 113/225 (50%), Gaps = 19/225 (8%)
Query: 2 FDRTEIENATGSFSE------NNIIGNSNLSTVYKGRLEDGEIVAVKKLN--FHQFSAES 53
F E++N T +F E N G VYKG + + VAVKKL + E
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 54 DKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRW 112
+ F +E K + +H NLV++LG++ + L L+ Y NGSL + + G W
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDL-CLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
R + ANG+++LH + I H D+K +NILLD F A +SDFG +R +
Sbjct: 124 H--XRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
Q + + GT Y APE A +T K D++SFG+V++E +T
Sbjct: 179 QXVX--XSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIIT 220
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 80/281 (28%), Positives = 130/281 (46%), Gaps = 42/281 (14%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLG 77
++G V K + + VA+K Q +ES+ K+F E + L + H N+VK+ G
Sbjct: 16 VVGRGAFGVVCKAKWRAKD-VAIK-----QIESESERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
L++EY E GSL +V+HG +T + + + G+ YLHS
Sbjct: 70 ACLNP---VCLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 125
Query: 138 PIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
++H D+KP N+LL + DFGT+ + H+ T +G+ ++APE
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-------TNNKGSAAWMAPEVFEG 178
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
+ K DVFS+GI++ E +T+R+P DE G + R + A+ NG T P
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRKP--FDEIGG---PAFR--IMWAVHNG-------TRP 224
Query: 257 KLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
L+ ++ L C S +P RP+M E++
Sbjct: 225 PLIKNLPKPIE---------SLMTRCWSKDPSQRPSMEEIV 256
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 95.1 bits (235), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 80/281 (28%), Positives = 130/281 (46%), Gaps = 42/281 (14%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLG 77
++G V K + + VA+K Q +ES+ K+F E + L + H N+VK+ G
Sbjct: 15 VVGRGAFGVVCKAKWRAKD-VAIK-----QIESESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
L++EY E GSL +V+HG +T + + + G+ YLHS
Sbjct: 69 ACLNP---VCLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 138 PIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
++H D+KP N+LL + DFGT+ + H+ T +G+ ++APE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-------TNNKGSAAWMAPEVFEG 177
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
+ K DVFS+GI++ E +T+R+P DE G + R + A+ NG T P
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP--FDEIGG---PAFR--IMWAVHNG-------TRP 223
Query: 257 KLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
L+ ++ L C S +P RP+M E++
Sbjct: 224 PLIKNLPKPIE---------SLMTRCWSKDPSQRPSMEEIV 255
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 94.4 bits (233), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 80
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + +++EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 81 VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 135
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEXTARQGAKFPIKWTAPEAALY 189
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 237
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 238 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 265
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 94.0 bits (232), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 80
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + +++EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 81 VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 135
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 189
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 237
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 238 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 265
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 70
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 71 VVSEEPIXIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVER---MNY 125
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEXTARQGAKFPIKWTAPEAALY 179
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 180 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 227
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C PE+RP L
Sbjct: 228 PECPESLH-------------DLMCQCWRKEPEERPTFEYL 255
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 80
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 81 VVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 135
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 189
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 237
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 238 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 265
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 80
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + +++EYM G L + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 81 VVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 135
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 189
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 237
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 238 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 265
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 69
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 70 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 124
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 178
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 179 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 226
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 227 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 254
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 80
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 81 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 135
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 189
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 237
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 238 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 265
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 71
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 72 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 126
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 180
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 181 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 228
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 229 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 256
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 246
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVER---MNY 301
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 355
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 403
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C PE+RP L
Sbjct: 404 PECPESLH-------------DLMCQCWRKEPEERPTFEYL 431
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 246
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVER---MNY 301
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 355
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 403
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C PE+RP L
Sbjct: 404 PECPESLH-------------DLMCQCWRKEPEERPTFEYL 431
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 73
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 74 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVER---MNY 128
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 182
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 183 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 230
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C PE+RP L
Sbjct: 231 PECPESLH-------------DLMCQCWRKEPEERPTFEYL 258
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQL--YA 247
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 248 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 302
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG R+++ + TA QG I + APE A
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIE------DNEYTARQGAKFPIKWTAPEAALY 356
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 357 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 404
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 405 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 432
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 329
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVER---MNY 384
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 438
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 486
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C PE+RP L
Sbjct: 487 PECPESLH-------------DLMCQCWRKEPEERPTFEYL 514
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 62 RHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 116
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ---G 184
+DYLH+ I+H D+K +NI L D + DFG + ++ S S F+ G
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSG 168
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 77
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 78 VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLR--LPQLVDMSAQIASGMAYVER---MNY 132
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEWTARQGAKFPIKWTAPEAALY 186
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 187 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 234
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C PE+RP L
Sbjct: 235 PECPESLH-------------DLMCQCWRKEPEERPTFEYL 262
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 77
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 78 VVSEEPIYIVTEYMNKGSLLDFLKGETGKYLR--LPQLVDMSAQIASGMAYVER---MNY 132
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 186
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 187 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 234
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C PE+RP L
Sbjct: 235 PECPESLH-------------DLMCQCWRKEPEERPTFEYL 262
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+++H LV++ YA
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKIRHEKLVQL--YA 80
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 81 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 135
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 189
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 237
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 238 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 265
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 80
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 81 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 135
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D+ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 189
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 237
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 238 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 265
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 246
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 247 VVSEEPIYIVGEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVER---MNY 301
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 355
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 403
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C PE+RP L
Sbjct: 404 PECPESLH-------------DLMCQCWRKEPEERPTFEYL 431
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 80
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM G L + G + R LP+ +D+ +A+G+ Y+ +
Sbjct: 81 VVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLR--LPQLVDMAAQIASGMAYVER---MNY 135
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + TA QG I + APE A
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 189
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-GVRQITD 255
T K DV+SFGI++ E TK R + +V + + + + G R
Sbjct: 190 GRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVNREVLDQVERGYRMPCP 237
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ S++ L C +PE+RP L
Sbjct: 238 PECPESLH-------------DLMCQCWRKDPEERPTFEYL 265
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 62 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 116
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ---G 184
+DYLH+ I+H D+K +NI L D + DFG + ++ S S F+ G
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSG 168
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 91.3 bits (225), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 9 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 67 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 121
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ---G 184
+DYLH+ I+H D+K +NI L D + DFG + ++ S S F+ G
Sbjct: 122 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSG 173
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 91.3 bits (225), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 18 NIIGNSNLSTVYKGRLE-DGE---IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
IIG+ + V GRL G+ VA+K L ++ + F EA + + H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ G G+L ++ EYMENGSL++ + ++T+ + + +L V G+ YL
Sbjct: 114 RLEGVV-TRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLS- 168
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
D+ VH D+ N+L+D + VSDFG SR+L+ D + +T + I + APE
Sbjct: 169 --DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAXTTTGGKIPIRWTAPEA 225
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLT 217
R ++ DV+SFG+V+ E L
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 91.3 bits (225), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 9 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 67 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 121
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ---G 184
+DYLH+ I+H D+K +NI L D + DFG + ++ S S F+ G
Sbjct: 122 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSG 173
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 91.3 bits (225), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 6 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 63
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 64 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 118
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ---G 184
+DYLH+ I+H D+K +NI L D + DFG + ++ S S F+ G
Sbjct: 119 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSG 170
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 171 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 91.3 bits (225), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 67/221 (30%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 62 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 116
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG----TSRMLDVHLQDLSSLSTAFQ 183
+DYLH+ I+H D+K +NI L D + DFG SR H LS
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH--QFEQLS---- 167
Query: 184 GTIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
G+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 67/221 (30%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 24 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 81
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 82 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 136
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG----TSRMLDVHLQDLSSLSTAFQ 183
+DYLH+ I+H D+K +NI L D + DFG SR H LS
Sbjct: 137 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH--QFEQLS---- 187
Query: 184 GTIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
G+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 188 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 90.9 bits (224), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 32 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 90 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 144
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ---G 184
+DYLH+ I+H D+K +NI L D + DFG + ++ S S F+ G
Sbjct: 145 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSG 196
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 197 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 90.9 bits (224), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 31 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 88
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 89 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 143
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ---G 184
+DYLH+ I+H D+K +NI L D + DFG + ++ S S F+ G
Sbjct: 144 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSG 195
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 196 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 90.9 bits (224), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 23/217 (10%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G + IG+ + TVYKG+ VAVK LN + + ++F E L++ +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++ +GY+ + A++ ++ E SL +H +++ + K ID+ A G+DYL
Sbjct: 82 ILLFMGYS--TAPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG----TSRMLDVHLQDLSSLSTAFQGTIG 187
H+ I+H D+K +NI L D + DFG SR H LS G+I
Sbjct: 137 HAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH--QFEQLS----GSIL 187
Query: 188 YLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 90.9 bits (224), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 67/221 (30%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G + IG+ + TVYKG+ VAVK LN + + ++F E L++
Sbjct: 32 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++ +GY+ + A++ ++ E SL +H + +++ + K ID+ A G
Sbjct: 90 RHVNILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQG 144
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG----TSRMLDVHLQDLSSLSTAFQ 183
+DYLH+ I+H D+K +NI L D + DFG SR H LS
Sbjct: 145 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH--QFEQLS---- 195
Query: 184 GTIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
G+I ++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 90.9 bits (224), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 18 NIIGNSNLSTVYKGRLE-DGE---IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
IIG+ + V GRL G+ VA+K L ++ + F EA + + H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ G G+L ++ EYMENGSL++ + ++T+ + + +L V G+ YL
Sbjct: 114 RLEGVV-TRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLS- 168
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
D+ VH D+ N+L+D + VSDFG SR+L+ D + +T + I + APE
Sbjct: 169 --DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWTAPEA 225
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLT 217
R ++ DV+SFG+V+ E L
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 23/217 (10%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G + IG+ + TVYKG+ VAVK LN + + ++F E L++ +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++ +GY+ + A++ ++ E SL +H +++ + K ID+ A G+DYL
Sbjct: 82 ILLFMGYS--TKPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG----TSRMLDVHLQDLSSLSTAFQGTIG 187
H+ I+H D+K +NI L D + DFG SR H LS G+I
Sbjct: 137 HAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH--QFEQLS----GSIL 187
Query: 188 YLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
++APE M+ + + DV++FGIV+ E +T + P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 21/216 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G + IG+ + TVYKG+ VAVK LN + + ++F E L++ +H N
Sbjct: 12 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 69
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++ +GY+ + A++ ++ E SL +H +++ + K ID+ A G+DYL
Sbjct: 70 ILLFMGYS--TKPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYL 124
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ---GTIGY 188
H+ I+H D+K +NI L D + DFG + ++ S S F+ G+I +
Sbjct: 125 HAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILW 176
Query: 189 LAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
+APE M+ + + DV++FGIV+ E +T + P
Sbjct: 177 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 88.2 bits (217), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 106/195 (54%), Gaps = 19/195 (9%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
E GE++ +K+L +F E+ ++F +E K ++ L+H N++K +G ++ +L I EY+
Sbjct: 33 ETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN-FITEYI 89
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ G+L +I +D S++ +R+ +A+G+ YLHS + I+H D+ N L+
Sbjct: 90 KGGTLRGIIKS--MD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRE 143
Query: 154 DFEAHVSDFGTSRML---DVHLQDLSSLSTAFQ-------GTIGYLAPEFAYMRIVTTKV 203
+ V+DFG +R++ + L SL + G ++APE R KV
Sbjct: 144 NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203
Query: 204 DVFSFGIVVMEFLTK 218
DVFSFGIV+ E + +
Sbjct: 204 DVFSFGIVLCEIIGR 218
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+GN V+ G VA+K L S ES F EA+ +K+LKH LV++ YA
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES---FLEEAQIMKKLKHDKLVQL--YA 71
Query: 80 WESGKLKALILEYMENGSLESVIH-GPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
S + ++ EYM GSL + G G LP +D+ VA G+ Y+ +
Sbjct: 72 VVSEEPIYIVTEYMNKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIER---MN 125
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAY 195
+H D++ +NIL+ ++DFG +R+++ + TA QG I + APE A
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIE------DNEXTARQGAKFPIKWTAPEAAL 179
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRR 220
T K DV+SFGI++ E +TK R
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGR 204
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 161 KYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 34 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFD 92
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 93 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 148
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 149 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 202
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 85.5 bits (210), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFD 75
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 76 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 131
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 185
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 109/205 (53%), Gaps = 15/205 (7%)
Query: 19 IIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+IG V +GRL+ VA+K L ++ + F EA + + +H N+++
Sbjct: 23 VIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-GGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 75 VLGYAWESGKLKALIL-EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ G + + +IL E+MENG+L+S + ++ ++T+ + + +L +A+G+ YL
Sbjct: 82 LEGVV--TNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLA- 135
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGTIGYLAPE 192
++ VH D+ NIL++ + VSDFG SR L+ + D + S+ + I + APE
Sbjct: 136 --EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLT 217
R T+ D +S+GIV+ E ++
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMS 218
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 44 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 102
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 103 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 158
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 159 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 212
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 110/206 (53%), Gaps = 17/206 (8%)
Query: 19 IIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+IG V +GRL+ VA+K L ++ + F EA + + +H N+++
Sbjct: 21 VIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-GGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 75 VLGYAWESGKLKALIL-EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ G + + +IL E+MENG+L+S + ++ ++T+ + + +L +A+G+ YL
Sbjct: 80 LEGVV--TNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLA- 133
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAP 191
++ VH D+ NIL++ + VSDFG SR L+ + D + +++ G I + AP
Sbjct: 134 --EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD-PTYTSSLGGKIPIRWTAP 190
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLT 217
E R T+ D +S+GIV+ E ++
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMS 216
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 84.3 bits (207), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 6 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 60
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 61 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 115
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 116 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEXTA 166
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 222
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ + ++L +C PEDRP + L
Sbjct: 223 LER----GYRMVRPDNCPEEL----------------YQLMRLCWKERPEDRPTFDYL 260
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 7 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 61
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 62 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 116
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 117 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEXTA 167
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 168 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 223
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ ++L +C PEDRP + L
Sbjct: 224 LER----GYRMVRPDNCPE----------------ELYQLMRLCWKERPEDRPTFDYL 261
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 12 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 66
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 67 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 121
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 122 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEXTA 172
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 173 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 228
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ + ++L +C PEDRP + L
Sbjct: 229 LER----GYRMVRPDNCPEEL----------------YQLMRLCWKERPEDRPTFDYL 266
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 6 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 60
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 61 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 115
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 116 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEXTA 166
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 222
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ ++L +C PEDRP + L
Sbjct: 223 LER----GYRMVRPDNCPE----------------ELYQLMRLCWKERPEDRPTFDYL 260
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 15 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 69
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 70 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 124
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 125 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEXTA 175
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 176 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 231
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G R + +Y +L +C PEDRP + L
Sbjct: 232 LER-------GYRMVRPDNCPEELY-------------QLMRLCWKERPEDRPTFDYL 269
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 14 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 68
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 69 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 123
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 124 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEXTA 174
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 175 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 230
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ + ++L +C PEDRP + L
Sbjct: 231 LER----GYRMVRPDNCPEEL----------------YQLMRLCWKERPEDRPTFDYL 268
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 84.0 bits (206), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 8 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 62
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 63 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 117
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 118 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEXTA 168
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 169 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 224
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ ++L +C PEDRP + L
Sbjct: 225 LER----GYRMVRPDNCPE----------------ELYQLMRLCWKERPEDRPTFDYL 262
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 84.0 bits (206), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG +R+L+ D + T G I
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLARVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 84.0 bits (206), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 6 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 60
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 61 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 115
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 116 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEYTA 166
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 222
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ ++L +C PEDRP + L
Sbjct: 223 LER----GYRMVRPDNCPE----------------ELYQLMRLCWKERPEDRPTFDYL 260
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 84.0 bits (206), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 1 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 55
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 56 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 110
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 111 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEYTA 161
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 162 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 217
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ ++L +C PEDRP + L
Sbjct: 218 LER----GYRMVRPDNCPE----------------ELYQLMRLCWKERPEDRPTFDYL 255
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 74/226 (32%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY----REAKTLKELKHRNLV 73
I+G +S V+ R L D VAVK L + D SFY REA+ L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 74 KV--LGYA-WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVANGLD 129
V G A +G L +++EY++ +L ++H G PKR I+V+ L+
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALN 130
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ H I+H D+KP+NIL+ V DFG +R + + + A GT YL
Sbjct: 131 FSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ-TAAVIGTAQYL 186
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+PE A V + DV+S G V+ E LT P G SP+S+
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSV 227
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 73/226 (32%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY----REAKTLKELKHRNLV 73
I+G +S V+ R L D VAVK L + D SFY REA+ L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 74 KV--LGYA-WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVANGLD 129
V G A +G L +++EY++ +L ++H G PKR I+V+ L+
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALN 130
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ H I+H D+KP+NI++ V DFG +R + ++ + A GT YL
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYL 186
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+PE A V + DV+S G V+ E LT P G SP+S+
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSV 227
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 12 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 66
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 67 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 121
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 122 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEYTA 172
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 173 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 228
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ + ++L +C PEDRP + L
Sbjct: 229 LER----GYRMVRPDNCPEEL----------------YQLMRLCWKERPEDRPTFDYL 266
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 16 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 70
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 71 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 125
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 126 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEYTA 176
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 177 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 232
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ + ++L +C PEDRP + L
Sbjct: 233 LER----GYRMVRPDNCPEEL----------------YQLMRLCWKERPEDRPTFDYL 270
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 83/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D E+ T E +G V+ G VAVK L Q S D +F EA
Sbjct: 11 DEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEAN 65
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVL 121
+K+L+H+ LV++ YA + + +I EYMENGSL + P G+ + T+ K +D+
Sbjct: 66 LMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMA 120
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+ ++ + +H D++ +NIL+ ++DFG +R+++ + TA
Sbjct: 121 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE------DNEYTA 171
Query: 182 FQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+G I + APE T K DV+SFGI++ E +T G G++ + Q
Sbjct: 172 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQN 227
Query: 239 VEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
+E+ G VR P+ + ++L +C PEDRP + L
Sbjct: 228 LER----GYRMVRPDNCPEEL----------------YQLMRLCWKERPEDRPTFDYL 265
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 18 NIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG V GRL+ EI VA+K L ++ + + F EA + + H N++
Sbjct: 35 KVIGVGEFGEVCSGRLKVPGKREICVAIKTLK-AGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ G + K +I EYMENGSL++ + + R+T+ + + +L + +G+ YL
Sbjct: 94 HLEGVVTKC-KPVMIITEYMENGSLDAFLRK---NDGRFTVIQLVGMLRGIGSGMKYLS- 148
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAP 191
D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I + AP
Sbjct: 149 --DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE---DDPEAAYTTRGGKIPIRWTAP 203
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLT 217
E R T+ DV+S+GIV+ E ++
Sbjct: 204 EAIAYRKFTSASDVWSYGIVMWEVMS 229
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 18 NIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG V GRL+ EI VA+K L ++ + + F EA + + H N++
Sbjct: 20 KVIGVGEFGEVCSGRLKVPGKREICVAIKTLK-AGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ G + K +I EYMENGSL++ + + R+T+ + + +L + +G+ YL
Sbjct: 79 HLEGVVTKC-KPVMIITEYMENGSLDAFLRK---NDGRFTVIQLVGMLRGIGSGMKYLS- 133
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAP 191
D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I + AP
Sbjct: 134 --DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE---DDPEAAYTTRGGKIPIRWTAP 188
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLT 217
E R T+ DV+S+GIV+ E ++
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMS 214
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ EYMENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG R+L+ D + T G I
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 79/281 (28%), Positives = 131/281 (46%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VAVK L Q S D +F EA +K+L+H+ LV++ YA
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEANLMKQLQHQRLVRL--YA 75
Query: 80 WESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ + +I EYMENGSL + P G+ + T+ K +D+ +A G+ ++ +
Sbjct: 76 VVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAY 195
+H D++ +NIL+ ++DFG +R+++ + TA +G I + APE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE------DAEXTAREGAKFPIKWTAPEAIN 183
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255
T K DV+SFGI++ E +T G G++ + Q +E+ G VR
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQNLER----GYRMVRPDNC 235
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ + ++L +C PEDRP + L
Sbjct: 236 PEEL----------------YQLMRLCWKERPEDRPTFDYL 260
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 83.2 bits (204), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 18 NIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG V GRL+ EI VA+K L ++ + + F EA + + H N++
Sbjct: 14 KVIGVGEFGEVCSGRLKVPGKREICVAIKTLK-AGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ G + K +I EYMENGSL++ + + R+T+ + + +L + +G+ YL
Sbjct: 73 HLEGVVTKC-KPVMIITEYMENGSLDAFLRK---NDGRFTVIQLVGMLRGIGSGMKYLS- 127
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAP 191
D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I + AP
Sbjct: 128 --DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLE---DDPEAAYTTRGGKIPIRWTAP 182
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLT 217
E R T+ DV+S+GIV+ E ++
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMS 208
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ + TVYKG+ VAVK L + E ++F E L++ +H N++ +GY
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ A++ ++ E SL +H V +++ + + ID+ A G+DYLH+ I
Sbjct: 102 TKDNL--AIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHAK---NI 153
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ------GTIGYLAPEF 193
+H DMK +NI L + DFG L + S + Q G++ ++APE
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFG--------LATVKSRWSGSQQVEQPTGSVLWMAPEV 205
Query: 194 AYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
M+ + + DV+S+GIV+ E +T P
Sbjct: 206 IRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 34 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 92
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 93 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 145
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 146 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAKLPV 200
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 36 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 94
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 95 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 147
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR-MLDVHLQDLSSLSTAFQGTIG 187
+L S VH D+ N +LD F V+DFG +R MLD + + T + +
Sbjct: 148 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHN-KTGAKLPVK 203
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY----REAKTLKELKHRNLV 73
I+G +S V+ R L D VAVK L + D SFY REA+ L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 74 KV--LGYA-WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVANGLD 129
V G A +G L +++EY++ +L ++H G PKR I+V+ L+
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALN 130
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ H I+H D+KP+NI++ V DFG +R + ++ + A GT YL
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYL 186
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+PE A V + DV+S G V+ E LT P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 71/287 (24%), Positives = 130/287 (45%), Gaps = 37/287 (12%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 27 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 87 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 139
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 140 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 191
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
E + + D++S G+ ++E R P G +G +++ +L++ +
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG----SGSGSMAIFELLDYIVNE------ 241
Query: 252 QITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
PKL S ++ C NP +R ++ +L++
Sbjct: 242 --PPPKLPSGVFSLEFQDFVNK--------CLIKNPAERADLKQLMV 278
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 53 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 111
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 164
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 165 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 219
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 220 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 18 NIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG V G L+ EI VA+K L ++ + + F EA + + H N++
Sbjct: 39 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ G +S + +I E+MENGSL+S + + ++T+ + + +L +A G+ YL
Sbjct: 98 HLEGVVTKSTPV-MIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLA- 152
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAP 191
D+ VH D+ NIL++ + VSDFG SR L+ D + ++A G I + AP
Sbjct: 153 --DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSALGGKIPIRWTAP 209
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLT 217
E R T+ DV+S+GIV+ E ++
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMS 235
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 27 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 85
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 86 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 138
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 139 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 193
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/289 (24%), Positives = 131/289 (45%), Gaps = 35/289 (12%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 68 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 121 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 172
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE--ENGLSPISLRQLVEKALANGING 249
E + + D++S G+ ++E R P + E+ P+++ +L++ +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNE---- 228
Query: 250 VRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
PKL S ++ C NP +R ++ +L++
Sbjct: 229 ----PPPKLPSGVFSLEFQDFVNK--------CLIKNPAERADLKQLMV 265
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 54 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 112
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 165
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 166 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 220
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 221 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 90
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 143
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 144 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 198
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 93
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 94 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 146
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 147 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 201
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 82.0 bits (201), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 34 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 92
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 93 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 145
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 146 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 200
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 82.0 bits (201), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R ++ + I+A+K L F A+ +K+ RE +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVL----FKAQLEKAGVEHQLRREVEI 61
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY +S ++ LILEY G++ + S++ + +
Sbjct: 62 QSHLRHPNILRLYGYFHDSTRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS A
Sbjct: 117 LANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRAALC 167
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ E MENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEXMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 161 KYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 33 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 91
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 92 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 144
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 145 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 199
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 152
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 205
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
+L S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 206 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPV 260
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFD 75
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ E MENGSL+S + +++T+ + + +L +A+G+
Sbjct: 76 HPNIIRLEGVVTKS-KPVMIVTEXMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 131
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 185
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 93
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 94 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 146
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 147 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 201
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 88
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 141
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 142 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPV 196
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 66
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G + + S++ + +
Sbjct: 67 QSHLRHPNILRLYGYFHDATRV-YLILEYAPRGEVYKELQ----KLSKFDEQRTATYITE 121
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 122 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 172
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/211 (30%), Positives = 111/211 (52%), Gaps = 17/211 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+ S + ++G V GRL+ EI VA+K L ++ + + F EA + +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFD 104
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N++++ G +S K ++ E MENGSL+S + +++T+ + + +L +A+G+
Sbjct: 105 HPNIIRLEGVVTKS-KPVMIVTEXMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGM 160
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG- 187
YL D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPI 214
Query: 188 -YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ +PE R T+ DV+S+GIV+ E ++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 45/281 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VAVK L Q S D +F EA +K+L+H+ LV++ YA
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPD-AFLAEANLMKQLQHQRLVRL--YA 71
Query: 80 WESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ + +I EYMENGSL + P G+ + T+ K +D+ +A G+ ++ +
Sbjct: 72 VVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIE---ERN 125
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAY 195
+H +++ +NIL+ ++DFG +R+++ + TA +G I + APE
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIE------DNEYTAREGAKFPIKWTAPEAIN 179
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255
T K DV+SFGI++ E +T G G++ + Q +E+ G VR
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTH----GRIPYPGMTNPEVIQNLER----GYRMVRPDNC 231
Query: 256 PKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+ ++L +C PEDRP + L
Sbjct: 232 PE----------------ELYQLMRLCWKERPEDRPTFDYL 256
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 33 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 91
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 92 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 144
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
+L S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 145 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPV 199
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 36 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 94
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 95 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 147
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
+L S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 148 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPV 202
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 93
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 94 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 146
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
+L S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 147 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPV 201
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 6 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 60
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 61 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI--- 117
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 118 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 171
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 73/295 (24%), Positives = 130/295 (44%), Gaps = 40/295 (13%)
Query: 13 SFSENNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELK 68
F+ ++G +V + +L EDG V AVK L ++ + F REA +KE
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 69 HRNLVKVLGYAWES---GKL--KALILEYMENGSLESVIHGPGVDHSRWTLPKR--IDVL 121
H ++ K++G + S G+L +IL +M++G L + + + + + LP + + +
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ +A G++YL S +H D+ N +L D V+DFG SR ++ D A
Sbjct: 144 VDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYRQGCA 198
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+ + +LA E + T DV++FG+ + E +T+ + EN +
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----------E 247
Query: 242 ALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
I G R P+ + +Y L C S++P+ RP+ L
Sbjct: 248 IYNYLIGGNRLKQPPECMEEVY-------------DLMYQCWSADPKQRPSFTCL 289
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 93
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 94 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 146
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
+L S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 147 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPV 201
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 17 NNIIGNSNLSTVYKGRL--EDGEIV--AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L DG+ + AVK LN E + F E +K+ H N+
Sbjct: 40 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 98
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGL 128
+ +LG S ++L YM++G L + I H P T+ I + VA G+
Sbjct: 99 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGM 151
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL--STAFQGTI 186
+L S VH D+ N +LD F V+DFG +R D++ ++ S+ T + +
Sbjct: 152 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPV 206
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 207 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 87
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 88 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 142
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 143 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 193
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 17/205 (8%)
Query: 19 IIGNSNLSTVYKGRLE-DGE---IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+IG V GRL+ G+ VA+K L ++ + + F EA + + H N+V
Sbjct: 50 VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG-YTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G GK +++E+MENG+L++ + ++T+ + + +L +A G+ YL
Sbjct: 109 LEGVV-TRGKPVMIVIEFMENGALDAFLRK---HDGQFTVIQLVGMLRGIAAGMRYLA-- 162
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAPE 192
D+ VH D+ NIL++ + VSDFG SR+++ D ++ T G I + APE
Sbjct: 163 -DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE---DDPEAVYTTTGGKIPVRWTAPE 218
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLT 217
R T+ DV+S+GIV+ E ++
Sbjct: 219 AIQYRKFTSASDVWSYGIVMWEVMS 243
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 74/280 (26%), Positives = 128/280 (45%), Gaps = 41/280 (14%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G+ V G+ + VAVK + + + S+ F++EA+T+ +L H LVK G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 80 WESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ + ++ EY+ NG L + + HG G++ S+ +++ V G+ +L S
Sbjct: 73 SKEYPI-YIVTEYISNGCLLNYLRSHGKGLEPSQ-----LLEMCYDVCEGMAFLESH--- 123
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
+H D+ N L+DRD VSDFG +R + + Q +SS+ T F + + APE +
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKF--PVKWSAPEVFHYF 180
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257
++K DV++FGI++ E + G P L E L ++ ++ P
Sbjct: 181 KYSSKSDVWAFGILMWEVFSL----------GKMPYDLYTNSEVVLK--VSQGHRLYRPH 228
Query: 258 LVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
L S +++ C PE RP +LL
Sbjct: 229 LASD------------TIYQIMYSCWHELPEKRPTFQQLL 256
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 61
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 62 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 117 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 167
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 1 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 55
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 56 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 112
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 113 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 166
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 2 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 56
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 57 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 113
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 114 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 167
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 168 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 78
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 79 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 133
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 134 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 184
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 3 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 57
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 114
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 115 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 168
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 7 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 61
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 62 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 118
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 119 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 172
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 173 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 17/205 (8%)
Query: 19 IIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+IG V GRL+ E+ VA+K L ++ + + F EA + + H N++
Sbjct: 29 VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G +S K ++ EYMENGSL++ + + ++T+ + + +L ++ G+ YL
Sbjct: 88 LEGVVTKS-KPVMIVTEYMENGSLDTFLKK---NDGQFTVIQLVGMLRGISAGMKYLS-- 141
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAPE 192
D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I + APE
Sbjct: 142 -DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPIRWTAPE 197
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLT 217
R T+ DV+S+GIV+ E ++
Sbjct: 198 AIAFRKFTSASDVWSYGIVMWEVVS 222
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 64
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 65 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 119
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS A
Sbjct: 120 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRAALC 170
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 66
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 67 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 121
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 122 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 172
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 61
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 62 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 117 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTELC 167
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 9 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 63
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 64 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 120
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 121 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 174
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 175 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 64
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 65 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 119
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 120 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 170
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 3 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 57
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 114
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 115 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 168
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 8 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 62
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 63 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 119
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 120 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 173
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 174 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 20 IGNSNLSTVYKGRLEDGE-IVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLG 77
+G VY R + I+A+K L Q A + RE + L+H N++++ G
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
Y ++ ++ LILEY G++ + SR+ + + +AN L Y HS
Sbjct: 80 YFHDATRV-YLILEYAPLGTVYRELQ----KLSRFDEQRTATYITELANALSYCHSKR-- 132
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
++H D+KP N+LL + E ++DFG S VH SS T GT+ YL PE R
Sbjct: 133 -VIHRDIKPENLLLGSNGELKIADFGWS----VHAP--SSRRTTLCGTLDYLPPEMIEGR 185
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP 221
+ KVD++S G++ EFL P
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPP 209
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQF-SAESDKSFYREAKTLKEL 67
A F +G VY R + + I+A+K L Q A + RE + L
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++++ GY ++ ++ LILEY G++ + S++ + + +AN
Sbjct: 70 RHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANA 124
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
L Y HS ++H D+KP N+LL E ++DFG S VH SS T GT+
Sbjct: 125 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLCGTLD 175
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
YL PE R+ KVD++S G++ EFL + P
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 61
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 62 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS A
Sbjct: 117 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRAALC 167
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 80.9 bits (198), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 6 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 60
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 61 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 117
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 118 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 171
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 34 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 88
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 145
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 146 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 199
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 200 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 10 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 64
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 65 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 121
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 122 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 175
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 176 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 60
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 61 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 115
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 116 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 166
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 3 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 57
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 114
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H D+ NIL++ + + DFG +++L +
Sbjct: 115 --KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDK 168
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 62
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 63 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 117
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S SS T
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS------CHAPSSRRTTLS 168
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 80.5 bits (197), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 61
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 62 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 117 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTXLC 167
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 80.5 bits (197), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 64
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 65 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 119
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 120 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 170
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 15 SENNIIGNSNLSTVYKGRLEDGE-----IVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
+ +IG VYKG L+ VA+K L ++ + F EA + + H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSH 105
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
N++++ G K +I EYMENG+L+ + + S L + +L +A G+
Sbjct: 106 HNIIRLEGVI-SKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLRGIAAGMK 161
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG-- 187
YL ++ VH D+ NIL++ + VSDFG SR+L+ D + T G I
Sbjct: 162 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE---DDPEATYTTSGGKIPIR 215
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ APE R T+ DV+SFGIV+ E +T
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 70/226 (30%), Positives = 105/226 (46%), Gaps = 26/226 (11%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY----REAKTLKELKHRNLV 73
I+G +S V+ R L VAVK L + D SFY REA+ L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRLHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 74 KVLGYA---WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVANGLD 129
V +G L +++EY++ +L ++H G PKR I+V+ L+
Sbjct: 76 AVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALN 130
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ H I+H D+KP+NI++ V DFG +R + ++ + A GT YL
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYL 186
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+PE A V + DV+S G V+ E LT P G SP+S+
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSV 227
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 62
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 63 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 117
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTDLC 168
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 61
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 62 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 117 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTDLC 167
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 66
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G + + S++ + +
Sbjct: 67 QSHLRHPNILRLYGYFHDATRV-YLILEYAPRGEVYKELQ----KLSKFDEQRTATYITE 121
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS
Sbjct: 122 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRXXLX 172
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 61
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 62 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 117 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTDLC 167
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVL----FKAQLEKAGVEHQLRREVEI 58
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 59 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 113
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 114 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 164
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 20 IGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLV 73
+G N +V R L+D GE+VAVKKL Q S E + F RE + LK L+H N+V
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 74 KVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDY 130
K G + +G+ LI+EY+ GSL + H +DH K + + G++Y
Sbjct: 93 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-----KLLQYTSQICKGMEY 147
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
L + +H D+ NIL++ + + DFG +++L ++ + + I + A
Sbjct: 148 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 203
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLT 217
PE + DV+SFG+V+ E T
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 20 IGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLV 73
+G N +V R L+D GE+VAVKKL Q S E + F RE + LK L+H N+V
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 74 KVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDY 130
K G + +G+ LI+EY+ GSL + H +DH K + + G++Y
Sbjct: 93 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-----KLLQYTSQICKGMEY 147
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
L + +H D+ NIL++ + + DFG +++L ++ + + I + A
Sbjct: 148 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYA 203
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLT 217
PE + DV+SFG+V+ E T
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 66
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 67 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 121
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 122 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTDLC 172
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 37/265 (13%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
EDG +K++N + S++ + RE L +KH N+V+ E+G L ++++Y
Sbjct: 47 EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL-YIVMDYC 105
Query: 94 ENGSLESVIHG-PGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
E G L I+ GV + +D + + L ++H D I+H D+K NI L
Sbjct: 106 EGGDLFKRINAQKGVLFQEDQI---LDWFVQICLALKHVH---DRKILHRDIKSQNIFLT 159
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
+D + DFG +R+L+ ++ L+ A GT YL+PE + K D+++ G V+
Sbjct: 160 KDGTVQLGDFGIARVLNSTVE----LARACIGTPYYLSPEICENKPYNNKSDIWALGCVL 215
Query: 213 MEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXX 272
E T + + S++ LV K ++ V S++
Sbjct: 216 YELCTLK--------HAFEAGSMKNLVLKIISGSFPPV----------SLHYSYDLRSLV 257
Query: 273 XXXFKLALVCTSSNPEDRPNMNELL 297
FK NP DRP++N +L
Sbjct: 258 SQLFK-------RNPRDRPSVNSIL 275
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/226 (31%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY----REAKTLKELKHRNLV 73
I+G +S V+ R L VAVK L + D SFY REA+ L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRLHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 74 KV--LGYA-WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVANGLD 129
V G A +G L +++EY++ +L ++H G PKR I+V+ L+
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALN 130
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ H I+H D+KP+NI++ V DFG +R + ++ + A GT YL
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYL 186
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+PE A V + DV+S G V+ E LT P G SP+S+
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSV 227
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+D +VAVK L S + K F+REA+ L L+H ++VK G E L ++ EYM
Sbjct: 41 QDKILVAVKTLK--DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL-IMVFEYM 97
Query: 94 ENGSLESVI--HGP-------GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
++G L + HGP G + T + + + +A G+ YL S + VH D+
Sbjct: 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDL 154
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N L+ + + DFG SR DV+ D + I ++ PE R TT+ D
Sbjct: 155 ATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 212
Query: 205 VFSFGIVVMEFLT 217
V+S G+V+ E T
Sbjct: 213 VWSLGVVLWEIFT 225
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 18 NIIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG V G L+ EI VA+K L ++ + + F EA + + H N++
Sbjct: 13 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ G +S + +I E+MENGSL+S + + ++T+ + + +L +A G+ YL
Sbjct: 72 HLEGVVTKSTPV-MIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLA- 126
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAP 191
D+ VH + NIL++ + VSDFG SR L+ D + ++A G I + AP
Sbjct: 127 --DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSALGGKIPIRWTAP 183
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLT 217
E R T+ DV+S+GIV+ E ++
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMS 209
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/226 (31%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY----REAKTLKELKHRNLV 73
I+G +S V+ R L VAVK L + D SFY REA+ L H +V
Sbjct: 36 ILGFGGMSEVHLARDLRLHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIV 92
Query: 74 KVL--GYA-WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVANGLD 129
V G A +G L +++EY++ +L ++H G PKR I+V+ L+
Sbjct: 93 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALN 147
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ H I+H D+KP+NI++ V DFG +R + ++ + A GT YL
Sbjct: 148 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYL 203
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+PE A V + DV+S G V+ E LT P G SP+S+
Sbjct: 204 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSV 244
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 66
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 67 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 121
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS T
Sbjct: 122 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRTTLC 172
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R KVD++S G++ EFL + P
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 20 IGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLV 73
+G N +V R L+D GE+VAVKKL Q S E + F RE + LK L+H N+V
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 74 KVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDY 130
K G + +G+ LI+E++ GSL + H +DH K + + G++Y
Sbjct: 78 KYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI-----KLLQYTSQICKGMEY 132
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
L + +H D+ NIL++ + + DFG +++L ++ + + I + A
Sbjct: 133 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYA 188
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLT 217
PE + DV+SFG+V+ E T
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 64
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 65 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 119
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E +++FG S VH SS T
Sbjct: 120 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWS----VHAP--SSRRTTLC 170
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 63
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 64 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 118
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E +++FG S VH SS T
Sbjct: 119 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWS----VHAP--SSRRTTLC 169
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 80/301 (26%), Positives = 125/301 (41%), Gaps = 49/301 (16%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
E G+F + + NLS +D +VAVK L +A D F REA+ L L
Sbjct: 22 ELGEGAFGKVFLAECYNLSPT-----KDKMLVAVKALKDPTLAARKD--FQREAELLTNL 74
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPG----VD------HSRWTLP 115
+H ++VK G + L ++ EYM++G L + HGP VD L
Sbjct: 75 QHEHIVKFYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 116 KRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ + + +A+G+ YL S + VH D+ N L+ + + DFG SR DV+ D
Sbjct: 134 QMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDY 188
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+ I ++ PE R TT+ DV+SFG+++ E T G P
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT----------YGKQP--W 236
Query: 236 RQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNE 295
QL + I R + P++ + + L C P+ R N+ E
Sbjct: 237 FQLSNTEVIECITQGRVLERPRVCPK------------EVYDVMLGCWQREPQQRLNIKE 284
Query: 296 L 296
+
Sbjct: 285 I 285
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 38/237 (16%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVK--KLNFHQFSAESDKSFYREAKT 63
EI+ A + E IIG VY+ G+ VAVK + + + +++ ++ +EAK
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVL 121
LKH N++ + G + L L++E+ G L V+ G KRI D+L
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLSG-----------KRIPPDIL 107
Query: 122 IS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE--------AHVSDFGTSRMLD 169
++ +A G++YLH +PI+H D+K SNIL+ + E ++DFG +R
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--- 164
Query: 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLD 225
+ +S A G ++APE + + DV+S+G+++ E LT P G+D
Sbjct: 165 -EWHRTTKMSAA--GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 63
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 64 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 118
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS
Sbjct: 119 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRXXLC 169
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 62
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 63 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 117
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRDTLC 168
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 61
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 62 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS
Sbjct: 117 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRXXLC 167
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESD-KS 56
D T+ E F + +G N +V R L+D GE+VAVKKL Q S E +
Sbjct: 4 DPTQFEERHLKFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRD 58
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWT 113
F RE + LK L+H N+VK G + +G+ LI+EY+ GSL + H +DH
Sbjct: 59 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 115
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
K + + G++YL + +H ++ NIL++ + + DFG +++L +
Sbjct: 116 --KLLQYTSQICKGMEYLGTKR---YIHRNLATRNILVENENRVKIGDFGLTKVLP-QDK 169
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + + I + APE + DV+SFG+V+ E T
Sbjct: 170 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 107
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 163
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 164 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 220
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 221 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 251
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 20 IGNSNLSTVYKGRLEDGE-IVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLG 77
+G VY R + I+A+K L Q A + RE + L+H N++++ G
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
Y ++ ++ LILEY G++ + SR+ + + +AN L Y HS
Sbjct: 80 YFHDATRV-YLILEYAPLGTVYRELQ----KLSRFDEQRTATYITELANALSYCHSKR-- 132
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
++H D+KP N+LL + E ++DFG S VH SS GT+ YL PE R
Sbjct: 133 -VIHRDIKPENLLLGSNGELKIADFGWS----VHAP--SSRRDTLCGTLDYLPPEMIEGR 185
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP 221
+ KVD++S G++ EFL P
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPP 209
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 70 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 130 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 182
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 183 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 234
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D++S G+ ++E R P
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 69/287 (24%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 11 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 71 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 123
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + ++ F GT Y++P
Sbjct: 124 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDEMANEFVGTRSYMSP 175
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
E + + D++S G+ ++E R P P+++ +L++ +
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPR--------PPMAIFELLDYIVNE------ 221
Query: 252 QITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
PKL S+++ C NP +R ++ +L++
Sbjct: 222 --PPPKLPSAVFSLEFQDFVNK--------CLIKNPAERADLKQLMV 258
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 87
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 88 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 142
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS
Sbjct: 143 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRDDLC 193
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKS-----FYREAKT 63
A F +G VY R + + I+A+K L F A+ +K+ RE +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQLRREVEI 64
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+H N++++ GY ++ ++ LILEY G++ + S++ + +
Sbjct: 65 QSHLRHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 119
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+AN L Y HS ++H D+KP N+LL E ++DFG S VH SS
Sbjct: 120 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRXXLC 170
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT+ YL PE R+ KVD++S G++ EFL + P
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 68 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 121 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 172
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D++S G+ ++E R P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 68 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 121 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 172
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D++S G+ ++E R P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 95 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 147
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 148 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 199
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D++S G+ ++E R P
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 68 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 121 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 172
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D++S G+ ++E R P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + +V +KL + RE + L E +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 68 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 121 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 172
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D++S G+ ++E R P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 78.2 bits (191), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 112/222 (50%), Gaps = 25/222 (11%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESD---KSFYREA 61
++++ + + + +G +TVYK R ++ +IVA+KK+ S D ++ RE
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV- 120
K L+EL H N++ +L + +L+ ++ME LE +I D+S P I
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNI-SLVFDFMET-DLEVIIK----DNSLVLTPSHIKAY 117
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
++ GL+YLH + I+H D+KP+N+LLD + ++DFG ++ S +
Sbjct: 118 MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-------SFGSPNR 167
Query: 181 AFQGTI---GYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTK 218
A+ + Y APE + R+ VD+++ G ++ E L +
Sbjct: 168 AYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 16/214 (7%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQF-SAESDKSFYREAKTLKEL 67
A F +G VY R + + I+A+K L Q A + RE + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H N++++ GY ++ ++ LILEY G++ + S++ + + +AN
Sbjct: 69 RHPNILRLYGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANA 123
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
L Y HS ++H D+KP N+LL E ++DFG S VH SS GT+
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS----VHAP--SSRRDDLCGTLD 174
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
YL PE R+ KVD++S G++ EFL + P
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 107
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 163
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 164 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 221 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 251
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 111
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 167
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 168 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 224
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 225 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 255
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 78.2 bits (191), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 109
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 165
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 166 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 222
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 223 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 253
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 77.8 bits (190), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 85
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 86 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 141
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 142 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 199 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 229
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 77.8 bits (190), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 152
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 208
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 209 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 265
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 266 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 296
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 77.8 bits (190), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 85
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 86 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 141
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 142 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 199 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 229
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 101
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 157
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 158 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 214
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 215 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 245
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 73
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 74 NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 129
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 187 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 217
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 77
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 78 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 133
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 134 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 190
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 191 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 221
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 92
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 93 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 148
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 149 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 205
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 206 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 236
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 73
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 129
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 187 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 217
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 81
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 82 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 137
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 138 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 194
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 195 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 225
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 78
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 79 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 134
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 135 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 191
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 192 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 222
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 77.8 bits (190), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 73
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 129
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 187 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 217
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 74
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 75 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 130
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 131 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 187
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 188 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 218
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 86
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 87 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 142
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 143 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 199
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 200 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 230
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 23/241 (9%)
Query: 5 TEIENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKT 63
T+ + G++ IG N + V R + G VAVK ++ Q + S + +RE +
Sbjct: 8 TDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRI 67
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
+K L H N+VK+ E+ K L++EY G + + V H R +
Sbjct: 68 MKILNHPNIVKLFE-VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQ 122
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ + + Y H Y IVH D+K N+LLD D ++DFG S V + L T F
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG----NKLDT-FC 174
Query: 184 GTIGYLAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
G+ Y APE F + +VDV+S G+++ ++ P D +N L++L E+
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERV 226
Query: 243 L 243
L
Sbjct: 227 L 227
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 31/216 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHR 70
S+++ +IGN + VY+ +L D GE+VA+KK+ DK F RE + +++L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 73
Query: 71 NLVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LI 122
N+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMY 129
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + +
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
+ Y APE + T+ +DV+S G V+ E L
Sbjct: 187 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELL 217
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 25/239 (10%)
Query: 20 IGNSNLSTVYKGRLEDGEI---VAVKKLNFH-QFSAESDKSFYREAKTLKELKHRNLVKV 75
+G +STVY ED + VA+K + + E+ K F RE +L H+N+V +
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG-LDYLHSG 134
+ E L++EY+E +L I G P +D I+ N LD +
Sbjct: 77 ID-VDEEDDCYYLVMEYIEGPTLSEYIESHG--------PLSVDTAINFTNQILDGIKHA 127
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+D+ IVH D+KP NIL+D + + DFG ++ L + + + GT+ Y +PE A
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS---ETSLTQTNHVLGTVQYFSPEQA 184
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR-QLVEKALANGINGVRQ 252
D++S GIV+ E L P NG + +S+ + ++ ++ N VR+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPF-----NGETAVSIAIKHIQDSVPNVTTDVRK 238
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/195 (31%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+D +VAVK L SA D F REA+ L L+H+++V+ G E G+ ++ EYM
Sbjct: 69 QDKMLVAVKALKEASESARQD--FQREAELLTMLQHQHIVRFFGVCTE-GRPLLMVFEYM 125
Query: 94 ENGSLESVI--HGPG---------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
+G L + HGP V L + + V VA G+ YL + VH
Sbjct: 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHR 182
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK 202
D+ N L+ + + DFG SR D++ D + I ++ PE R TT+
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 240
Query: 203 VDVFSFGIVVMEFLT 217
DV+SFG+V+ E T
Sbjct: 241 SDVWSFGVVLWEIFT 255
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/195 (31%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+D +VAVK L SA D F REA+ L L+H+++V+ G E G+ ++ EYM
Sbjct: 40 QDKMLVAVKALKEASESARQD--FQREAELLTMLQHQHIVRFFGVCTE-GRPLLMVFEYM 96
Query: 94 ENGSLESVI--HGPG---------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
+G L + HGP V L + + V VA G+ YL + VH
Sbjct: 97 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHR 153
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK 202
D+ N L+ + + DFG SR D++ D + I ++ PE R TT+
Sbjct: 154 DLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 211
Query: 203 VDVFSFGIVVMEFLT 217
DV+SFG+V+ E T
Sbjct: 212 SDVWSFGVVLWEIFT 226
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 62/195 (31%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+D +VAVK L SA D F REA+ L L+H+++V+ G E G+ ++ EYM
Sbjct: 46 QDKMLVAVKALKEASESARQD--FQREAELLTMLQHQHIVRFFGVCTE-GRPLLMVFEYM 102
Query: 94 ENGSLESVI--HGPG---------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
+G L + HGP V L + + V VA G+ YL + VH
Sbjct: 103 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHR 159
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK 202
D+ N L+ + + DFG SR D++ D + I ++ PE R TT+
Sbjct: 160 DLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 217
Query: 203 VDVFSFGIVVMEFLT 217
DV+SFG+V+ E T
Sbjct: 218 SDVWSFGVVLWEIFT 232
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 68/279 (24%), Positives = 129/279 (46%), Gaps = 39/279 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ V+ G + + VA+K + + A S++ F EA+ + +L H LV++ G
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
E + L+ E+ME+G L + + + + + V G+ YL + +
Sbjct: 72 LEQAPI-CLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRI 198
+H D+ N L+ + VSDFG +R + L D + ST + + + +PE F++ R
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
++K DV+SFG+++ E ++ + + N ++VE ++ G ++ P+L
Sbjct: 182 -SSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVED-ISTGF----RLYKPRL 228
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
S+ +++ C PEDRP + LL
Sbjct: 229 AST------------HVYQIMNHCWKERPEDRPAFSRLL 255
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 68/279 (24%), Positives = 129/279 (46%), Gaps = 39/279 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ V+ G + + VA+K + + A S++ F EA+ + +L H LV++ G
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
E + L+ E+ME+G L + + + + + V G+ YL + +
Sbjct: 72 LEQAPI-CLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EACV 124
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRI 198
+H D+ N L+ + VSDFG +R + L D + ST + + + +PE F++ R
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
++K DV+SFG+++ E ++ + + N ++VE ++ G ++ P+L
Sbjct: 182 -SSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVED-ISTGF----RLYKPRL 228
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
S+ +++ C PEDRP + LL
Sbjct: 229 AST------------HVYQIMNHCWKERPEDRPAFSRLL 255
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLSFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV--- 75
IGN V R G+ VA+KK+ + K RE K LK KH N++ +
Sbjct: 63 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 76 LGYAWESGKLKAL--ILEYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDY 130
L G+ K++ +L+ ME+ L +IH ++H R+ L + GL Y
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRY-------FLYQLLRGLKY 174
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
+HS ++H D+KPSN+L++ + E + DFG +R L + T + T Y A
Sbjct: 175 MHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 191 PEFAY-MRIVTTKVDVFSFGIVVMEFLTKRR 220
PE + T +D++S G + E L +R+
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ V+ G + + VA+K + + A S++ F EA+ + +L H LV++ G
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
E + L+ E+ME+G L + + TL + + + V G+ YL + +
Sbjct: 70 LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL---LGMCLDVCEGMAYLE---EACV 122
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRI 198
+H D+ N L+ + VSDFG +R + L D + ST + + + +PE F++ R
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
++K DV+SFG+++ E ++ G P R E + I+ ++ P+L
Sbjct: 180 -SSKSDVWSFGVLMWEVFSE----------GKIPYENRSNSE--VVEDISTGFRLYKPRL 226
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
S+ +++ C PEDRP + LL
Sbjct: 227 AST------------HVYQIMNHCWKERPEDRPAFSRLL 253
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 17/223 (7%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G N V K + ++ +KL + RE + L E +V G
Sbjct: 24 LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDI 137
+ G++ ++ +E+M+ GSL+ V+ +P+ I V I+V GL YL + I
Sbjct: 84 YSDGEI-SICMEHMDGGSLDQVLK------EAKRIPEEILGKVSIAVLRGLAYLREKHQI 136
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
+H D+KPSNIL++ E + DFG S L + S++ +F GT Y+APE
Sbjct: 137 --MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMAPERLQGT 188
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
+ + D++S G+ ++E R P + L I R +V+
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVD 231
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV--- 75
IGN V R G+ VA+KK+ + K RE K LK KH N++ +
Sbjct: 62 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 76 LGYAWESGKLKAL--ILEYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDY 130
L G+ K++ +L+ ME+ L +IH ++H R+ L + GL Y
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRY-------FLYQLLRGLKY 173
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
+HS ++H D+KPSN+L++ + E + DFG +R L + T + T Y A
Sbjct: 174 MHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 191 PEFAY-MRIVTTKVDVFSFGIVVMEFLTKRR 220
PE + T +D++S G + E L +R+
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 20 IGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+G N +V R + G +VAVK+L + + F RE + LK L +VK
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVK 72
Query: 75 VLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYL 131
G ++ G+ + L++EY+ +G L + H +D SR L + G++YL
Sbjct: 73 YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLL-----YSSQICKGMEYL 127
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
S VH D+ NIL++ + ++DFG +++L + +D + Q I + AP
Sbjct: 128 GSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDXXVVREPGQSPIFWYAP 183
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL--------VEKAL 243
E I + + DV+SFG+V+ E T D+ S LR + + + L
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFTY-----CDKSCSPSAEFLRMMGCERDVPALCRLL 238
Query: 244 ANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
G R P + ++ +L +C + +P+DRP+ + L
Sbjct: 239 ELLEEGQRLPAPPACPAEVH-------------ELMKLCWAPSPQDRPSFSAL 278
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 39/279 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ V+ G + + VA+K + + A S++ F EA+ + +L H LV++ G
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
E + L+ E+ME+G L + + + + + V G+ YL + +
Sbjct: 75 LEQAPI-CLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EACV 127
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRI 198
+H D+ N L+ + VSDFG +R + L D + ST + + + +PE F++ R
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 184
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
++K DV+SFG+++ E ++ G P R E + I+ ++ P+L
Sbjct: 185 -SSKSDVWSFGVLMWEVFSE----------GKIPYENRSNSE--VVEDISTGFRLYKPRL 231
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
S+ +++ C PEDRP + LL
Sbjct: 232 AST------------HVYQIMNHCWRERPEDRPAFSRLL 258
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 11 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 71 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 126
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 127 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 179
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 20 IGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+G N +V R + G +VAVK+L + + F RE + LK L +VK
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 75 VLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYL 131
G ++ G+ L++EY+ +G L + H +D SR L + G++YL
Sbjct: 76 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-----YSSQICKGMEYL 130
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
S VH D+ NIL++ + ++DFG +++L + +D + Q I + AP
Sbjct: 131 GSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWYAP 186
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL--------VEKAL 243
E I + + DV+SFG+V+ E T D+ S LR + + + L
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFTY-----CDKSCSPSAEFLRMMGSERDVPALSRLL 241
Query: 244 ANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
G R P + ++ +L +C + +P+DRP+ + L
Sbjct: 242 ELLEEGQRLPAPPACPAEVH-------------ELMKLCWAPSPQDRPSFSAL 281
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 63 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 171
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 11 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 71 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 126
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 127 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 179
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 20 IGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+G N +V R + G +VAVK+L + + F RE + LK L +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 75 VLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYL 131
G ++ G+ L++EY+ +G L + H +D SR L + G++YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-----YSSQICKGMEYL 143
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
S VH D+ NIL++ + ++DFG +++L + +D + Q I + AP
Sbjct: 144 GSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWYAP 199
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL--------VEKAL 243
E I + + DV+SFG+V+ E T D+ S LR + + + L
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTY-----CDKSCSPSAEFLRMMGCERDVPALSRLL 254
Query: 244 ANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
G R P + ++ +L +C + +P+DRP+ + L
Sbjct: 255 ELLEEGQRLPAPPACPAEVH-------------ELMKLCWAPSPQDRPSFSAL 294
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 63 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 171
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 29/215 (13%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
S+++ +IGN + VY+ +L D GE+VA+KK+ ++ K+ RE + +++L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKN--RELQIMRKLDHCN 74
Query: 72 LVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LIS 123
+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH---YSRAKQTLPV-IYVKLYMYQ 130
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTAF 182
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + + +
Sbjct: 131 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 183 QGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
Y APE + T+ +DV+S G V+ E L
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELL 217
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 29/215 (13%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
S+++ +IGN + VY+ +L D GE+VA+KK+ ++ K+ RE + +++L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKN--RELQIMRKLDHCN 74
Query: 72 LVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LIS 123
+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMYQ 130
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTAF 182
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + + +
Sbjct: 131 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 183 QGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
Y APE + T+ +DV+S G V+ E L
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELL 217
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 8 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 68 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 123
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 124 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 176
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 29/215 (13%)
Query: 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
S+++ +IGN + VY+ +L D GE+VA+KK+ ++ K+ RE + +++L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKN--RELQIMRKLDHCN 74
Query: 72 LVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LIS 123
+V++ + + SG+ K L+L+Y+ H ++ TLP I V +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---YSRAKQTLPV-IYVKLYMYQ 130
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTAF 182
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S + + +
Sbjct: 131 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 183 QGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
Y APE + T+ +DV+S G V+ E L
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELL 217
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 65 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 173
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L++ + + + LP L + GL +
Sbjct: 67 IVKLLDVIHTENKL-YLVFEFLHQ-DLKTFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 122
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 23/234 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G+ VAVK ++ Q ++ S + +RE + +K L H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
N+VK+ E+ K L++EY G + + V H R + + + + Y
Sbjct: 74 NIVKLFE-VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQY 128
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H + IVH D+K N+LLD D ++DFG S + AF G Y A
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-----TFGNKLDAFCGAPPYAA 180
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 226
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 39/279 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ V+ G + + VA+K + + A S++ F EA+ + +L H LV++ G
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
E + L+ E+ME+G L + + + + + V G+ YL + +
Sbjct: 73 LEQAPI-CLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRI 198
+H D+ N L+ + VSDFG +R + L D + ST + + + +PE F++ R
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
++K DV+SFG+++ E ++ G P R E + I+ ++ P+L
Sbjct: 183 -SSKSDVWSFGVLMWEVFSE----------GKIPYENRSNSE--VVEDISTGFRLYKPRL 229
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
S+ +++ C PEDRP + LL
Sbjct: 230 AST------------HVYQIMNHCWRERPEDRPAFSRLL 256
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L++ + + + LP L + GL +
Sbjct: 63 IVKLLDVIHTENKL-YLVFEHVHQ-DLKTFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 171
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 20 IGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+G N +V R + G +VAVK+L + + F RE + LK L +VK
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 75 VLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYL 131
G ++ G+ L++EY+ +G L + H +D SR L + G++YL
Sbjct: 77 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-----YSSQICKGMEYL 131
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
S VH D+ NIL++ + ++DFG +++L + +D + Q I + AP
Sbjct: 132 GSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWYAP 187
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL--------VEKAL 243
E I + + DV+SFG+V+ E T D+ S LR + + + L
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFTY-----CDKSCSPSAEFLRMMGCERDVPALCRLL 242
Query: 244 ANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
G R P + ++ +L +C + +P+DRP+ + L
Sbjct: 243 ELLEEGQRLPAPPACPAEVH-------------ELMKLCWAPSPQDRPSFSAL 282
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 67 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 122
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 63 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 171
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 67 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 122
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 6 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 66 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 121
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 174
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 63 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 171
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 6 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 66 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 121
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 174
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 65 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 173
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 8 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 68 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 123
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 124 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 176
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 65 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 173
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 6 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 66 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 121
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 122 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 174
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 65 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 121 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 173
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKDFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 74.3 bits (181), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E+++ L+ + + + LP L + GL +
Sbjct: 67 IVKLLDVIHTENKL-YLVFEHVDQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 122
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 74.3 bits (181), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
++G VY GR L + +A+K++ + + + + E K LKH+N+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-----SVANGLDYLH 132
E+G +K + +E + GSL +++ S+W K + I + GL YLH
Sbjct: 87 SFSENGFIK-IFMEQVPGGSLSALL------RSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 133 SGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
D IVH D+K N+L++ +SDFGTS+ L ++ + F GT+ Y+AP
Sbjct: 140 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK----RLAGINPCTETFTGTLQYMAP 192
Query: 192 EF--AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E R D++S G ++E T + P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 74.3 bits (181), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 23/234 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G+ VAVK ++ Q ++ S + +RE + +K L H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
N+VK+ E+ K L++EY G + + V H R + + + + Y
Sbjct: 74 NIVKLFE-VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQY 128
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H + IVH D+K N+LLD D ++DFG S + L T F G+ Y A
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG----NKLDT-FCGSPPYAA 180
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 226
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 74.3 bits (181), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 23/234 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G+ VAVK ++ Q ++ S + +RE + +K L H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
N+VK+ E+ K L++EY G + + V H R + + + + Y
Sbjct: 74 NIVKLFE-VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQY 128
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H + IVH D+K N+LLD D ++DFG S + L T F G+ Y A
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG----NKLDT-FCGSPPYAA 180
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 226
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
++G VY GR L + +A+K++ + + + + E K LKH+N+V+ LG
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-----SVANGLDYLH 132
E+G +K + +E + GSL +++ S+W K + I + GL YLH
Sbjct: 73 SFSENGFIK-IFMEQVPGGSLSALL------RSKWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 133 SGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
D IVH D+K N+L++ +SDFGTS+ L ++ + F GT+ Y+AP
Sbjct: 126 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK----RLAGINPCTETFTGTLQYMAP 178
Query: 192 EF--AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E R D++S G ++E T + P
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 67/279 (24%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ V+ G + + VA+K + + + S+ F EA+ + +L H LV++ G
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTI---KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
E + L+ E+ME+G L + + + + + V G+ YL + +
Sbjct: 92 LEQAPI-CLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EACV 144
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRI 198
+H D+ N L+ + VSDFG +R + L D + ST + + + +PE F++ R
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSR- 200
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
++K DV+SFG+++ E ++ + + N ++VE ++ G ++ P+L
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVED-ISTGF----RLYKPRL 248
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
S+ +++ C PEDRP + LL
Sbjct: 249 AST------------HVYQIMNHCWKERPEDRPAFSRLL 275
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ + L+ + + + LP L + GL +
Sbjct: 67 IVKLLDVIHTENKL-YLVFEFL-SMDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 122
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 123 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 6 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ + L+ + + + LP L + GL +
Sbjct: 66 IVKLLDVIHTENKL-YLVFEFL-SMDLKDFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 121
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 174
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 7 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ + L+ + + + LP L + GL +
Sbjct: 67 IVKLLDVIHTENKL-YLVFEFL-SMDLKDFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 122
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+KK+ + + RE LKEL H N
Sbjct: 5 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ + L+ + + + LP L + GL +
Sbjct: 65 IVKLLDVIHTENKL-YLVFEFL-SMDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 120
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ T+ Y AP
Sbjct: 121 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 173
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 67/234 (28%), Positives = 105/234 (44%), Gaps = 23/234 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G VA+K ++ Q + S + +RE + +K L H
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
N+VK+ E+ K LI+EY G + + V H R + + + + Y
Sbjct: 75 NIVKLFE-VIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQY 129
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H IVH D+K N+LLD D ++DFG S V AF G Y A
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-----GGKLDAFCGAPPYAA 181
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 227
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+ K+ + + RE LKEL H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 64 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 172
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R + GE+VA+ K+ + + RE LKEL H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ L+ + + + LP L + GL +
Sbjct: 63 IVKLLDVIHTENKL-YLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 171
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 23/234 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G+ VAV+ ++ Q ++ S + +RE + +K L H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
N+VK+ E+ K L++EY G + + V H R + + + + Y
Sbjct: 74 NIVKLFE-VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQY 128
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H + IVH D+K N+LLD D ++DFG S + L T F G+ Y A
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG----NKLDT-FCGSPPYAA 180
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 226
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 23/234 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G VA+K ++ Q + S + +RE + +K L H
Sbjct: 12 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
N+VK+ E+ K LI+EY G + + V H R + + + + Y
Sbjct: 72 NIVKLFE-VIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQY 126
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H IVH D+K N+LLD D ++DFG S V L T F G+ Y A
Sbjct: 127 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG----GKLDT-FCGSPPYAA 178
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 224
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 71/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 3 LDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 57
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I+E+M G+L +D+ R + +
Sbjct: 58 AAVMKEIKHPNLVQLLGVCTREPPF-YIIIEFMTYGNL--------LDYLRECNRQEVSA 108
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 109 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 162
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234
+ + I + APE + K DV++FG+++ E T G+ G+ P
Sbjct: 163 TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDPSQ 218
Query: 235 LRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMN 294
+ +L+EK Y ++L C NP DRP+
Sbjct: 219 VYELLEKD--------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFA 258
Query: 295 EL 296
E+
Sbjct: 259 EI 260
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G + VAVK L S ++ F EA +K L+H LV++
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 77
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ +I EYM GSL + + + LPK ID +A G+ Y+
Sbjct: 78 TREEPI-YIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NY 131
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
+H D++ +N+L+ ++DFG +R+++ + TA +G I + APE
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIE------DNEYTAREGAKFPIKWTAPEAINF 185
Query: 197 RIVTTKVDVFSFGIVVMEFLT 217
T K DV+SFGI++ E +T
Sbjct: 186 GCFTIKSDVWSFGILLYEIVT 206
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 23/234 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G+ VAV+ ++ Q ++ S + +RE + +K L H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
N+VK+ E+ K L++EY G + + V H R + + + + Y
Sbjct: 74 NIVKLFE-VIETEKTLYLVMEYASGGEVFDYL----VAHGRMKEKEARAKFRQIVSAVQY 128
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H + IVH D+K N+LLD D ++DFG S + F G+ Y A
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-----TFGNKLDEFCGSPPYAA 180
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 226
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 8/162 (4%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E K L ++ R +V L YA+E+ L++ M G + I+ D+ + P+ I
Sbjct: 235 EKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ +GL++LH I++ D+KP N+LLD D +SD G L V L+ + +
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG----LAVELKAGQTKT 346
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ GT G++APE VD F+ G+ + E + R P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 8/162 (4%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E K L ++ R +V L YA+E+ L++ M G + I+ D+ + P+ I
Sbjct: 235 EKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ +GL++LH I++ D+KP N+LLD D +SD G L V L+ + +
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG----LAVELKAGQTKT 346
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ GT G++APE VD F+ G+ + E + R P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 8/162 (4%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E K L ++ R +V L YA+E+ L++ M G + I+ D+ + P+ I
Sbjct: 235 EKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ +GL++LH I++ D+KP N+LLD D +SD G L V L+ + +
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG----LAVELKAGQTKT 346
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ GT G++APE VD F+ G+ + E + R P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 8/162 (4%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E K L ++ R +V L YA+E+ L++ M G + I+ D+ + P+ I
Sbjct: 235 EKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ +GL++LH I++ D+KP N+LLD D +SD G L V L+ + +
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG----LAVELKAGQTKT 346
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ GT G++APE VD F+ G+ + E + R P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ VAVK + S E+ F EA +K L+H LVK+ +A
Sbjct: 23 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKL--HA 77
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I E+M GSL + + S+ LPK ID +A G+ ++
Sbjct: 78 VVTKEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 132
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
+H D++ +NIL+ ++DFG +R+++ + TA +G I + APE
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIE------DNEYTAREGAKFPIKWTAPEAINF 186
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRR 220
T K DV+SFGI++ME +T R
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGR 210
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 71/302 (23%), Positives = 123/302 (40%), Gaps = 51/302 (16%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 3 LDKWEMERT--DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 57
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + +
Sbjct: 58 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVSA 108
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 109 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 162
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234
+ + I + APE + K DV++FG+++ E T G+ G+ P
Sbjct: 163 TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDPSQ 218
Query: 235 LRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMN 294
+ +L+EK Y ++L C NP DRP+
Sbjct: 219 VYELLEKD--------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFA 258
Query: 295 EL 296
E+
Sbjct: 259 EI 260
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ VAVK + S E+ F EA +K L+H LVK+ +A
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKL--HA 250
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I E+M GSL + + S+ LPK ID +A G+ ++
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 305
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
+H D++ +NIL+ ++DFG +R+++ + TA +G I + APE
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE------DNEYTAREGAKFPIKWTAPEAINF 359
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRR 220
T K DV+SFGI++ME +T R
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGR 383
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG VYK + GE A+KK+ + + RE LKELKH N+VK+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 80 WESGKLKALILEYMEN----------GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+L L+ E+++ G LESV L+ + NG+
Sbjct: 70 HTKKRL-VLVFEHLDQDLKKLLDVCEGGLESVTAK--------------SFLLQLLNGIA 114
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
Y H D ++H D+KP N+L++R+ E ++DFG +R + ++ + T+ Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 190 APEFAY-MRIVTTKVDVFSFGIVVMEFL 216
AP+ + +T +D++S G + E +
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 18/162 (11%)
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG---PGVDHS---------RWTLP 115
KH+N++ +LG + G L +I+EY G+L + PG+++S + +
Sbjct: 81 KHKNIINLLGACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 116 KRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ VA G++YL S +H D+ N+L+ D ++DFG +R D+H D
Sbjct: 140 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDY 194
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+T + + ++APE + RI T + DV+SFG+++ E T
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 13/210 (6%)
Query: 17 NNIIGNSNLSTVYKGRLEDGEI----VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
+ +IG + VY G D A+K L+ + ++F RE ++ L H N+
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ ++G L ++L YM +G L I P + T+ I + VA G++YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP---TVKDLISFGLQVARGMEYL- 140
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR-MLDVHLQDLSSLSTAFQGTIGYLAP 191
+ VH D+ N +LD F V+DFG +R +LD + A + + + A
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA-RLPVKWTAL 197
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E TTK DV+SFG+++ E LT+ P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG VYK + GE A+KK+ + + RE LKELKH N+VK+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 80 WESGKLKALILEYMEN----------GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+L L+ E+++ G LESV L+ + NG+
Sbjct: 70 HTKKRL-VLVFEHLDQDLKKLLDVCEGGLESVTAK--------------SFLLQLLNGIA 114
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
Y H D ++H D+KP N+L++R+ E ++DFG +R + ++ + T+ Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 190 APEFAY-MRIVTTKVDVFSFGIVVMEFL 216
AP+ + +T +D++S G + E +
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 22/193 (11%)
Query: 39 VAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENG 96
VAVK L + E D S E + +K + KH+N++ +LG + G L +I+EY G
Sbjct: 56 VAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL-YVIVEYASKG 112
Query: 97 SLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+L + PG+++S + + + VA G++YL S +H D+
Sbjct: 113 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 169
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L+ D ++DFG +R D+H D +T + + ++APE + RI T + D
Sbjct: 170 AARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 227
Query: 205 VFSFGIVVMEFLT 217
V+SFG+++ E T
Sbjct: 228 VWSFGVLLWEIFT 240
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G+ VAVK ++ Q ++ S + +RE + +K L H
Sbjct: 7 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLES--VIHGPGVDHSRWTLPKRIDV-LISVANG 127
N+VK+ E+ K L++EY G + V HG W K + +
Sbjct: 67 NIVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHG-------WMKEKEARAKFRQIVSA 118
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+ Y H + IVH D+K N+LLD D ++DFG S + L T F G+
Sbjct: 119 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG----NKLDT-FCGSPP 170
Query: 188 YLAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
Y APE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 219
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 6 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 60
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I+E+M G+L +D+ R + ++
Sbjct: 61 AAVMKEIKHPNLVQLLGVCTREPPF-YIIIEFMTYGNL--------LDYLRECNRQEVNA 111
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 112 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 165
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 166 TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 215
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 216 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 258
Query: 292 NMNEL 296
+ E+
Sbjct: 259 SFAEI 263
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 22/193 (11%)
Query: 39 VAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENG 96
VAVK L + E D S E + +K + KH+N++ +LG + G L +I+EY G
Sbjct: 104 VAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL-YVIVEYASKG 160
Query: 97 SLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+L + PG+++S + + + VA G++YL S +H D+
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 217
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L+ D ++DFG +R D+H D +T + + ++APE + RI T + D
Sbjct: 218 AARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 205 VFSFGIVVMEFLT 217
V+SFG+++ E T
Sbjct: 276 VWSFGVLLWEIFT 288
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 22/193 (11%)
Query: 39 VAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENG 96
VAVK L + E D S E + +K + KH+N++ +LG + G L +I+EY G
Sbjct: 63 VAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL-YVIVEYASKG 119
Query: 97 SLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+L + PG+++S + + + VA G++YL S +H D+
Sbjct: 120 NLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 176
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L+ D ++DFG +R D+H D +T + + ++APE + RI T + D
Sbjct: 177 AARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 205 VFSFGIVVMEFLT 217
V+SFG+++ E T
Sbjct: 235 VWSFGVLLWEIFT 247
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 18/162 (11%)
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG---PGVDHS---------RWTLP 115
KH+N++ +LG + G L +I+EY G+L + PG+++S + +
Sbjct: 84 KHKNIINLLGACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 116 KRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ VA G++YL S +H D+ N+L+ D ++DFG +R D+H D
Sbjct: 143 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDY 197
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+T + + ++APE + RI T + DV+SFG+++ E T
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 97/193 (50%), Gaps = 22/193 (11%)
Query: 39 VAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENG 96
VAVK L + E D S E + +K + KH+N++ +LG + G L +I+EY G
Sbjct: 63 VAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL-YVIVEYASKG 119
Query: 97 SLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+L + PG+++S + + + VA G++YL S +H D+
Sbjct: 120 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 176
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L+ D ++DFG +R D+H D +T + + ++APE + RI T + D
Sbjct: 177 AARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 205 VFSFGIVVMEFLT 217
V+SFG+++ E T
Sbjct: 235 VWSFGVLLWEIFT 247
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TG+FSE +I + T +L + +A K L + S E+ E L ++KH
Sbjct: 27 GTGAFSE--VILAEDKRT---QKLVAIKCIAKKALEGKEGSMEN------EIAVLHKIKH 75
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
N+V L +ESG LI++ + G L I V+ +T ++ V + +
Sbjct: 76 PNIV-ALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVK 130
Query: 130 YLHSGYDIPIVHCDMKPSNIL---LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
YLH D+ IVH D+KP N+L LD D + +SDFG S+M D S LSTA GT
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTAC-GTP 182
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GY+APE + + VD +S G++ L P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TG+FSE +I + T ++VA+K + + + S E L ++KH
Sbjct: 27 GTGAFSE--VILAEDKRT--------QKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKH 75
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
N+V L +ESG LI++ + G L I V+ +T ++ V + +
Sbjct: 76 PNIV-ALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVK 130
Query: 130 YLHSGYDIPIVHCDMKPSNIL---LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
YLH D+ IVH D+KP N+L LD D + +SDFG S+M D S LSTA GT
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTAC-GTP 182
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GY+APE + + VD +S G++ L P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG VYK + GE A+KK+ + + RE LKELKH N+VK+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 80 WESGKLKALILEYMEN----------GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+L L+ E+++ G LESV L+ + NG+
Sbjct: 70 HTKKRL-VLVFEHLDQDLKKLLDVCEGGLESVTAK--------------SFLLQLLNGIA 114
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
Y H D ++H D+KP N+L++R+ E ++DFG +R + ++ + T+ Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYR 167
Query: 190 APEFAY-MRIVTTKVDVFSFGIVVMEFL 216
AP+ + +T +D++S G + E +
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV 195
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 12 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 70
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 71 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D++
Sbjct: 130 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET 184
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 241
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 242 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 278
Query: 292 NMNELL 297
+ E++
Sbjct: 279 SFLEII 284
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 12 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 70
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 71 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D++
Sbjct: 130 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET 184
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 241
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 242 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 278
Query: 292 NMNELL 297
+ E++
Sbjct: 279 SFLEII 284
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 23/234 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
G++ IG N + V R + G+ VAVK ++ Q ++ S + +RE + K L H
Sbjct: 14 GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
N+VK+ E+ K L+ EY G + + V H R + + + + Y
Sbjct: 74 NIVKLFE-VIETEKTLYLVXEYASGGEVFDYL----VAHGRXKEKEARAKFRQIVSAVQY 128
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H + IVH D+K N+LLD D ++DFG S + AF G Y A
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF-----TFGNKLDAFCGAPPYAA 180
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE F + +VDV+S G+++ ++ P D +N L++L E+ L
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQN------LKELRERVL 226
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 13 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 71
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 72 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D++
Sbjct: 131 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET 185
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 242
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 243 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 279
Query: 292 NMNELL 297
+ E++
Sbjct: 280 SFLEII 285
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 33/218 (15%)
Query: 20 IGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESD-----KSFYREAKTLKELKHRNLV 73
IG V+KGRL +D +VA+K L E++ + F RE + L H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHS---RWTLPKRIDVLISVANGLDY 130
K+ G + +++E++ G L + +D + +W++ ++ +++ +A G++Y
Sbjct: 87 KLYGLMHNPPR---MVMEFVPCGDLYHRL----LDKAHPIKWSV--KLRLMLDIALGIEY 137
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFE-----AHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+ + + PIVH D++ NI L E A V+DFGTS+ Q + S+S G
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVS-GLLGN 189
Query: 186 IGYLAPEF--AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++APE A T K D +SF +++ LT P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 76/310 (24%), Positives = 134/310 (43%), Gaps = 47/310 (15%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDK 55
F E E A + + +G + VY+G + E VA+K +N S
Sbjct: 6 FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERI 64
Query: 56 SFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWT 113
F EA +KE ++V++LG G+ +I+E M G L+S + P ++++
Sbjct: 65 EFLNEASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 114 LPKRIDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169
P + +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--D 178
Query: 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEE 227
++ D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 238
Query: 228 NGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNP 287
LR ++E L + + P ++ F+L +C NP
Sbjct: 239 Q-----VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNP 272
Query: 288 EDRPNMNELL 297
+ RP+ E++
Sbjct: 273 KMRPSFLEII 282
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TG+FSE +I + T ++VA+K + + + S E L ++KH
Sbjct: 27 GTGAFSE--VILAEDKRT--------QKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKH 75
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
N+V L +ESG LI++ + G L I V+ +T ++ V + +
Sbjct: 76 PNIV-ALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVK 130
Query: 130 YLHSGYDIPIVHCDMKPSNIL---LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
YLH D+ IVH D+KP N+L LD D + +SDFG S+M D S LSTA GT
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTAC-GTP 182
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GY+APE + + VD +S G++ L P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 64
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 65 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D++
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET 178
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 235
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 236 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 272
Query: 292 NMNELL 297
+ E++
Sbjct: 273 SFLEII 278
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 41 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 99
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 100 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D++
Sbjct: 159 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET 213
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 214 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 270
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 271 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 307
Query: 292 NMNELL 297
+ E++
Sbjct: 308 SFLEII 313
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 77
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 78 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D++
Sbjct: 137 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET 191
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 248
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 249 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 285
Query: 292 NMNELL 297
+ E++
Sbjct: 286 SFLEII 291
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 22/193 (11%)
Query: 39 VAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENG 96
VAVK L + E D S E + +K + KH+N++ +LG + G L +I+EY G
Sbjct: 63 VAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL-YVIVEYASKG 119
Query: 97 SLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+L + PG++ S + + + VA G++YL S +H D+
Sbjct: 120 NLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDL 176
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L+ D ++DFG +R D+H D +T + + ++APE + RI T + D
Sbjct: 177 AARNVLVTEDNVMKIADFGLAR--DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 205 VFSFGIVVMEFLT 217
V+SFG+++ E T
Sbjct: 235 VWSFGVLLWEIFT 247
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TG+FSE +I + T ++VA+K + + + S E L ++KH
Sbjct: 27 GTGAFSE--VILAEDKRT--------QKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKH 75
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
N+V L +ESG LI++ + G L I V+ +T ++ V + +
Sbjct: 76 PNIV-ALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVK 130
Query: 130 YLHSGYDIPIVHCDMKPSNIL---LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
YLH D+ IVH D+KP N+L LD D + +SDFG S+M D S LSTA GT
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTAC-GTP 182
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GY+APE + + VD +S G++ L P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 126/305 (41%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 10 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 64
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I+E+M G+L +D+ R + ++
Sbjct: 65 AAVMKEIKHPNLVQLLGVCTREPPF-YIIIEFMTYGNL--------LDYLRECNRQEVNA 115
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 116 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 169
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 219
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 220 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 292 NMNEL 296
+ E+
Sbjct: 263 SFAEI 267
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 9 NATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
G + +G V + +D GE VA+K+ + S ++ + + E + +K+L
Sbjct: 12 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKL 70
Query: 68 KHRNLVKVLG-----YAWESGKLKALILEYMENGSLESVIH----GPGVDHSRWTLPKRI 118
H N+V L L +EY E G L ++ G+ P R
Sbjct: 71 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG----PIRT 126
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFGTSRMLDVHLQDL 175
+L +++ L YLH I+H D+KP NI+L + + D G ++ LD
Sbjct: 127 -LLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ----- 177
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
L T F GT+ YLAPE + T VD +SFG + E +T RP
Sbjct: 178 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 9 NATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
G + +G V + +D GE VA+K+ + S ++ + + E + +K+L
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKL 69
Query: 68 KHRNLVKVLG-----YAWESGKLKALILEYMENGSLESVIH----GPGVDHSRWTLPKRI 118
H N+V L L +EY E G L ++ G+ P R
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG----PIRT 125
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFGTSRMLDVHLQDL 175
+L +++ L YLH I+H D+KP NI+L + + D G ++ LD
Sbjct: 126 -LLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ----- 176
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
L T F GT+ YLAPE + T VD +SFG + E +T RP
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 75/306 (24%), Positives = 132/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 9 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 67
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P + ++ P
Sbjct: 68 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D++
Sbjct: 127 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET 181
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 238
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 239 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 275
Query: 292 NMNELL 297
+ E++
Sbjct: 276 SFLEII 281
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 5 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 59
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I+E+M G+L +D+ R + +
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPF-YIIIEFMTYGNL--------LDYLRECNRQEVSA 110
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 111 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 164
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 214
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 215 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 292 NMNEL 296
+ E+
Sbjct: 258 SFAEI 262
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TVY + G+ VA++++N Q + E ++E K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G +++EY+ GSL V+ +D + R L++LHS
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ--- 136
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K NILL D ++DFG + S + GT ++APE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L+E +P+ L+ NG ++ +P+
Sbjct: 193 YGPKVDIWSLGIMAIEMI-EGEPPYLNE----NPLRALYLI------ATNGTPELQNPEK 241
Query: 259 VSSIY 263
+S+I+
Sbjct: 242 LSAIF 246
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 42/292 (14%)
Query: 9 NATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLN-FHQFSAESDKSFYREAKTLKE 66
N +F IG S VY+ L DG VA+KK+ F A++ +E LK+
Sbjct: 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 67 LKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISV 124
L H N++K E +L ++LE + G L +I + +P+R + +
Sbjct: 89 LNHPNVIKYYASFIEDNELN-IVLELADAGDLSRMIKH--FKKQKRLIPERTVWKYFVQL 145
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
+ L+++HS ++H D+KP+N+ + + D G R SS +TA
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF-------FSSKTTAAHS 195
Query: 185 TIG---YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+G Y++PE + K D++S G ++ E + P D+ N L L +K
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKK 249
Query: 242 ALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNM 293
+ Q P L S Y +L +C + +PE RP++
Sbjct: 250 --------IEQCDYPPLPSDHYSEELR--------QLVNMCINPDPEKRPDV 285
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 75/306 (24%), Positives = 132/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 77
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P + ++ P
Sbjct: 78 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D++
Sbjct: 137 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYET 191
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E L ++ GL E
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 248
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 249 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 285
Query: 292 NMNELL 297
+ E++
Sbjct: 286 SFLEII 291
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 71.2 bits (173), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TVY + G+ VA++++N Q + E ++E K+ N+V L
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLD- 85
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G +++EY+ GSL V+ +D + R L++LHS
Sbjct: 86 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ--- 137
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K NILL D ++DFG + S + GT ++APE +
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMAPEVVTRKA 193
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L+E +P+ L+ NG ++ +P+
Sbjct: 194 YGPKVDIWSLGIMAIEMI-EGEPPYLNE----NPLRALYLI------ATNGTPELQNPEK 242
Query: 259 VSSIY 263
+S+I+
Sbjct: 243 LSAIF 247
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TVY + G+ VA++++N Q + E ++E K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G +++EY+ GSL V+ +D + R L++LHS
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ--- 136
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K NILL D ++DFG + S + GT ++APE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMAPEVVTRKA 192
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L+E +P+ L+ NG ++ +P+
Sbjct: 193 YGPKVDIWSLGIMAIEMI-EGEPPYLNE----NPLRALYLI------ATNGTPELQNPEK 241
Query: 259 VSSIY 263
+S+I+
Sbjct: 242 LSAIF 246
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 7/193 (3%)
Query: 32 RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGKLKALIL 90
R DG+I+ K+L++ + + E L+ELKH N+V+ + + +++
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD--IPIVHCDMKPSN 148
EY E G L SVI + + V+ + L H D ++H D+KP+N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
+ LD + DFG +R+L+ +S + AF GT Y++PE K D++S
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHD----TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 209 GIVVMEFLTKRRP 221
G ++ E P
Sbjct: 203 GCLLYELCALMPP 215
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 70.9 bits (172), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 71/302 (23%), Positives = 123/302 (40%), Gaps = 51/302 (16%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 3 LDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 57
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + +
Sbjct: 58 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVSA 108
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 109 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 162
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234
+ + I + APE + K DV++FG+++ E T G+ G+ P
Sbjct: 163 TFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----YGMSPYPGIDPSQ 218
Query: 235 LRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMN 294
+ +L+EK Y ++L C NP DRP+
Sbjct: 219 VYELLEKD--------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFA 258
Query: 295 EL 296
E+
Sbjct: 259 EI 260
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 47/306 (15%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 13 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 71
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 72 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D+
Sbjct: 131 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXET 185
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRP-TGLDEENGLS 231
D + +++PE + TT DV+SFG+V+ E T +P GL E
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 242
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
LR ++E L + + P ++ F+L +C NP+ RP
Sbjct: 243 --VLRFVMEGGLLDKPDNC-----PDML----------------FELMRMCWQYNPKMRP 279
Query: 292 NMNELL 297
+ E++
Sbjct: 280 SFLEII 285
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TVY + G+ VA++++N Q + E ++E K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G +++EY+ GSL V+ +D + R L++LHS
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ--- 136
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K NILL D ++DFG + S + GT ++APE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSEMVGTPYWMAPEVVTRKA 192
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L+E +P+ L+ NG ++ +P+
Sbjct: 193 YGPKVDIWSLGIMAIEMI-EGEPPYLNE----NPLRALYLI------ATNGTPELQNPEK 241
Query: 259 VSSIY 263
+S+I+
Sbjct: 242 LSAIF 246
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 57 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 116
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 117 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 166
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 167 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 218
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 219 VGCIMAELLTGR 230
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 5 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 59
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I+E+M G+L +D+ R + +
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPF-YIIIEFMTYGNL--------LDYLRECNRQEVSA 110
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 111 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 164
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 214
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 215 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 292 NMNEL 296
+ E+
Sbjct: 258 SFAEI 262
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 10 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 64
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 65 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 115
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 116 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 169
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 170 TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 219
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 220 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 292 NMNEL 296
+ E+
Sbjct: 263 SFAEI 267
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 6 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 60
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 61 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 111
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 112 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 165
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 166 TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 215
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 216 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 258
Query: 292 NMNEL 296
+ E+
Sbjct: 259 SFAEI 263
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 24/230 (10%)
Query: 9 NATGSFSENNIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
+++ F + +GN +TVYKG G VA+K++ + RE +KEL
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKEL 60
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI----- 122
KH N+V++ KL L+ E+M+N L+ + V ++ P+ +++ +
Sbjct: 61 KHENIVRLYDVIHTENKL-TLVFEFMDN-DLKKYMDSRTVGNT----PRGLELNLVKYFQ 114
Query: 123 -SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ GL + H I+H D+KP N+L+++ + + DFG +R + + SS
Sbjct: 115 WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV- 170
Query: 182 FQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRR--PTGLDEEN 228
T+ Y AP+ R +T +D++S G ++ E +T + P DEE
Sbjct: 171 ---TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ 217
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 66 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 126 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 175
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 176 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 227
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 228 VGCIMAELLTGR 239
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 43 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 103 HLMGADLNNIVKCAKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 152
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 153 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 204
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 205 VGCIMAELLTGR 216
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 7 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 61
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 62 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 112
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 113 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 166
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 167 TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 216
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 217 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 259
Query: 292 NMNEL 296
+ E+
Sbjct: 260 SFAEI 264
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 10 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 64
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 65 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 115
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 116 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 169
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 219
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 220 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 292 NMNEL 296
+ E+
Sbjct: 263 SFAEI 267
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 22/193 (11%)
Query: 39 VAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENG 96
VAVK L + E D S E + +K + KH+N++ +LG + G L +I+EY G
Sbjct: 63 VAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL-YVIVEYASKG 119
Query: 97 SLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+L + PG+++ + + + VA G++YL S +H D+
Sbjct: 120 NLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 176
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L+ D ++DFG +R D+H D +T + + ++APE + RI T + D
Sbjct: 177 AARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 205 VFSFGIVVMEFLT 217
V+SFG+++ E T
Sbjct: 235 VWSFGVLLWEIFT 247
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 43 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 103 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 152
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 153 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 204
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 205 VGCIMAELLTGR 216
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG---PGVDHS---------RWTLP 115
KH+N++ +LG + G L +I+EY G+L + PG+++ + +
Sbjct: 77 KHKNIINLLGACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 116 KRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ VA G++YL S +H D+ N+L+ D ++DFG +R D+H D
Sbjct: 136 DLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDY 190
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+T + + ++APE + RI T + DV+SFG+++ E T
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 74/229 (32%), Positives = 111/229 (48%), Gaps = 42/229 (18%)
Query: 60 EAKTLKELKHRNLVKVLGYAWES-GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
E L E+ H +VK L YA+++ GKL LIL+++ G L + + S+ +
Sbjct: 76 ERDILVEVNHPFIVK-LHYAFQTEGKL-YLILDFLRGGDLFTRL-------SKEVMFTEE 126
Query: 119 DV---LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
DV L +A LD+LHS + I++ D+KP NILLD + ++DFG S+ D
Sbjct: 127 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDH 179
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENG----- 229
+ +F GT+ Y+APE R T D +SFG+++ E LT P G D +
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
Query: 230 ---------LSPIS---LRQLVEKALAN----GINGVRQITDPKLVSSI 262
LSP + LR L ++ AN G +GV +I S+I
Sbjct: 240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 67 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 127 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 176
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 177 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 228
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 229 VGCIMAELLTGR 240
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 7 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 61
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 62 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 112
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 113 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 166
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 167 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 216
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 217 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 259
Query: 292 NMNEL 296
+ E+
Sbjct: 260 SFAEI 264
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 7 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 61
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 62 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 112
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 113 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 166
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 167 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 216
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 217 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 259
Query: 292 NMNEL 296
+ E+
Sbjct: 260 SFAEI 264
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 53 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 113 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 162
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 163 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 214
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 215 VGCIMAELLTGR 226
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 74/229 (32%), Positives = 111/229 (48%), Gaps = 42/229 (18%)
Query: 60 EAKTLKELKHRNLVKVLGYAWES-GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
E L E+ H +VK L YA+++ GKL LIL+++ G L + + S+ +
Sbjct: 76 ERDILVEVNHPFIVK-LHYAFQTEGKL-YLILDFLRGGDLFTRL-------SKEVMFTEE 126
Query: 119 DV---LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
DV L +A LD+LHS + I++ D+KP NILLD + ++DFG S+ D
Sbjct: 127 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDH 179
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENG----- 229
+ +F GT+ Y+APE R T D +SFG+++ E LT P G D +
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
Query: 230 ---------LSPIS---LRQLVEKALAN----GINGVRQITDPKLVSSI 262
LSP + LR L ++ AN G +GV +I S+I
Sbjct: 240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 9 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 63
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 114
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 115 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 168
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 218
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 219 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 261
Query: 292 NMNEL 296
+ E+
Sbjct: 262 SFAEI 266
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TV+K + E EIVA+K++ S RE LKELKH+N+V+ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR-LHD 68
Query: 79 AWESGKLKALILEYME----------NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
S K L+ E+ + NG L+ P + S L + GL
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKS---------FLFQLLKGL 114
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ HS ++H D+KP N+L++R+ E ++DFG +R + ++ S+ T+ Y
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV----TLWY 167
Query: 189 LAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP 221
P+ + ++ +T +D++S G + E RP
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 74/229 (32%), Positives = 111/229 (48%), Gaps = 42/229 (18%)
Query: 60 EAKTLKELKHRNLVKVLGYAWES-GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
E L E+ H +VK L YA+++ GKL LIL+++ G L + + S+ +
Sbjct: 77 ERDILVEVNHPFIVK-LHYAFQTEGKL-YLILDFLRGGDLFTRL-------SKEVMFTEE 127
Query: 119 DV---LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
DV L +A LD+LHS + I++ D+KP NILLD + ++DFG S+ D
Sbjct: 128 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDH 180
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENG----- 229
+ +F GT+ Y+APE R T D +SFG+++ E LT P G D +
Sbjct: 181 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 240
Query: 230 ---------LSPIS---LRQLVEKALAN----GINGVRQITDPKLVSSI 262
LSP + LR L ++ AN G +GV +I S+I
Sbjct: 241 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 289
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + F T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------AGFVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 10 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 64
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 65 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 115
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 116 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 169
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 219
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 220 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 292 NMNEL 296
+ E+
Sbjct: 263 SFAEI 267
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + F T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------AGFVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 18 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 72
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 73 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 123
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 124 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 177
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 178 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 227
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 228 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 270
Query: 292 NMNEL 296
+ E+
Sbjct: 271 SFAEI 275
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 5 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 59
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 110
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 111 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 164
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 214
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 215 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 292 NMNEL 296
+ E+
Sbjct: 258 SFAEI 262
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 5 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 59
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + +
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVSA 110
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 111 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 164
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 214
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 215 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 292 NMNEL 296
+ E+
Sbjct: 258 SFAEI 262
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 10 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 64
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + +
Sbjct: 65 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVSA 115
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 116 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 169
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 219
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 220 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 262
Query: 292 NMNEL 296
+ E+
Sbjct: 263 SFAEI 267
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 5 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 59
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 110
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 111 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 164
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 214
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 215 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 292 NMNEL 296
+ E+
Sbjct: 258 SFAEI 262
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 43 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 103 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 152
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + F T Y APE +M T VD++S
Sbjct: 153 AVNEDCELKILDFGLARHTDDEM-------AGFVATRWYRAPEIMLNWMHYNQT-VDIWS 204
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 205 VGCIMAELLTGR 216
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 52 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 112 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 161
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 162 AVNEDXELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 213
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 214 VGCIMAELLTGR 225
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 49 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 109 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 158
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 159 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 210
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 211 VGCIMAELLTGR 222
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 44 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 104 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 153
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 154 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 205
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 206 VGCIMAELLTGR 217
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 59 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 119 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 168
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 169 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 220
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 221 VGCIMAELLTGR 232
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 59 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 119 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 168
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 169 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 220
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 221 VGCIMAELLTGR 232
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 5 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 59
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + +
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVSA 110
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 111 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GD 164
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSPYP 214
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 215 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
Query: 292 NMNEL 296
+ E+
Sbjct: 258 SFAEI 262
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 52 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 112 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 161
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 162 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 213
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 214 VGCIMAELLTGR 225
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 46 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 105
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 106 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 155
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 156 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 207
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 208 VGCIMAELLTGR 219
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 58 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 118 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 167
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 168 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 219
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 220 VGCIMAELLTGR 231
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 49 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 109 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 158
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 159 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 210
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 211 VGCIMAELLTGR 222
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 53 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 113 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 162
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 163 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 214
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 215 VGCIMAELLTGR 226
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 45 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 104
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 105 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 154
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 155 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 206
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 207 VGCIMAELLTGR 218
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 163
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 164 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 215
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 216 VGCIMAELLTGR 227
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 52 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 112 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 161
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 162 AVNEDXELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 213
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 214 VGCIMAELLTGR 225
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 66 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 126 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 175
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 176 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 227
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 228 VGCIMAELLTGR 239
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 70 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 130 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 179
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 180 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 231
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 232 VGCIMAELLTGR 243
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 49 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 109 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 158
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 159 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 210
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 211 VGCIMAELLTGR 222
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKXQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDXELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKXQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G + VAVK L S ++ F EA +K L+H LV++
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 76
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I E+M GSL + + + LPK ID +A G+ Y+
Sbjct: 77 TKEEPI-YIITEFMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NY 130
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
+H D++ +N+L+ ++DFG +R+++ + TA +G I + APE
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIE------DNEYTAREGAKFPIKWTAPEAINF 184
Query: 197 RIVTTKVDVFSFGIVVMEFLT 217
T K +V+SFGI++ E +T
Sbjct: 185 GCFTIKSNVWSFGILLYEIVT 205
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 58 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 118 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 167
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 168 AVNEDXELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 219
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 220 VGCIMAELLTGR 231
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 52 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 112 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 161
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 162 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 213
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 214 VGCIMAELLTGR 225
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 33 LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL---- 88
++ G +AVKKL+ S K YRE + LK +KH N++ +L + L+
Sbjct: 73 VKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVY 132
Query: 89 ILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146
++ ++ L +++ + DH ++ ++ + GL Y+HS I+H D+KP
Sbjct: 133 LVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKP 182
Query: 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVD 204
SN+ ++ D E + DFG +R D + T + T Y APE +M T VD
Sbjct: 183 SNLAVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNMT-VD 234
Query: 205 VFSFGIVVMEFLTKRRP-TGLDEENGLSPI 233
++S G ++ E LT R G D N L I
Sbjct: 235 IWSVGCIMAELLTGRTLFPGTDHINQLQQI 264
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 67 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 127 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 176
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 177 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 228
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 229 VGCIMAELLTGR 240
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 44 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 104 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 153
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 154 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 205
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 206 VGCIMAELLTGR 217
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 59 GLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 119 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 168
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 169 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 220
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 221 VGCIMAELLTGR 232
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 43 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 103 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 152
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 153 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 204
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 205 VGCIMAELLTGR 216
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TVY + G+ VA++++N Q + E ++E K+ N+V L
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLD- 85
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G +++EY+ GSL V+ +D + R L++LHS
Sbjct: 86 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ--- 137
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H ++K NILL D ++DFG + S + GT ++APE +
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAPEVVTRKA 193
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L+E +P+ L+ NG ++ +P+
Sbjct: 194 YGPKVDIWSLGIMAIEMI-EGEPPYLNE----NPLRALYLI------ATNGTPELQNPEK 242
Query: 259 VSSIY 263
+S+I+
Sbjct: 243 LSAIF 247
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 53 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 113 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 162
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 163 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 214
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 215 VGCIMAELLTGR 226
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKSQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDSELKILDFGLCRHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 53 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 113 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 162
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 163 AVNEDSELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 214
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 215 VGCIMAELLTGR 226
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 4 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 62
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 63 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N ++ DF + DFG +R D+
Sbjct: 122 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXET 176
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
D + +++PE + TT DV+SFG+V+ E T
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 49 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 109 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 158
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE +M T VD++S
Sbjct: 159 AVNEDSELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 210
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 211 VGCIMAELLTGR 222
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 7/193 (3%)
Query: 32 RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGKLKALIL 90
R DG+I+ K+L++ + + E L+ELKH N+V+ + + +++
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD--IPIVHCDMKPSN 148
EY E G L SVI + + V+ + L H D ++H D+KP+N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
+ LD + DFG +R+L+ +S + F GT Y++PE K D++S
Sbjct: 147 VFLDGKQNVKLGDFGLARILNHD----TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 209 GIVVMEFLTKRRP 221
G ++ E P
Sbjct: 203 GCLLYELCALMPP 215
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 33/218 (15%)
Query: 20 IGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESD-----KSFYREAKTLKELKHRNLV 73
IG V+KGRL +D +VA+K L E++ + F RE + L H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHS---RWTLPKRIDVLISVANGLDY 130
K+ G + +++E++ G L + +D + +W++ ++ +++ +A G++Y
Sbjct: 87 KLYGLMHNPPR---MVMEFVPCGDLYHRL----LDKAHPIKWSV--KLRLMLDIALGIEY 137
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFE-----AHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+ + + PIVH D++ NI L E A V+DFG S+ Q + S+S G
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVS-GLLGN 189
Query: 186 IGYLAPEF--AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++APE A T K D +SF +++ LT P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRN 71
F +G VY R + + I+A+K L Q E + RE + L+H N
Sbjct: 17 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++++ Y + ++ L+LE+ G L + H R+ + + +A+ L Y
Sbjct: 77 ILRMYNYFHDRKRI-YLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYC 131
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H + ++H D+KP N+L+ E ++DFG S VH L GT+ YL P
Sbjct: 132 H---ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMC--GTLDYLPP 182
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + KVD++ G++ EFL P
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSF 208
++ D E + DFG +R D + T + T Y APE + VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNAMHYNQTVDIWSV 209
Query: 209 GIVVMEFLTKR 219
G ++ E LT R
Sbjct: 210 GCIMAELLTGR 220
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 7/193 (3%)
Query: 32 RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGKLKALIL 90
R DG+I+ K+L++ + + E L+ELKH N+V+ + + +++
Sbjct: 27 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86
Query: 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD--IPIVHCDMKPSN 148
EY E G L SVI + + V+ + L H D ++H D+KP+N
Sbjct: 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
+ LD + DFG +R+L+ H +D + F GT Y++PE K D++S
Sbjct: 147 VFLDGKQNVKLGDFGLARILN-HDEDFAK---EFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 209 GIVVMEFLTKRRP 221
G ++ E P
Sbjct: 203 GCLLYELCALMPP 215
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRN 71
F +G VY R + + I+A+K L Q E + RE + L+H N
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++++ Y + ++ L+LE+ G L + H R+ + + +A+ L Y
Sbjct: 76 ILRMYNYFHDRKRI-YLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYC 130
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H + ++H D+KP N+L+ E ++DFG S VH L GT+ YL P
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMC--GTLDYLPP 181
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + KVD++ G++ EFL P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 61 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 117
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 178 ---CIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTTNGRLPVKWMAPEALF 232
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 107 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 163
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 224 ---CIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 278
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 279 DRVYTHQSDVWSFGVLMWEIFT 300
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 33 EAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 91 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 140 ERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 198 LTAMLAGELP 207
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 51/273 (18%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VAVK L + +E + E LK++ H +++K+ G + G L LI+EY + GSL
Sbjct: 56 VAVKMLKENASPSEL-RDLLSEFNVLKQVNHPHVIKLYGACSQDGPL-LLIVEYAKYGSL 113
Query: 99 ESVIH-----GPGV---------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ GPG D T+ I ++ G+ YL ++
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMK 170
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
+VH D+ NIL+ + +SDFG SR DV+ +D + + + ++A E + I
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSR--DVYEEDSXVKRSQGRIPVKWMAIESLFDHI 228
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
TT+ DV+SFG+++ E +T G + G+ P L L++ ++ P
Sbjct: 229 YTTQSDVWSFGVLLWEIVT----LGGNPYPGIPPERLFNLLKTG--------HRMERPDN 276
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
S ++L L C P+ RP
Sbjct: 277 CSE------------EMYRLMLQCWKQEPDKRP 297
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 20 IGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRNLVKVLG 77
+G VY R + + I+A+K L Q E + RE + L+H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
Y + ++ L+LE+ G L + H R+ + + +A+ L Y H +
Sbjct: 82 YFHDRKRI-YLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCH---ER 133
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
++H D+KP N+L+ E ++DFG S VH L GT+ YL PE +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMC--GTLDYLPPEMIEGK 187
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP 221
KVD++ G++ EFL P
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPP 211
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKAL 88
K + ++ VAVK L + E E + +K + KH+N++ +LG + G L +
Sbjct: 61 KDKPKEAVTVAVKMLK-DDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-YV 118
Query: 89 ILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYD 136
I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-- 176
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 177 -KCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALFD 233
Query: 197 RIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 61 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 117
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 176
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 177 --KCIHRDLAARNVLVTENNVMRIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 232
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--------HGPGVDHSRWTLPKRIDVLISVA 125
++LG G+ +++E M +G L+S + + PG TL + I + +A
Sbjct: 84 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIA 140
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+G+ YL++ VH D+ N ++ DF + DFG +R D++ D
Sbjct: 141 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLP 195
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
+ ++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 242
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 209 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 263
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 264 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 314
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H ++ N L+ + V+DFG SR++ D
Sbjct: 315 VVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT---GD 368
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 369 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY----------GMSPYP 418
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 419 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 461
Query: 292 NMNEL 296
+ E+
Sbjct: 462 SFAEI 466
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 48 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 104
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 105 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 163
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 164 --KCIHRDLTARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 219
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 220 DRVYTHQSDVWSFGVLMWEIFT 241
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + D+G +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDYGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 51/273 (18%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VAVK L + +E + E LK++ H +++K+ G + G L LI+EY + GSL
Sbjct: 56 VAVKMLKENASPSEL-RDLLSEFNVLKQVNHPHVIKLYGACSQDGPL-LLIVEYAKYGSL 113
Query: 99 ESVIH-----GPGV---------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ GPG D T+ I ++ G+ YL ++
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMS 170
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
+VH D+ NIL+ + +SDFG SR DV+ +D + + + ++A E + I
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSR--DVYEEDSXVKRSQGRIPVKWMAIESLFDHI 228
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
TT+ DV+SFG+++ E +T G + G+ P L L++ ++ P
Sbjct: 229 YTTQSDVWSFGVLLWEIVT----LGGNPYPGIPPERLFNLLKTG--------HRMERPDN 276
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
S ++L L C P+ RP
Sbjct: 277 CSE------------EMYRLMLQCWKQEPDKRP 297
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 251 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 305
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + ++
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVNA 356
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H ++ N L+ + V+DFG SR++ D
Sbjct: 357 VVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT---GD 410
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 411 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY----------GMSPYP 460
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 461 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 503
Query: 292 NMNEL 296
+ E+
Sbjct: 504 SFAEI 508
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 53 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 109
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 110 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 168
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 169 --KCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 224
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 225 DRVYTHQSDVWSFGVLMWEIFT 246
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 50 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 106
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 107 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 165
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 166 --KCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 221
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 222 DRVYTHQSDVWSFGVLMWEIFT 243
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEIXINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--------HGPGVDHSRWTLPKRIDVLISVA 125
++LG G+ +++E M +G L+S + + PG TL + I + +A
Sbjct: 83 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIA 139
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+G+ YL++ VH D+ N ++ DF + DFG +R D++ D
Sbjct: 140 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLP 194
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
+ ++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 241
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYR 59
E E A + + +G + VY+G + E VA+K +N S F
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLN 64
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
EA +KE ++V++LG G+ +I+E M G L+S + P ++++ P
Sbjct: 65 EASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 118 IDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ +I +A+G+ YL++ VH D+ N + DF + DFG +R D++
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYET 178
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
D + +++PE + TT DV+SFG+V+ E T
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--------HGPGVDHSRWTLPKRIDVLISVA 125
++LG G+ +++E M +G L+S + + PG TL + I + +A
Sbjct: 84 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIA 140
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+G+ YL++ VH D+ N ++ DF + DFG +R D+ D
Sbjct: 141 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLP 195
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
+ ++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 242
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 27/192 (14%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK-----ALIL 90
GE VA+KKL+ S K YRE LK ++H N++ +L + L+ L++
Sbjct: 67 GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126
Query: 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIPIVHCDMKPSNI 149
+M+ L+ ++ G++ S ++I L+ + GL Y+HS +VH D+KP N+
Sbjct: 127 PFMQT-DLQKIM---GMEFSE----EKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNL 175
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--FAYMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE ++M T VD++S
Sbjct: 176 AVNEDCELKILDFGLARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQT-VDIWS 227
Query: 208 FGIVVMEFLTKR 219
G ++ E LT +
Sbjct: 228 VGCIMAEMLTGK 239
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--------HGPGVDHSRWTLPKRIDVLISVA 125
++LG G+ +++E M +G L+S + + PG TL + I + +A
Sbjct: 84 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIA 140
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+G+ YL++ VH D+ N ++ DF + DFG +R D+ D
Sbjct: 141 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLP 195
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
+ ++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 242
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 61 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPL-Y 117
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 176
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 177 --KCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 232
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 51/273 (18%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VAVK L + +E + E LK++ H +++K+ G + G L LI+EY + GSL
Sbjct: 56 VAVKMLKENASPSEL-RDLLSEFNVLKQVNHPHVIKLYGACSQDGPL-LLIVEYAKYGSL 113
Query: 99 ESVIH-----GPGV---------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ GPG D T+ I ++ G+ YL ++
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMK 170
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
+VH D+ NIL+ + +SDFG SR DV+ +D + + + ++A E + I
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSR--DVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
TT+ DV+SFG+++ E +T G + G+ P L L++ ++ P
Sbjct: 229 YTTQSDVWSFGVLLWEIVT----LGGNPYPGIPPERLFNLLKTG--------HRMERPDN 276
Query: 259 VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
S ++L L C P+ RP
Sbjct: 277 CSE------------EMYRLMLQCWKQEPDKRP 297
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 18 NIIGNSNLSTVYKGRL--EDGEI--VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
I+G +V +G L EDG VAVK + S + F EA +K+ H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 74 KVLGYAWE---SGKLKAL-ILEYMENGSLESVIHGPGVDHSRW-TLPKRIDV------LI 122
++LG E G K + IL +M+ G L + + +SR T PK I + ++
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-----YSRLETGPKHIPLQTLLKFMV 154
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+A G++YL + +H D+ N +L D V+DFG S+ ++ D
Sbjct: 155 DIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIA 209
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK 218
+ + ++A E R+ T+K DV++FG+ + E T+
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 61 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 117
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 176
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 177 --KCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKNTTNGRLPVKWMAPEALF 232
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--------HGPGVDHSRWTLPKRIDVLISVA 125
++LG G+ +++E M +G L+S + + PG TL + I + +A
Sbjct: 81 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIA 137
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+G+ YL++ VH D+ N ++ DF + DFG +R D+ D
Sbjct: 138 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXRKGGKGLLP 192
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
+ ++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 239
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 33 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 91 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 140 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 198 LTAMLAGELP 207
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 33 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 91 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 140 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 198 LTAMLAGELP 207
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 61 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPL-Y 117
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + +A G++YL S
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 176
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 177 --KCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 232
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 33 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 91 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 140 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 198 LTAMLAGELP 207
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TV+K + E EIVA+K++ S RE LKELKH+N+V+ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR-LHD 68
Query: 79 AWESGKLKALILEYME----------NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
S K L+ E+ + NG L+ P + S L + GL
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKS---------FLFQLLKGL 114
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ HS ++H D+KP N+L++R+ E +++FG +R + ++ S+ T+ Y
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWY 167
Query: 189 LAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP 221
P+ + ++ +T +D++S G + E RP
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 13 SFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
+++ +IGN + V++ +L + + VA+KK+ DK F RE + ++ +KH N
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-------LQDKRFKNRELQIMRIVKHPN 93
Query: 72 LVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN 126
+V + + + +G K L+LEY+ + H + + L ++ + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLR 152
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
L Y+HS I I H D+KP N+LLD + DFG++++L ++S + + +
Sbjct: 153 SLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--- 206
Query: 186 IGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
Y APE + TT +D++S G V+ E +
Sbjct: 207 --YRAPELIFGATNYTTNIDIWSTGCVMAELM 236
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 23/201 (11%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ VAVK + S E+ F EA +K L+H LVK+ +A
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKL--HA 244
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I E+M GSL + + S+ LPK ID +A G+ ++
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 299
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D++ +NIL+ ++DFG +R+ + I + APE
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV-------------GAKFPIKWTAPEAINFGSF 346
Query: 200 TTKVDVFSFGIVVMEFLTKRR 220
T K DV+SFGI++ME +T R
Sbjct: 347 TIKSDVWSFGILLMEIVTYGR 367
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFGLARHTDDEM-------TGXVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 25/225 (11%)
Query: 18 NIIGNSNLSTVY----KGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
++G + V+ R + G + A+K L E L ++ H +V
Sbjct: 34 KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 74 KVLGYAWES-GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LISVANGLD 129
K L YA+++ GKL LIL+++ G L + + S+ + DV L +A GLD
Sbjct: 94 K-LHYAFQTEGKL-YLILDFLRGGDLFTRL-------SKEVMFTEEDVKFYLAELALGLD 144
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+LHS + I++ D+KP NILLD + ++DFG S+ D + +F GT+ Y+
Sbjct: 145 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----EAIDHEKKAYSFCGTVEYM 197
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPI 233
APE + + D +S+G+++ E LT P G D + ++ I
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 33 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 91 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 140 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 198 LTAMLAGELP 207
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 72/273 (26%), Positives = 111/273 (40%), Gaps = 39/273 (14%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VA+K++N + D+ +E + + + H N+V +L L+++ + G
Sbjct: 36 EKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPNIVSYYTSFVVKDEL-WLVMKLLSGG 93
Query: 97 SLESVI--------HGPGV-DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
S+ +I H GV D S +L V GL+YLH I H D+K
Sbjct: 94 SVLDIIKHIVAKGEHKSGVLDESTIA-----TILREVLEGLEYLHKNGQI---HRDVKAG 145
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLS--SLSTAFQGTIGYLAPE-FAYMRIVTTKVD 204
NILL D ++DFG S L D++ + F GT ++APE +R K D
Sbjct: 146 NILLGEDGSVQIADFGVSAFLATG-GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 204
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYX 264
++SFGI +E T P + P+ + L Q P L + +
Sbjct: 205 IWSFGITAIELATGAAPY-----HKYPPMKVLML-----------TLQNDPPSLETGVQD 248
Query: 265 XXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
K+ +C +PE RP ELL
Sbjct: 249 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 67.8 bits (164), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 32 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 89
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 90 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 139 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 196
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 197 LTAMLAGELP 206
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 72/273 (26%), Positives = 111/273 (40%), Gaps = 39/273 (14%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VA+K++N + D+ +E + + + H N+V +L L+++ + G
Sbjct: 41 EKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPNIVSYYTSFVVKDEL-WLVMKLLSGG 98
Query: 97 SLESVI--------HGPGV-DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
S+ +I H GV D S +L V GL+YLH I H D+K
Sbjct: 99 SVLDIIKHIVAKGEHKSGVLDESTIA-----TILREVLEGLEYLHKNGQI---HRDVKAG 150
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLS--SLSTAFQGTIGYLAPE-FAYMRIVTTKVD 204
NILL D ++DFG S L D++ + F GT ++APE +R K D
Sbjct: 151 NILLGEDGSVQIADFGVSAFLATG-GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYX 264
++SFGI +E T P + P+ + L Q P L + +
Sbjct: 210 IWSFGITAIELATGAAPY-----HKYPPMKVLML-----------TLQNDPPSLETGVQD 253
Query: 265 XXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
K+ +C +PE RP ELL
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 31 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 88
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 89 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 137
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 138 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 195
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 196 LTAMLAGELP 205
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 33 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 91 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 140 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 198 LTAMLAGELP 207
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 163
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R H D T + T Y APE +M T VD++S
Sbjct: 164 AVNEDCELKILDFGLAR----HTAD---EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWS 215
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 216 VGCIMAELLTGR 227
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 30/222 (13%)
Query: 17 NNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV 75
++I+G + V++GR + G++ A+K N F D RE + LK+L H+N+VK+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKL 72
Query: 76 LGYAWE-SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLH 132
E + + K LI+E+ GSL +V+ P + + LP+ + VL V G+++L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 133 SGYDIPIVHCDMKPSNIL--LDRDFEA--HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
IVH ++KP NI+ + D ++ ++DFG +R L+ Q +S GT Y
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-----LYGTEEY 181
Query: 189 LAPEFAYMRIVTTK---------VDVFSFGIVVMEFLTKRRP 221
L P+ Y R V K VD++S G+ T P
Sbjct: 182 LHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 61 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 117
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG++ S + T + +A G++YL S
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 178 ---CIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTTNGRLPVKWMAPEALF 232
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 61/190 (32%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E K L H N+VK G+ E G ++ L LEY G
Sbjct: 33 EAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 91 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 140 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 198 LTAMLAGELP 207
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 57/305 (18%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + + VAVK L E F +E
Sbjct: 212 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKE 266
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L +D+ R + +
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNL--------LDYLRECNRQEVSA 317
Query: 121 LI------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
++ +++ ++YL +H ++ N L+ + V+DFG SR++ D
Sbjct: 318 VVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT---GD 371
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY----------GMSPYP 421
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRP 291
I L Q+ E L+ Y ++L C NP DRP
Sbjct: 422 GIDLSQVYE-----------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 464
Query: 292 NMNEL 296
+ E+
Sbjct: 465 SFAEI 469
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 163
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R H D T + T Y APE +M T VD++S
Sbjct: 164 AVNEDCELKILDFGLAR----HTAD---EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWS 215
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 216 VGCIMAELLTGR 227
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 67.8 bits (164), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 70 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 130 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 179
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + + T Y APE +M T VD++S
Sbjct: 180 AVNEDCELKILDFGLARHTDDEM-------XGYVATRWYRAPEIMLNWMHYNQT-VDIWS 231
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 232 VGCIMAELLTGR 243
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 54 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 163
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R H D T + T Y APE +M T VD++S
Sbjct: 164 AVNEDCELKILDFGLAR----HTAD---EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWS 215
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 216 VGCIMAELLTGR 227
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DF +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDFYLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 27/192 (14%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK-----ALIL 90
GE VA+KKL+ S K YRE LK ++H N++ +L + L+ L++
Sbjct: 49 GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108
Query: 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIPIVHCDMKPSNI 149
+M+ L+ ++ G+ S ++I L+ + GL Y+HS +VH D+KP N+
Sbjct: 109 PFMQT-DLQKIM---GLKFSE----EKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNL 157
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--FAYMRIVTTKVDVFS 207
++ D E + DFG +R D + T + T Y APE ++M T VD++S
Sbjct: 158 AVNEDCELKILDFGLARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQT-VDIWS 209
Query: 208 FGIVVMEFLTKR 219
G ++ E LT +
Sbjct: 210 VGCIMAEMLTGK 221
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/282 (23%), Positives = 118/282 (41%), Gaps = 43/282 (15%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG N V+ GRL D +VAVK + F +EA+ LK+ H N+V+++G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ + +++E ++ G + + G +R + + ++ A G++YL S
Sbjct: 181 CTQKQPI-YIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG----TIGYLAPEFA 194
+H D+ N L+ +SDFG SR ++ + A G + + APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR------EEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
+++ DV+SFGI++ E + G LS R+ VEK ++
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS----LGASPYPNLSNQQTREFVEKG--------GRLP 335
Query: 255 DPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+L F+L C + P RP+ + +
Sbjct: 336 CPELCPD------------AVFRLMEQCWAYEPGQRPSFSTI 365
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 35/205 (17%)
Query: 36 GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELK-HRNLVKVLG-YAWESGKLKALILEY 92
GE+VAVKK+ F F +D + +RE L EL H N+V +L ++ + L+ +Y
Sbjct: 34 GEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92
Query: 93 MENGSLESVIHGPGVD--HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNIL 150
ME L +VI ++ H ++ + + I V+ YLHSG ++H DMKPSNIL
Sbjct: 93 MET-DLHAVIRANILEPVHKQYVVYQLIKVI-------KYLHSG---GLLHRDMKPSNIL 141
Query: 151 LDRDFEAHVSDFGTSRML-----------------DVHLQDLSSLSTAFQGTIGYLAPEF 193
L+ + V+DFG SR + D + T + T Y APE
Sbjct: 142 LNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI 201
Query: 194 AYMRIVTTK-VDVFSFGIVVMEFLT 217
TK +D++S G ++ E L
Sbjct: 202 LLGSTKYTKGIDMWSLGCILGEILC 226
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++I + + Y ++ EIV K Q +D E L + H
Sbjct: 15 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK----QVEHTND-----ERLMLSIVTH 65
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
++++ G ++ + +I++Y+E G L S++ R+ P V L+
Sbjct: 66 PFIIRMWG-TFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALE 120
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS I++ D+KP NILLD++ ++DFG ++ + ++ GT Y+
Sbjct: 121 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY-------VPDVTYXLCGTPDYI 170
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
APE + +D +SFGI++ E L P
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F E +IG+ V+K + DG+ +K++ ++ AE RE K L +L H N+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDHVNI 66
Query: 73 VKVLGYAWES--------------GKLKALI--LEYMENGSLESVIHGPGVDHSRWTLPK 116
V G W+ K K L +E+ + G+LE I + L
Sbjct: 67 VHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA- 124
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+++ + G+DY+HS +++ D+KPSNI L + + DFG L +
Sbjct: 125 -LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR 180
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
S +GT+ Y++PE + +VD+++ G+++ E L
Sbjct: 181 S-----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--------HGPGVDHSRWTLPKRIDVLISVA 125
++LG G+ +++E M +G L+S + + PG TL + I + +A
Sbjct: 84 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIA 140
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+G+ YL++ VH ++ N ++ DF + DFG +R D++ D
Sbjct: 141 DGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLP 195
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
+ ++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 242
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 67 GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 127 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 176
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + DFG +R D + T Y APE +M T VD++S
Sbjct: 177 AVNEDCELKILDFGLARHTDDEM-------XGXVATRWYRAPEIMLNWMHYNQT-VDIWS 228
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 229 VGCIMAELLTGR 240
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--------HGPGVDHSRWTLPKRIDVLISVA 125
++LG G+ +++E M +G L+S + + PG TL + I + +A
Sbjct: 85 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIA 141
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+G+ YL++ VH ++ N ++ DF + DFG +R D++ D
Sbjct: 142 DGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLP 196
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
+ ++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 243
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/282 (23%), Positives = 118/282 (41%), Gaps = 43/282 (15%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG N V+ GRL D +VAVK + F +EA+ LK+ H N+V+++G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ + +++E ++ G + + G +R + + ++ A G++YL S
Sbjct: 181 CTQKQPI-YIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG----TIGYLAPEFA 194
+H D+ N L+ +SDFG SR ++ + A G + + APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR------EEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
+++ DV+SFGI++ E + G LS R+ VEK ++
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS----LGASPYPNLSNQQTREFVEKG--------GRLP 335
Query: 255 DPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P+L F+L C + P RP+ + +
Sbjct: 336 CPELCPD------------AVFRLMEQCWAYEPGQRPSFSTI 365
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 20 IGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESD-----KSFYREAKTLKELKHRNLV 73
IG V+KGRL +D +VA+K L E++ + F RE + L H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHS---RWTLPKRIDVLISVANGLDY 130
K+ G + +++E++ G L + +D + +W++ ++ +++ +A G++Y
Sbjct: 87 KLYGLMHNPPR---MVMEFVPCGDLYHRL----LDKAHPIKWSV--KLRLMLDIALGIEY 137
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFE-----AHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+ + + PIVH D++ NI L E A V+DF S+ Q + S+S G
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVS-GLLGN 189
Query: 186 IGYLAPEF--AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++APE A T K D +SF +++ LT P
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + FG +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILGFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 92 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 146
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + AF GT Y++P
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANAFVGTAQYVSP 201
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 38/235 (16%)
Query: 14 FSENNI-----IGNSNLSTVYKGR------LEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
+ NNI IG V++ R E +VAVK L + SA+ F REA
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAA 102
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLE------------SVIHGPGVDHS 110
+ E + N+VK+LG GK L+ EYM G L S+ H +
Sbjct: 103 LMAEFDNPNIVKLLGVC-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 111 RWTLP--------KRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162
R + P +++ + VA G+ YL + VH D+ N L+ + ++DF
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
G SR +++ D I ++ PE + TT+ DV+++G+V+ E +
Sbjct: 219 GLSR--NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 77/286 (26%), Positives = 119/286 (41%), Gaps = 42/286 (14%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F++ + IG + VYKG E+VA+K ++ + E + +E L + +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYI 79
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ G +S KL +I+EY+ GS ++ PG + +L + GLDYLH
Sbjct: 80 TRYFGSYLKSTKL-WIIMEYLGGGSALDLLK-PGPLEETYI----ATILREILKGLDYLH 133
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
S I H D+K +N+LL + ++DFG + L D F GT ++APE
Sbjct: 134 SERKI---HRDIKAANVLLSEQGDVKLADFGVAG----QLTDTQIKRNXFVGTPFWMAPE 186
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
K D++S GI +E L K P D L P+ + L+ K + G Q
Sbjct: 187 VIKQSAYDFKADIWSLGITAIE-LAKGEPPNSD----LHPMRVLFLIPKNSPPTLEG--Q 239
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFK-LALVCTSSNPEDRPNMNELL 297
+ P FK C + +P RP ELL
Sbjct: 240 HSKP-------------------FKEFVEACLNKDPRFRPTAKELL 266
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + D G +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDAGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 30/222 (13%)
Query: 12 GSFSENNI-IGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
G F + +I IG + TVYKG + + VA +L + + + F EA+ LK L+H
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQH 84
Query: 70 RNLVKVLGYAWES----GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS-- 123
N+V+ +WES K L+ E +G+L++ + R+ + K I VL S
Sbjct: 85 PNIVRFYD-SWESTVKGKKCIVLVTELXTSGTLKTYL-------KRFKVXK-IKVLRSWC 135
Query: 124 --VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL--SSLS 179
+ GL +LH+ PI+H D+K NI + G+ ++ D+ L L +S +
Sbjct: 136 RQILKGLQFLHTRTP-PIIHRDLKCDNIFI-------TGPTGSVKIGDLGLATLKRASFA 187
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
A GT + APE Y VDV++FG +E T P
Sbjct: 188 KAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 25 LSTVYKGRLED-------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
L T+ KG D G VAVK + + + ++F EA + +L+H NLV++LG
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E ++ EYM GSL + G S + + V ++YL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
VH D+ N+L+ D A VSDFG ++ + SS + + + APE +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 189
Query: 198 IVTTKVDVFSFGIVVMEFLTKRR 220
+TK DV+SFGI++ E + R
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGR 212
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + D G +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDRGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 61 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 117
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+ Y G+L + PG+++S + T + +A G++YL S
Sbjct: 118 VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 176
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 177 --KCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 232
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFT 254
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 9/183 (4%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYME 94
GE VAVK L + +E + L+ L H N+VK G E G LI+E++
Sbjct: 50 GEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154
+GSL+ + + ++ L +++ + + G+DYL S VH D+ N+L++ +
Sbjct: 109 SGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 162
Query: 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
+ + DFG ++ ++ ++ ++ + + APE DV+SFG+ + E
Sbjct: 163 HQVKIGDFGLTKAIETD-KEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 221
Query: 215 FLT 217
LT
Sbjct: 222 LLT 224
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 35/232 (15%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--------HGPGVDHSRWTLPKRIDVLISVA 125
++LG G+ +++E M +G L+S + + PG TL + I + +A
Sbjct: 84 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIA 140
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+G+ YL++ VH D+ N ++ DF + DFG +R D+ + +G
Sbjct: 141 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETAYYRKGG 190
Query: 186 IG-----YLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
G ++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 242
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 25 LSTVYKGRLED-------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
L T+ KG D G VAVK + + + ++F EA + +L+H NLV++LG
Sbjct: 11 LQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E ++ EYM GSL + G S + + V ++YL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN--- 121
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
VH D+ N+L+ D A VSDFG ++ + SS + + + APE +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 174
Query: 198 IVTTKVDVFSFGIVVMEFLT 217
+TK DV+SFGI++ E +
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 25 LSTVYKGRLED-------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
L T+ KG D G VAVK + + + ++F EA + +L+H NLV++LG
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E ++ EYM GSL + G S + + V ++YL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
VH D+ N+L+ D A VSDFG ++ + SS + + + APE +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 361
Query: 198 IVTTKVDVFSFGIVVMEFLT 217
+TK DV+SFGI++ E +
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 9/183 (4%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYME 94
GE VAVK L + +E + L+ L H N+VK G E G LI+E++
Sbjct: 38 GEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 96
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154
+GSL+ + + ++ L +++ + + G+DYL S VH D+ N+L++ +
Sbjct: 97 SGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 150
Query: 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
+ + DFG ++ ++ ++ ++ + + APE DV+SFG+ + E
Sbjct: 151 HQVKIGDFGLTKAIETD-KEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 209
Query: 215 FLT 217
LT
Sbjct: 210 LLT 212
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 26/192 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILE 91
G VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++
Sbjct: 47 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 92 YMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
++ L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+
Sbjct: 107 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNL 156
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFS 207
++ D E + D G +R D + T + T Y APE +M T VD++S
Sbjct: 157 AVNEDCELKILDGGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWS 208
Query: 208 FGIVVMEFLTKR 219
G ++ E LT R
Sbjct: 209 VGCIMAELLTGR 220
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 17 NNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV 75
++I+G + V++GR + G++ A+K N F D RE + LK+L H+N+VK+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKL 72
Query: 76 LGYAWE-SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLH 132
E + + K LI+E+ GSL +V+ P + + LP+ + VL V G+++L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 133 SGYDIPIVHCDMKPSNIL--LDRDFEA--HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
IVH ++KP NI+ + D ++ ++DFG +R L+ Q GT Y
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-----FVXLYGTEEY 181
Query: 189 LAPEFAYMRIVTTK---------VDVFSFGIVVMEFLTKRRP 221
L P+ Y R V K VD++S G+ T P
Sbjct: 182 LHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G+ VAVKK++ + + + + E +++ H N+V + ++ G +++E++E
Sbjct: 70 GKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHDNVVDMYS-SYLVGDELWVVMEFLEG 126
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V +SV L YLH+ ++H D+K +ILL D
Sbjct: 127 GALTDI-----VTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDG 178
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + L GT ++APE T+VD++S GI+V+E
Sbjct: 179 RIKLSDFGFCAQVSKEVPKRKXLV----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 234
Query: 216 LTKRRP 221
+ P
Sbjct: 235 IDGEPP 240
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G VYK + G IVA+K++ + RE LKEL H N+V ++
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 80 WESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
S + L+ E+ME L+ V+ + G+ S+ + L + G+ + H
Sbjct: 89 -HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI-----YLYQLLRGVAHCHQHR-- 139
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-M 196
I+H D+KP N+L++ D ++DFG +R + ++ + T+ Y AP+
Sbjct: 140 -ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGS 194
Query: 197 RIVTTKVDVFSFGIVVMEFLTKR 219
+ +T VD++S G + E +T +
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 94 FVK-LYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 148
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + +F GT Y++P
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANSFVGTAQYVSP 203
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D+++ G ++ + + P
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPP 233
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G VYK + G IVA+K++ + RE LKEL H N+V ++
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 80 WESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
S + L+ E+ME L+ V+ + G+ S+ + L + G+ + H
Sbjct: 89 -HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI-----YLYQLLRGVAHCHQHR-- 139
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-M 196
I+H D+KP N+L++ D ++DFG +R + ++ + T+ Y AP+
Sbjct: 140 -ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGS 194
Query: 197 RIVTTKVDVFSFGIVVMEFLTKR 219
+ +T VD++S G + E +T +
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 60/190 (31%), Positives = 85/190 (44%), Gaps = 20/190 (10%)
Query: 37 EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96
E VAVK ++ + + + ++ +E L H N+VK G+ E G ++ L LEY G
Sbjct: 33 EAVAVKIVDMKR-AVDCPENIKKEICINAMLNHENVVKFYGHRRE-GNIQYLFLEYCSGG 90
Query: 97 SL----ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L E I P D R+ + G+ YLH I I H D+KP N+LLD
Sbjct: 91 ELFDRIEPDIGMPEPDAQRF--------FHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIV 211
+SDFG + + + L GT+ Y+APE R VDV+S GIV
Sbjct: 140 ERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 212 VMEFLTKRRP 221
+ L P
Sbjct: 198 LTAMLAGELP 207
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 25 LSTVYKGRLED-------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
L T+ KG D G VAVK + + + ++F EA + +L+H NLV++LG
Sbjct: 17 LQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E ++ EYM GSL + G S + + V ++YL
Sbjct: 73 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN-- 128
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
VH D+ N+L+ D A VSDFG ++ + SS + + + APE
Sbjct: 129 -FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREA 180
Query: 198 IVTTKVDVFSFGIVVMEFLTKRR 220
+TK DV+SFGI++ E + R
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFGR 203
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 61 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 117
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+ Y G+L + PG+++S + T + +A G++YL S
Sbjct: 118 VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ- 176
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R D++ D +T + + ++APE +
Sbjct: 177 --KCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEALF 232
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 95 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 149
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + +F GT Y++P
Sbjct: 150 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANSFVGTAQYVSP 204
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 234
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 67/252 (26%), Positives = 109/252 (43%), Gaps = 25/252 (9%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKH 69
G + + +G V G+ E G VAVK LN + S + RE + LK +H
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+++K+ + +++EY+ G L I G R + + + +G+D
Sbjct: 76 PHIIKLYQVISTPSDI-FMVMEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVD 130
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
Y H +VH D+KP N+LLD A ++DFG S M + D L + G+ Y
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM----MSDGEFLRXSC-GSPNYA 182
Query: 190 APEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248
APE R+ +VD++S G+++ L P D L K + +GI
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF---------KKICDGIF 233
Query: 249 GVRQITDPKLVS 260
Q +P ++S
Sbjct: 234 YTPQYLNPSVIS 245
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 48/186 (25%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++VAVKK++ + + + + E +++ +H N+V++ ++ G +++E++E
Sbjct: 99 GKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN-SYLVGDELWVVMEFLEG 155
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V ++V L LH+ ++H D+K +ILL D
Sbjct: 156 GALTDI-----VTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDG 207
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + L GT ++APE +VD++S GI+V+E
Sbjct: 208 RVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 263
Query: 216 LTKRRP 221
+ P
Sbjct: 264 VDGEPP 269
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 39 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 99 FVK-LYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 153
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 154 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 208
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 238
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 91 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 145
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + +F GT Y++P
Sbjct: 146 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANSFVGTAQYVSP 200
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 230
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 48/186 (25%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++VAVKK++ + + + + E +++ +H N+V++ ++ G +++E++E
Sbjct: 56 GKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN-SYLVGDELWVVMEFLEG 112
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V ++V L LH+ ++H D+K +ILL D
Sbjct: 113 GALTDI-----VTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDG 164
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + L GT ++APE +VD++S GI+V+E
Sbjct: 165 RVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 220
Query: 216 LTKRRP 221
+ P
Sbjct: 221 VDGEPP 226
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 72/300 (24%), Positives = 123/300 (41%), Gaps = 51/300 (17%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYREA 61
D+ E+E + + +G VY G + + VAVK L E F +EA
Sbjct: 25 DKWEMERT--DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE---FLKEA 79
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+KE+KH NLV++LG ++ EYM G+L +D+ R + + +
Sbjct: 80 AVMKEIKHPNLVQLLGVCTLEPPF-YIVTEYMPYGNL--------LDYLRECNREEVTAV 130
Query: 122 I------SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ +++ ++YL +H D+ N L+ + V+DFG SR++ D
Sbjct: 131 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMT---GDT 184
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+ + I + APE + K DV++FG+++ E T G+SP
Sbjct: 185 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT----------YGMSPYP- 233
Query: 236 RQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNE 295
GI+ + Q+ D L+ Y ++L C +P DRP+ E
Sbjct: 234 ----------GID-LSQVYD--LLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAE 280
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 47/233 (20%)
Query: 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F E +IG+ V+K + DG+ ++++ ++ AE RE K L +L H N+
Sbjct: 14 FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE------REVKALAKLDHVNI 67
Query: 73 VKVLGYAWES---------------------------GKLKALI--LEYMENGSLESVIH 103
V G W+ K K L +E+ + G+LE I
Sbjct: 68 VHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 104 GPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163
+ L +++ + G+DY+HS ++H D+KPSNI L + + DFG
Sbjct: 127 KRRGEKLDKVLA--LELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
L L++ T +GT+ Y++PE + +VD+++ G+++ E L
Sbjct: 182 ----LVTSLKN-DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 12 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 72 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 126
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 127 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 181
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 211
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 94 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 148
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 203
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 48/186 (25%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++VAVKK++ + + + + E +++ +H N+V++ ++ G +++E++E
Sbjct: 45 GKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN-SYLVGDELWVVMEFLEG 101
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V ++V L LH+ ++H D+K +ILL D
Sbjct: 102 GALTDI-----VTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDG 153
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + L GT ++APE +VD++S GI+V+E
Sbjct: 154 RVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 216 LTKRRP 221
+ P
Sbjct: 210 VDGEPP 215
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 28/201 (13%)
Query: 24 NLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83
++ + Y RL + VAVKKL+ S + YRE + LK LKH N++ +L +
Sbjct: 35 SVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPAT 92
Query: 84 KLK----ALILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
++ ++ + L +++ + +H ++ ++ + GL Y+HS
Sbjct: 93 SIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-------LVYQLLRGLKYIHSA--- 142
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--Y 195
I+H D+KPSN+ ++ D E + DFG +R D + T + T Y APE +
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM-------TGYVATRWYRAPEIMLNW 195
Query: 196 MRIVTTKVDVFSFGIVVMEFL 216
M T VD++S G ++ E L
Sbjct: 196 MHYNQT-VDIWSVGCIMAELL 215
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 48/186 (25%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++VAVKK++ + + + + E +++ +H N+V++ ++ G +++E++E
Sbjct: 176 GKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN-SYLVGDELWVVMEFLEG 232
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V ++V L LH+ ++H D+K +ILL D
Sbjct: 233 GALTDI-----VTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDG 284
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + L GT ++APE +VD++S GI+V+E
Sbjct: 285 RVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 340
Query: 216 LTKRRP 221
+ P
Sbjct: 341 VDGEPP 346
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 48/186 (25%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++VAVKK++ + + + + E +++ +H N+V++ ++ G +++E++E
Sbjct: 54 GKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN-SYLVGDELWVVMEFLEG 110
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V ++V L LH+ ++H D+K +ILL D
Sbjct: 111 GALTDI-----VTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDG 162
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + L GT ++APE +VD++S GI+V+E
Sbjct: 163 RVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 218
Query: 216 LTKRRP 221
+ P
Sbjct: 219 VDGEPP 224
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 22/227 (9%)
Query: 9 NATGSFSENNIIGNSNLSTVY--KGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE 66
N +F ++G+ S V+ K RL G++ A+K + + A D S E LK+
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIK--KSPAFRDSSLENEIAVLKK 62
Query: 67 LKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN 126
+KH N+V L +ES L+++ + G L I GV +T V+ V +
Sbjct: 63 IKHENIV-TLEDIYESTTHYYLVMQLVSGGELFDRILERGV----YTEKDASLVIQQVLS 117
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ YLH IVH D+KP N+L + + + ++DFG S+M + +STA
Sbjct: 118 AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-----EQNGIMSTAC- 168
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
GT GY+APE + + VD +S G++ L P + E+ L
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 95 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 149
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 150 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 204
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 234
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 2 FDRTEIENA--TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESD-KSFY 58
FD EI A GSF + I+ ++ +Y A+K +N + ++ ++ +
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMY----------AMKYMNKQKCVERNEVRNVF 63
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
+E + ++ L+H LV L Y+++ + ++++ + G L + V T+ I
Sbjct: 64 KELQIMQGLEHPFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFI 121
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ LDYL + I+H DMKP NILLD H++DF + ML Q
Sbjct: 122 CELVM---ALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ----- 170
Query: 179 STAFQGTIGYLAPEFAYMRI---VTTKVDVFSFGIVVMEFLTKRRP 221
T GT Y+APE R + VD +S G+ E L RRP
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 37 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 97 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 151
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 152 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 206
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 236
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 48/186 (25%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++VAVKK++ + + + + E +++ +H N+V++ ++ G +++E++E
Sbjct: 49 GKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN-SYLVGDELWVVMEFLEG 105
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V ++V L LH+ ++H D+K +ILL D
Sbjct: 106 GALTDI-----VTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDG 157
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + L GT ++APE +VD++S GI+V+E
Sbjct: 158 RVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 213
Query: 216 LTKRRP 221
+ P
Sbjct: 214 VDGEPP 219
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 11 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 71 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 125
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 126 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 180
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 210
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 70 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 124
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 179
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 94 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 148
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 203
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 9 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 69 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 123
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 124 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 178
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 208
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 92 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 146
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 201
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 94 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 148
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 203
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 92 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 146
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 201
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 16 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 76 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 130
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 131 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 185
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 215
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 94 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 148
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 203
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 24 NLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83
++ + Y RL + VAVKKL+ S + YRE + LK LKH N++ +L
Sbjct: 43 SVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVF---- 96
Query: 84 KLKALILEYMENGSLESVIHGPGVDH---SRWTLPKRIDVLI-SVANGLDYLHSGYDIPI 139
A +E L + + G +++ S+ + + L+ + GL Y+HS I
Sbjct: 97 -TPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA---GI 152
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMR 197
+H D+KPSN+ ++ D E + DFG +R D + T + T Y APE +M
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEEM-------TGYVATRWYRAPEIMLNWMH 205
Query: 198 IVTTKVDVFSFGIVVMEFLTKR 219
T VD++S G ++ E L +
Sbjct: 206 YNQT-VDIWSVGCIMAELLQGK 226
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 64.3 bits (155), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 91 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 145
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 146 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 200
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 230
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 64.3 bits (155), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 36 GEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94
G+ AVK ++ Q ++DK S RE + LK+L H N++K+ + + G L+ E
Sbjct: 74 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF-YLVGEVYT 132
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-- 152
G L I + R++ ++ V +G+ Y+H IVH D+KP N+LL+
Sbjct: 133 GGELFDEI----ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESK 185
Query: 153 -RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
+D + DFG S + + + TA+ Y+APE + K DV+S G++
Sbjct: 186 SKDANIRIIDFGLSTHFEASKKMKDKIGTAY-----YIAPEVLH-GTYDEKCDVWSTGVI 239
Query: 212 VMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
+ L+ P NG + + + VEK
Sbjct: 240 LYILLSGCPPF-----NGANEYDILKKVEKG 265
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 64.3 bits (155), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 36 GEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94
G+ AVK ++ Q ++DK S RE + LK+L H N++K+ + + G L+ E
Sbjct: 75 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF-YLVGEVYT 133
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-- 152
G L I + R++ ++ V +G+ Y+H IVH D+KP N+LL+
Sbjct: 134 GGELFDEI----ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESK 186
Query: 153 -RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
+D + DFG S + + + TA+ Y+APE + K DV+S G++
Sbjct: 187 SKDANIRIIDFGLSTHFEASKKMKDKIGTAY-----YIAPEVLH-GTYDEKCDVWSTGVI 240
Query: 212 VMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
+ L+ P NG + + + VEK
Sbjct: 241 LYILLSGCPPF-----NGANEYDILKKVEKG 266
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 64.3 bits (155), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + STV R L A+K L E+ + RE + L H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T +++ + L+YL
Sbjct: 94 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYL 148
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 203
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 64.3 bits (155), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 28/245 (11%)
Query: 7 IENATGSFSE----NNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDK-SFYRE 60
++++T FS+ ++G + V + + G+ AVK ++ Q ++DK S RE
Sbjct: 23 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 82
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ LK+L H N++K+ + + G L+ E G L I + R++ +
Sbjct: 83 VQLLKQLDHPNIMKLYEFFEDKGYF-YLVGEVYTGGELFDEI----ISRKRFSEVDAARI 137
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFGTSRMLDVHLQDLSS 177
+ V +G+ Y+H IVH D+KP N+LL+ +D + DFG S + +
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237
+ TA+ Y+APE + K DV+S G+++ L +G NG + + +
Sbjct: 195 IGTAY-----YIAPEVLH-GTYDEKCDVWSTGVILYILL-----SGCPPFNGANEYDILK 243
Query: 238 LVEKA 242
VEK
Sbjct: 244 KVEKG 248
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 64.3 bits (155), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLG 77
+G + +VYK E G+IVA+K Q ESD + +E +++ ++VK G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+++ L +++EY GS+ +I + + T + +L S GL+YLH I
Sbjct: 92 SYFKNTDL-WIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
H D+K NILL+ + A ++DFG + L D + GT ++APE
Sbjct: 148 ---HRDIKAGNILLNTEGHAKLADFGVAG----QLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP 221
D++S GI +E + P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 63.9 bits (154), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 65/246 (26%), Positives = 115/246 (46%), Gaps = 30/246 (12%)
Query: 7 IENATGSFSE----NNIIGNSNLSTVY--KGRLEDGEIVAVKKLNFHQFSAESDK-SFYR 59
++++T FS+ ++G + V K ++ G+ AVK ++ Q ++DK S R
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E + LK+L H N++K+ + + G L+ E G L I + R++
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYF-YLVGEVYTGGELFDEI----ISRKRFSEVDAAR 130
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFGTSRMLDVHLQDLS 176
++ V +G+ Y+H IVH D+KP N+LL+ +D + DFG S + +
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236
+ TA+ Y+APE + K DV+S G+++ L+ P NG + +
Sbjct: 188 KIGTAY-----YIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPF-----NGANEYDIL 236
Query: 237 QLVEKA 242
+ VEK
Sbjct: 237 KKVEKG 242
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 90/188 (47%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VA+KK++ + ++ RE K L +H N++ + + ++A +E M++ L
Sbjct: 71 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGI------NDIIRAPTIEQMKDVYL 123
Query: 99 ESVIHGPGVDHSRWTLPKRID------VLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
V H G D + + + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 124 --VTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 178
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 179 TTXDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 237
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 238 LAEMLSNR 245
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 24 NLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83
++ + Y RL + VAVKKL+ S + YRE + LK LKH N++ +L +
Sbjct: 43 SVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPAT 100
Query: 84 KLK----ALILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
++ ++ + L +++ + +H ++ ++ + GL Y+HS
Sbjct: 101 SIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-------LVYQLLRGLKYIHSA--- 150
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--Y 195
I+H D+KPSN+ ++ D E + DFG +R D + T + T Y APE +
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-------TGYVATRWYRAPEIMLNW 203
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKR 219
M T VD++S G ++ E L +
Sbjct: 204 MHYNQT-VDIWSVGCIMAELLQGK 226
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 78/289 (26%), Positives = 121/289 (41%), Gaps = 48/289 (16%)
Query: 14 FSENNIIGNSNLSTVYKG---RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
F++ IG + V+KG R + ++VA+K ++ + E + +E L +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSS 81
Query: 71 NLVKVLGYAWESGKLKALILEYMENGS-LESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+ K G + KL +I+EY+ GS L+ + GP + T+ K I GLD
Sbjct: 82 YVTKYYGSYLKGSKL-WIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI------LKGLD 134
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS I H D+K +N+LL + ++DFG + L D F GT ++
Sbjct: 135 YLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAG----QLTDTQIKRNTFVGTPFWM 187
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249
APE +K D++S GI +E L K P D + P+ + L+ K
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIE-LAKGEPPNSD----MHPMRVLFLIPKN------- 235
Query: 250 VRQITDPKLVSSIYXXXXXXXXXXXXFKLAL-VCTSSNPEDRPNMNELL 297
P LV FK + C + +P RP ELL
Sbjct: 236 ----NPPTLVGDF----------TKSFKEFIDACLNKDPSFRPTAKELL 270
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRN 71
F +G VY R + IVA+K L Q E + RE + L H N
Sbjct: 25 FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++++ Y ++ ++ LILEY G L + + T ++ +A+ L Y
Sbjct: 85 ILRLYNYFYDRRRI-YLILEYAPRGELYKELQKSCTFDEQRT----ATIMEELADALMYC 139
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H ++H D+KP N+LL E ++DFG S VH L + GT+ YL P
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMC--GTLDYLPP 190
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E R+ KVD++ G++ E L P
Sbjct: 191 EMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 27/225 (12%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVL 76
+G V++G + GE VAVK FS+ +KS++RE + L+H N++ +
Sbjct: 44 CVGKGRYGEVWRGSWQ-GENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFI 97
Query: 77 G---YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH- 132
+ S LI Y E GSL + +D + +++S+A+GL +LH
Sbjct: 98 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV-----SCLRIVLSIASGLAHLHI 152
Query: 133 ----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ I H D+K NIL+ ++ + ++D G + M L + GT Y
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 212
Query: 189 LAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEE 227
+APE I +VD+++FG+V+ E + G+ E+
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 257
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 12/210 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRN 71
F I+G + ST R L A+K L E+ + RE + L H
Sbjct: 32 FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK L + ++ + L Y +NG L I G T R + + L+YL
Sbjct: 92 FVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RF-YTAEIVSALEYL 146
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + + F GT Y++P
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQARANXFVGTAQYVSP 201
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + D+++ G ++ + + P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 27/225 (12%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVL 76
+G V++G + GE VAVK FS+ +KS++RE + L+H N++ +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 77 G---YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH- 132
+ S LI Y E GSL + +D + +++S+A+GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLHI 123
Query: 133 ----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ I H D+K NIL+ ++ + ++D G + M L + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 189 LAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEE 227
+APE I +VD+++FG+V+ E + G+ E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 27/225 (12%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVL 76
+G V++G + GE VAVK FS+ +KS++RE + L+H N++ +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 77 G---YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH- 132
+ S LI Y E GSL + +D + +++S+A+GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV-----SCLRIVLSIASGLAHLHI 123
Query: 133 ----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ I H D+K NIL+ ++ + ++D G + M L + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 189 LAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEE 227
+APE I +VD+++FG+V+ E + G+ E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 36 GEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94
G+ AVK ++ Q ++DK S RE + LK+L H N+ K+ + + G L+ E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYF-YLVGEVYT 109
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-- 152
G L I + R++ ++ V +G+ Y H IVH D+KP N+LL+
Sbjct: 110 GGELFDEI----ISRKRFSEVDAARIIRQVLSGITYXHKN---KIVHRDLKPENLLLESK 162
Query: 153 -RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
+D + DFG S + + + TA+ Y+APE + K DV+S G++
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKXKDKIGTAY-----YIAPEVLHG-TYDEKCDVWSTGVI 216
Query: 212 VMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
+ L+ P NG + + + VEK
Sbjct: 217 LYILLSGCPPF-----NGANEYDILKKVEKG 242
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIV----AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
++G+ TVYKG + +GE V A+K LN +++ F EA + + H +L
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHL 102
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V++LG L+ + M +G L +H + L ++ + +A G+ YL
Sbjct: 103 VRLLGVCLSP--TIQLVTQLMPHGCLLEYVHEHKDNIGSQLL---LNWCVQIAKGMMYLE 157
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+VH D+ N+L+ ++DFG +R+L+ ++ + + + I ++A E
Sbjct: 158 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN--ADGGKMPIKWMALE 212
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLT 217
+ R T + DV+S+G+ + E +T
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMT 237
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 14 FSENNIIGNSNLSTVYKG---RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
F++ IG + V+KG R + ++VA+K ++ + E + +E L +
Sbjct: 29 FTKLEKIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSP 85
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
+ K G + KL +I+EY+ GS ++ +D ++ +L + GLDY
Sbjct: 86 YVTKYYGSYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDY 139
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LHS I H D+K +N+LL E ++DFG + L D F GT ++A
Sbjct: 140 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAG----QLTDTQIKRNTFVGTPFWMA 192
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE +K D++S GI +E P
Sbjct: 193 PEVIKQSAYDSKADIWSLGITAIELARGEPP 223
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 18/220 (8%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKH 69
G + + +G V G + G VAVK LN + S + RE + LK +H
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+++K+ +++EY+ G L I H R + + + + +D
Sbjct: 71 PHIIKLYQVISTPTDF-FMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVD 125
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
Y H +VH D+KP N+LLD A ++DFG S M + D L T+ G+ Y
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM----MSDGEFLRTSC-GSPNYA 177
Query: 190 APEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRPTGLDEEN 228
APE R+ +VD++S G+++ L P D+E+
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLP--FDDEH 215
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 19 IIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
++G + V K R +D G IVA+KK K RE K LK+L+H NLV +L
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 78 YAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
+ K L+ E++++ L+ + P G+D+ + K L + NG+ + HS
Sbjct: 92 VC-KKKKRWYLVFEFVDHTILDDLELFPNGLDYQ--VVQK---YLFQIINGIGFCHSH-- 143
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
I+H D+KP NIL+ + + DFG +R L + T Y APE
Sbjct: 144 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP----GEVYDDEVATRWYRAPELLVG 198
Query: 197 RIVTTK-VDVFSFGIVVMEFL 216
+ K VDV++ G +V E
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMF 219
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 79
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 80 NPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 132
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 133 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 187
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 238
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 239 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 275
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 77
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 78 NPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 130
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 185
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 236
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 237 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 273
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 77
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 78 NPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 130
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPI 185
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 236
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 237 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 273
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 79
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 80 NPHVCRLLGICLTSTV--QLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 132
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 133 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPI 187
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 238
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 239 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 275
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 78
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 79 NPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 131
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 186
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 237
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 238 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 274
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 14 FSENNIIGNSNLSTVYKG---RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
F++ IG + V+KG R + ++VA+K ++ + E + +E L +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSP 65
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
+ K G + KL +I+EY+ GS ++ +D ++ +L + GLDY
Sbjct: 66 YVTKYYGSYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDY 119
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LHS I H D+K +N+LL E ++DFG + L D F GT ++A
Sbjct: 120 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAG----QLTDTQIKRNTFVGTPFWMA 172
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE +K D++S GI +E P
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPP 203
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 14 FSENNIIGNSNLSTVYKG---RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
F++ IG + V+KG R + ++VA+K ++ + E + +E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSP 80
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
+ K G + KL +I+EY+ GS ++ +D ++ +L + GLDY
Sbjct: 81 YVTKYYGSYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDY 134
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LHS I H D+K +N+LL E ++DFG + L D F GT ++A
Sbjct: 135 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAG----QLTDTQIKRNXFVGTPFWMA 187
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE +K D++S GI +E P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIV----AVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
++G+ TVYKG + +GE V A+K LN +++ F EA + + H +L
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHL 79
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V++LG L+ + M +G L +H + L ++ + +A G+ YL
Sbjct: 80 VRLLGVC--LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLL---LNWCVQIAKGMMYLE 134
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+VH D+ N+L+ ++DFG +R+L+ ++ + + + I ++A E
Sbjct: 135 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN--ADGGKMPIKWMALE 189
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLT 217
+ R T + DV+S+G+ + E +T
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMT 214
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 76
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 77 NPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 129
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 130 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 184
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 235
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 236 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 272
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 42/248 (16%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F E ++G V K R D A+KK+ + + E + E L L H+ +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYV 64
Query: 73 VKVLGYAW----------ESGKLKALI---LEYMENGSLESVIHGPGVDHSR---WTLPK 116
V+ AW + K K+ + +EY ENG+L +IH ++ R W L +
Sbjct: 65 VRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS----RMLDVHL 172
+I L Y+HS I+H D+KP NI +D + DFG + R LD+
Sbjct: 124 QI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 173 QDLSSLS------TAFQGTIGYLAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225
D +L T+ GT Y+A E K+D++S GI+ E + TG++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-FSTGME 233
Query: 226 EENGLSPI 233
N L +
Sbjct: 234 RVNILKKL 241
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VAVKKL+ + K YRE LK + H+N++ +L L+ L++E M
Sbjct: 52 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VIH +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLCQVIHM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R + + T + T Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTACTNF-----MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 ELV 219
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 75
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 76 NPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 128
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 183
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 234
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 235 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 271
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ + + VY A+K L+ + SD +F+ E + + +
Sbjct: 85 GAFGEVQLVRHKSTRKVY----------AMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V L YA++ + +++EYM G L +++ V +W +V+++ LD +
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLA----LDAI 189
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS + +H D+KP N+LLD+ ++DFGT + ++ + + TA GT Y++P
Sbjct: 190 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISP 243
Query: 192 EFAYMR----IVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D +S G+ + E L P
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ + + VY A+K L+ + SD +F+ E + + +
Sbjct: 80 GAFGEVQLVRHKSTRKVY----------AMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V L YA++ + +++EYM G L +++ V +W +V+++ LD +
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLA----LDAI 184
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS + +H D+KP N+LLD+ ++DFGT + ++ + + TA GT Y++P
Sbjct: 185 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISP 238
Query: 192 EFAYMR----IVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D +S G+ + E L P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 14 FSENNIIGNSNLSTVYKG---RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
F++ IG + V+KG R + ++VA+K ++ + E + +E L +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQ--KVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSP 65
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
+ K G + KL +I+EY+ GS ++ +D ++ +L + GLDY
Sbjct: 66 YVTKYYGSYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDY 119
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LHS I H D+K +N+LL E ++DFG + L D F GT ++A
Sbjct: 120 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAG----QLTDTQIKRNXFVGTPFWMA 172
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE +K D++S GI +E P
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPP 203
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ + + VY A+K L+ + SD +F+ E + + +
Sbjct: 85 GAFGEVQLVRHKSTRKVY----------AMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V L YA++ + +++EYM G L +++ V +W +V+++ LD +
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLA----LDAI 189
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS + +H D+KP N+LLD+ ++DFGT + ++ + + TA GT Y++P
Sbjct: 190 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISP 243
Query: 192 EFAYMR----IVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D +S G+ + E L P
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VAVKKL+ + K YRE LK + H+N++ +L L+ L++E M
Sbjct: 50 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VIH +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 110 -DANLCQVIHM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 159
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R + + T + T Y APE VD++S G ++
Sbjct: 160 DCTLKILDFGLARTASTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 214
Query: 214 EFL 216
E +
Sbjct: 215 ELV 217
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 129/292 (44%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 76
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 77 NPHVCRLLGICLTS--TVQLIMQLMPFGXLLDYVREHKDNIG-SQYLL----NWCVQIAK 129
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 130 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 184
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 235
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 236 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 272
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 70/287 (24%), Positives = 126/287 (43%), Gaps = 48/287 (16%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G+ VYK + E G + A K + S E + + E + L H +VK+LG
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDI 137
+ GKL +I E+ G++++++ ++ R +I V+ + L++LHS
Sbjct: 77 YYHDGKLWIMI-EFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALNFLHSKR-- 129
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST--AFQGTIGYLAPEFAY 195
I+H D+K N+L+ + + ++DFG S ++L +L +F GT ++APE
Sbjct: 130 -IIHRDLKAGNVLMTLEGDIRLADFGVSA------KNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 196 MRIVTT-----KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
+ K D++S GI ++E P + L+P+ + + K
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPP-----HHELNPMRVLLKIAK--------- 228
Query: 251 RQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+DP ++ K+AL NPE RP+ +LL
Sbjct: 229 ---SDP---PTLLTPSKWSVEFRDFLKIAL---DKNPETRPSAAQLL 266
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 82
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 83 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 135
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPI 190
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 241
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 242 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 278
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 127/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 77
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 78 NPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 130
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPI 185
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 236
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y C + + RP EL+I
Sbjct: 237 --GERLPQPPICTIDVYMIMRK-------------CWMIDADSRPKFRELII 273
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRN 71
FS+ IG+ + VY R + + E+VA+KK+++ + S E + +E + L++L+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 72 LVKVLGY------AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
++ G AW L++EY GS ++ H + I + A
Sbjct: 116 TIQYRGCYLREHTAW-------LVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGA 163
Query: 126 -NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
GL YLHS ++H D+K NILL + DFG++ ++ + + F G
Sbjct: 164 LQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APANXFVG 212
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
T ++APE KVDV+S GI +E L +R+P
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 251
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 69/287 (24%), Positives = 127/287 (44%), Gaps = 48/287 (16%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G+ VYK + E G + A K + S E + + E + L H +VK+LG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDI 137
+ GKL +++E+ G++++++ ++ R +I V+ + L++LHS
Sbjct: 85 YYHDGKL-WIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALNFLHSKR-- 137
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST--AFQGTIGYLAPEFAY 195
I+H D+K N+L+ + + ++DFG S ++L +L +F GT ++APE
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGVSA------KNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 196 MRIVTT-----KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
+ K D++S GI ++E P + L+P+ + + K
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP-----HHELNPMRVLLKIAK--------- 236
Query: 251 RQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+DP ++ K+AL NPE RP+ +LL
Sbjct: 237 ---SDP---PTLLTPSKWSVEFRDFLKIAL---DKNPETRPSAAQLL 274
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRN 71
FS+ IG+ + VY R + + E+VA+KK+++ + S E + +E + L++L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA-NGLDY 130
++ G + L++EY GS ++ H + I + A GL Y
Sbjct: 77 TIQYRG-CYLREHTAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAY 130
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LHS ++H D+K NILL + DFG++ ++ + + F GT ++A
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APANXFVGTPYWMA 179
Query: 191 PEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
PE KVDV+S GI +E L +R+P
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 23 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 81
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 82 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 134
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 135 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 189
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 240
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 241 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 277
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 82
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 83 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 135
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 190
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 241
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 242 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 278
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 77
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 78 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 130
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 185
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 236
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 237 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 273
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 78
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 79 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 131
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 186
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 237
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 238 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 274
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 69
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 70 NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 122
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 123 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 177
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 228
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 229 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 265
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 75
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 76 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 128
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPI 183
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 234
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 235 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 271
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 42 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 100
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 101 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 153
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 154 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 208
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 259
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 260 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 296
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G+ VYK + ++ ++A K+ S E + + E L H N+VK+L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIP 138
+ L LI E+ G++++V+ ++ R +I V+ + L+YLH D
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVM----LELERPLTESQIQVVCKQTLDALNYLH---DNK 155
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-- 196
I+H D+K NIL D + ++DFG S +Q S F GT ++APE
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS----FIGTPYWMAPEVVMCET 211
Query: 197 ---RIVTTKVDVFSFGIVVMEFLTKRRP 221
R K DV+S GI ++E P
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPP 239
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 78
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 79 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 131
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 186
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 237
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 238 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 274
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 75
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 76 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 128
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 183
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 234
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 235 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 271
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 19 IIGNSNLSTVYKGR----LEDGEIVAVKKLNFHQFSAESDKSFYREAK--TLKELKHRNL 72
++G V++ R G+I A+K L + + + +A+ L+E+KH +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V ++ YA+++G LILEY+ G L + G+ + L ++ L +LH
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI----FMEDTACFYLAEISMALGHLH 138
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
I++ D+KP NI+L+ ++DFG + + D +++ F GTI Y+APE
Sbjct: 139 QK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHD-GTVTHTFCGTIEYMAPE 191
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
VD +S G ++ + LT P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 14 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 72
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 73 NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAE 125
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 126 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 180
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 231
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 232 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 268
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G+ VYK + ++ ++A K+ S E + + E L H N+VK+L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIP 138
+ L LI E+ G++++V+ ++ R +I V+ + L+YLH D
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVM----LELERPLTESQIQVVCKQTLDALNYLH---DNK 155
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-- 196
I+H D+K NIL D + ++DFG S +Q S F GT ++APE
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----FIGTPYWMAPEVVMCET 211
Query: 197 ---RIVTTKVDVFSFGIVVMEFLTKRRP 221
R K DV+S GI ++E P
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPP 239
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 60.8 bits (146), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 54/183 (29%), Positives = 80/183 (43%), Gaps = 23/183 (12%)
Query: 45 NFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIH 103
N +F E Y E LK L H N++K+ +E K L+ E+ E G L E +I+
Sbjct: 85 NIEKFHEE----IYNEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 104 GPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD---FEAHVS 160
D +++ + +G+ YLH IVH D+KP NILL+ +
Sbjct: 140 RHKFDECDAA-----NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191
Query: 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRR 220
DFG S + L TA+ Y+APE + K DV+S G+++ L
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAY-----YIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
Query: 221 PTG 223
P G
Sbjct: 246 PFG 248
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 60.8 bits (146), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 19 IIGNSNLSTVYKGR----LEDGEIVAVKKLNFHQFSAESDKSFYREAK--TLKELKHRNL 72
++G V++ R G+I A+K L + + + +A+ L+E+KH +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V ++ YA+++G LILEY+ G L + G+ + L ++ L +LH
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI----FMEDTACFYLAEISMALGHLH 138
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
I++ D+KP NI+L+ ++DFG + + D +++ F GTI Y+APE
Sbjct: 139 QK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHD-GTVTHXFCGTIEYMAPE 191
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
VD +S G ++ + LT P
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 75
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 76 NPHVCRLLGICLTS--TVQLITQLMPFGXLLDYVREHKDNIG-SQYLL----NWCVQIAK 128
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 183
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 234
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 235 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 271
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 17 NNIIGNSNLSTVYKGRLEDGEI---VAVKKLNFHQFSAESD-KSFYREAKTLKELKHR-N 71
++IG N V K R++ + A+K++ +++++ D + F E + L +L H N
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRID 119
++ +LG G L L +EY +G+L + V S + + +
Sbjct: 88 IINLLGACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
VA G+DYL +H D+ NIL+ ++ A ++DFG SR +V+++
Sbjct: 147 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----K 198
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
T + + ++A E + TT DV+S+G+++ E ++
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLXQVIQM-ELDHERMSY-----LLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DXTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFLTKR 219
E + +
Sbjct: 217 EMVRHK 222
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 17 NNIIGNSNLSTVYKGRLEDGEI---VAVKKLNFHQFSAESD-KSFYREAKTLKELKHR-N 71
++IG N V K R++ + A+K++ +++++ D + F E + L +L H N
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPN 77
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRID 119
++ +LG G L L +EY +G+L + V S + + +
Sbjct: 78 IINLLGACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
VA G+DYL +H D+ NIL+ ++ A ++DFG SR +V+++
Sbjct: 137 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----K 188
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
T + + ++A E + TT DV+S+G+++ E ++
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 20/220 (9%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
AT + IG TVYK R G VA+K + S RE L+ L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 69 ---HRNLVKVLGYAWESGKLK----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
H N+V+++ S + L+ E+++ + P T+ D++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---KDLM 118
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
GLD+LH+ IVH D+KP NIL+ ++DFG +R+ + + T
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTL 175
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ Y APE T VD++S G + E +R+P
Sbjct: 176 W-----YRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 20/220 (9%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
AT + IG TVYK R G VA+K + S RE L+ L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 69 ---HRNLVKVLGYAWESGKLK----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
H N+V+++ S + L+ E+++ + P T+ D++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---KDLM 118
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
GLD+LH+ IVH D+KP NIL+ ++DFG +R+ + L+ +
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LAPVVV- 173
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T+ Y APE T VD++S G + E +R+P
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 18/220 (8%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKH 69
G + + +G V G + G VAVK LN + S + RE + LK +H
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+++K+ +++EY+ G L I H R + + + + +D
Sbjct: 71 PHIIKLYQVISTPTDF-FMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVD 125
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
Y H +VH D+KP N+LLD A ++DFG S M + D L + G+ Y
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM----MSDGEFLRDSC-GSPNYA 177
Query: 190 APEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRPTGLDEEN 228
APE R+ +VD++S G+++ L P D+E+
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLP--FDDEH 215
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 77
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 78 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 130
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 131 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA--EGGKVPI 185
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 236
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y C + + RP EL+I
Sbjct: 237 --GERLPQPPICTIDVYMIMRK-------------CWMIDADSRPKFRELII 273
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 75
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 76 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 128
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 183
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 234
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y C + + RP EL+I
Sbjct: 235 --GERLPQPPICTIDVYMIMRK-------------CWMIDADSRPKFRELII 271
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 78
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 79 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 131
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 132 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 186
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 237
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y C + + RP EL+I
Sbjct: 238 --GERLPQPPICTIDVYMIMRK-------------CWMIDADSRPKFRELII 274
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 69/292 (23%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 27 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 85
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 86 NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 138
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 139 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 193
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 244
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y C + + RP EL+I
Sbjct: 245 --GERLPQPPICTIDVYMIMRK-------------CWMIDADSRPKFRELII 281
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 36/224 (16%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNF-HQFSAESDKSFYREAKTLKELKHRNLVK-VL 76
+IG VYKG L D VAVK +F ++ + ++K+ YR + ++H N+ + ++
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYR----VPLMEHDNIARFIV 74
Query: 77 G--YAWESGKLK-ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
G G+++ L++EY NGSL + + S W R+ SV GL YLH+
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRL--AHSVTRGLAYLHT 129
Query: 134 G------YDIPIVHCDMKPSNILLDRDFEAHVSDFGTS------RMLDVHLQDLSSLSTA 181
Y I H D+ N+L+ D +SDFG S R++ +D +++S
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 182 FQGTIGYLAPEFAYMRI-------VTTKVDVFSFGIVVMEFLTK 218
GTI Y+APE + +VD+++ G++ E +
Sbjct: 190 --GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 D-ANLXQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DXTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFLTKR 219
E + +
Sbjct: 217 EMVRHK 222
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 68/292 (23%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++ + TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 24 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 82
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI++ M G L + H + S++ L + + +A
Sbjct: 83 NPHVCRLLGICLTS--TVQLIMQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 135
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 190
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 241
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 242 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 278
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 14/225 (6%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRN 71
F N++G + + VY+ + G VA+K ++ + A + E K +LKH +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++++ Y +E L+LE NG + + S + +I+ G+ YL
Sbjct: 73 ILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT---GMLYL 128
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS I+H D+ SN+LL R+ ++DFG + L + + +L GT Y++P
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISP 181
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE-ENGLSPISL 235
E A + DV+S G + L R P D +N L+ + L
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL 226
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 20 IGNSNLSTVYKGR--LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVK 74
IG V+K R G VA+K++ S RE L+ L+ H N+V+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 75 VLGYAWESGKLK----ALILEYMENG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
+ S + L+ E+++ + + PGV D++ + GL
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-----DMMFQLLRGL 133
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
D+LHS +VH D+KP NIL+ + ++DFG +R+ + L+S+ T+ Y
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV----TLWY 185
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
APE T VD++S G + E +R+P
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLXQVIQM-ELDHERMSY-----LLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DXTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFLTKR 219
E + +
Sbjct: 217 EMVRHK 222
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 36 GEIVAVKKLNFHQFSAE-SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94
G VA+KKL + F +E K YRE + LK ++H N++ +L L Y+
Sbjct: 50 GAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ + + G + H + RI L+ + GL Y+H+ I+H D+KP N+ ++
Sbjct: 109 MPFMGTDL-GKLMKHEKLG-EDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNE 163
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--FAYMRIVTTKVDVFSFGIV 211
D E + DFG +R D + T Y APE +MR T VD++S G +
Sbjct: 164 DCELKILDFGLARQADSEMXGXVV-------TRWYRAPEVILNWMRYTQT-VDIWSVGCI 215
Query: 212 VMEFLTKR 219
+ E +T +
Sbjct: 216 MAEMITGK 223
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 105 -DANLXQVIQM-ELDHERMSY-----LLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKS 154
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 155 DXTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 214 EFLTKR 219
E + +
Sbjct: 210 EMVRHK 215
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
LK +KH LV L +++++ +L+Y+ G L H + R L R +
Sbjct: 93 LKNVKHPFLVG-LHFSFQTADKLYFVLDYINGGEL--FYH---LQRERCFLEPRARFYAA 146
Query: 124 -VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+A+ L YLHS + IV+ D+KP NILLD ++DFG + H +S ++ F
Sbjct: 147 EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH----NSTTSTF 199
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT YLAPE + + VD + G V+ E L P
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ + VY A+K L+ + SD +F+ E + + +
Sbjct: 86 GAFGEVQLVRHKASQKVY----------AMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V L A++ K +++EYM G L +++ V +W +V+++ LD +
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVLA----LDAI 190
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS + ++H D+KP N+LLD+ ++DFGT +D + TA GT Y++P
Sbjct: 191 HS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE--TGMVHCDTAV-GTPDYISP 244
Query: 192 EFAYMR----IVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D +S G+ + E L P
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 30/235 (12%)
Query: 18 NIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
++G+ TVYKG + DGE VA+K L S +++K EA + + +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-----IDVLISVANG 127
++LG S L+ + M G L +DH R + ++ + +A G
Sbjct: 82 SRLLGICLTS--TVQLVTQLMPYGCL--------LDHVRENRGRLGSQDLLNWCMQIAKG 131
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+ YL D+ +VH D+ N+L+ ++DFG +R+LD+ + + + I
Sbjct: 132 MSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIK 186
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
++A E R T + DV+S+G+ V E +T G +G+ + L+EK
Sbjct: 187 WMALESILRRRFTHQSDVWSYGVTVWELMT----FGAKPYDGIPAREIPDLLEKG 237
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G+ VYK + ++ ++A K+ S E + + E L H N+VK+L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIP 138
+ L LI E+ G++++V+ ++ R +I V+ + L+YLH D
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVM----LELERPLTESQIQVVCKQTLDALNYLH---DNK 155
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-- 196
I+H D+K NIL D + ++DFG S +Q F GT ++APE
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ----RRDXFIGTPYWMAPEVVMCET 211
Query: 197 ---RIVTTKVDVFSFGIVVMEFLTKRRP 221
R K DV+S GI ++E P
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPP 239
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 20 IGNSNLSTVYKGR--LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVK 74
IG V+K R G VA+K++ S RE L+ L+ H N+V+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 75 VLGYAWESGKLK----ALILEYMENG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
+ S + L+ E+++ + + PGV D++ + GL
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-----DMMFQLLRGL 133
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
D+LHS +VH D+KP NIL+ + ++DFG +R+ + L+S+ T+ Y
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV----TLWY 185
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
APE T VD++S G + E +R+P
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 20/220 (9%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
AT + IG TVYK R G VA+K + S RE L+ L+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 69 ---HRNLVKVLGYAWESGKLK----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
H N+V+++ S + L+ E+++ + P T+ D++
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---KDLM 118
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
GLD+LH+ IVH D+KP NIL+ ++DFG +R+ + L +
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVV- 173
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T+ Y APE T VD++S G + E +R+P
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 20 IGNSNLSTVYKGR--LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVK 74
IG V+K R G VA+K++ S RE L+ L+ H N+V+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 75 VLGYAWESGKLK----ALILEYMENG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
+ S + L+ E+++ + + PGV D++ + GL
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-----DMMFQLLRGL 133
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
D+LHS +VH D+KP NIL+ + ++DFG +R+ + L+S+ T+ Y
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV----TLWY 185
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
APE T VD++S G + E +R+P
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/176 (31%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E + LK L H N++K+ +E +++E E G L I + +
Sbjct: 70 EIEVLKSLDHPNIIKIFE-VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH----VSDFGTSRML--DVHLQ 173
++ + N L Y HS + +VH D+KP NIL +D H + DFG + + D H
Sbjct: 129 LMKQMMNALAYFHSQH---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH-- 182
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP---TGLDE 226
ST GT Y+APE + R VT K D++S G+V+ LT P T L+E
Sbjct: 183 -----STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 36/232 (15%)
Query: 7 IENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-----RE 60
+ N + F +++G V + GEIVA+KK+ DK + RE
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE------PFDKPLFALRTLRE 59
Query: 61 AKTLKELKHRNLVKVLGY----AWESGKLKALILEYMENGSLESVIHGPGV--DHSRWTL 114
K LK KH N++ + ++E+ +I E M+ L VI + DH ++
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-- 116
Query: 115 PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
+ + LH ++H D+KPSN+L++ + + V DFG +R++D D
Sbjct: 117 -----FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 175 LSSLS------TAFQGTIGYLAPEFAYMRIVTTK-VDVFSFGIVVMEFLTKR 219
S + T + T Y APE ++ +DV+S G ++ E +R
Sbjct: 169 NSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/176 (31%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 74 KVLGYAWESGKLKAL------------ILEYMENGSLESVIHGP-GVDHSRWTLPKRIDV 120
+VL AWE L + ++EY+ G L I D SR T
Sbjct: 70 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-----Y 124
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ GL +LHS IV+ D+K NILLD+D ++DFG + + L D + +
Sbjct: 125 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGD--AKTN 177
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPISL 235
F GT Y+APE + VD +SFG+++ E L + P G DEE I +
Sbjct: 178 EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 233
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 11/210 (5%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + ++G V ++ G++ A KKL + ++ K + E +
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V L YA+E+ L+L M G L+ I+ G + + + + + GL+ L
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDL 302
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H IV+ D+KP NILLD +SD G L VH+ + ++ GT+GY+AP
Sbjct: 303 HRER---IVYRDLKPENILLDDHGHIRISDLG----LAVHVPEGQTIKGRV-GTVGYMAP 354
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E T D ++ G ++ E + + P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 18/216 (8%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG S V + +L G A K +N + SA + REA+ + LKH N+V++
Sbjct: 12 IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 79 AWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E G L+ + + G L E ++ + D + L+ + + +
Sbjct: 72 ISEEG-FHYLVFDLVTGGELFEDIVAREYYSEA--------DASHCIQQILEAVLHCHQM 122
Query: 138 PIVHCDMKPSNILLDRDFEA---HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+VH D+KP N+LL + ++DFG L + +Q F GT GYL+PE
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFG----LAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
VD+++ G+++ L P ++++ L
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKL 214
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 11/210 (5%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + ++G V ++ G++ A KKL + ++ K + E +
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V L YA+E+ L+L M G L+ I+ G + + + + + GL+ L
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDL 302
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H IV+ D+KP NILLD +SD G L VH+ + ++ GT+GY+AP
Sbjct: 303 HRER---IVYRDLKPENILLDDHGHIRISDLG----LAVHVPEGQTIKGRV-GTVGYMAP 354
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E T D ++ G ++ E + + P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 D-ANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DXTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFLTKR 219
E + +
Sbjct: 217 EMVRHK 222
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 67/248 (27%), Positives = 105/248 (42%), Gaps = 42/248 (16%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F E ++G V K R D A+KK+ + + E + E L L H+ +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYV 64
Query: 73 VKVLGYAW----------ESGKLKALI---LEYMENGSLESVIHGPGVDHSR---WTLPK 116
V+ AW + K K+ + +EY EN +L +IH ++ R W L +
Sbjct: 65 VRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS----RMLDVHL 172
+I L Y+HS I+H D+KP NI +D + DFG + R LD+
Sbjct: 124 QI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 173 QDLSSLS------TAFQGTIGYLAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225
D +L T+ GT Y+A E K+D++S GI+ E + TG++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-FSTGME 233
Query: 226 EENGLSPI 233
N L +
Sbjct: 234 RVNILKKL 241
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/176 (31%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 74 KVLGYAWESGKLKAL------------ILEYMENGSLESVIHGP-GVDHSRWTLPKRIDV 120
+VL AWE L + ++EY+ G L I D SR T
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-----Y 123
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ GL +LHS IV+ D+K NILLD+D ++DFG + + L D + +
Sbjct: 124 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGD--AKTN 176
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPISL 235
F GT Y+APE + VD +SFG+++ E L + P G DEE I +
Sbjct: 177 XFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 23/223 (10%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKL---NFHQFSAESDKSFYREAKTLK 65
AT + IG TVYK R G VA+K + N S RE L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 66 ELK---HRNLVKVLGYAWESGKLK----ALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
L+ H N+V+++ S + L+ E+++ + P T+
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---K 123
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
D++ GLD+LH+ IVH D+KP NIL+ ++DFG +R+ +
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA----- 175
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T T+ Y APE T VD++S G + E +R+P
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 217
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 23/238 (9%)
Query: 20 IGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG + V+K R D G+IVA+KK + K RE + LK+LKH NLV +L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYD 136
+L L+ EY ++ +V+H +D + +P+ + + +++ H
Sbjct: 71 FRRKRRLH-LVFEYCDH----TVLH--ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN- 122
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
+H D+KP NIL+ + + DFG +R+ L S T Y +PE
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARL----LTGPSDYYDDEVATRWYRSPELLVG 176
Query: 197 RI-VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
VDV++ G V E L +G+ G S + L+ K L + I +Q+
Sbjct: 177 DTQYGPPVDVWAIGCVFAELL-----SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLSQVIQM-ELDHERMSY-----LLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G+++
Sbjct: 162 DATLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 90 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 150 D-ANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 199
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 200 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 214 EFLTKR 219
E + +
Sbjct: 255 EMVRHK 260
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLSQVIQM-ELDHERMSY-----LLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G+++
Sbjct: 162 DATLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V G+ VA+K + + + S+ F EAK + L H LV++ G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYM NG L + + + H R+ + +++ V ++YL S
Sbjct: 89 TKQRPI-FIITEYMANGCLLNYLR--EMRH-RFQTQQLLEMCKDVCEAMEYLESK---QF 141
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D+ N L++ VSDFG SR + L D + S + + + PE
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEETSSVGSKFPVRWSPPEVLMYSKF 198
Query: 200 TTKVDVFSFGIVVMEFLT 217
++K D+++FG+++ E +
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 105 D-ANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 154
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 155 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 214 EFLTKR 219
E + +
Sbjct: 210 EMVRHK 215
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 46 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 106 D-ANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 155
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 156 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 210
Query: 214 EFLTKR 219
E + +
Sbjct: 211 EMVRHK 216
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 46 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 106 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 155
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 156 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 210
Query: 214 EFLTKR 219
E + +
Sbjct: 211 EMVRHK 216
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 53 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 113 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 162
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 163 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 214 EFLTKR 219
E + +
Sbjct: 218 EMVRHK 223
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 51 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 110
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 111 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 160
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 161 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 215
Query: 214 EFLTKR 219
E + +
Sbjct: 216 EMVRHK 221
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFLTKR 219
E + +
Sbjct: 217 EMVRHK 222
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFLTKR 219
E + +
Sbjct: 217 EMVRHK 222
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 47/277 (16%)
Query: 28 VYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW-ESGKLK 86
++KGR + +IV VK L +S + F E L+ H N++ VLG
Sbjct: 26 LWKGRWQGNDIV-VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 87 ALILEYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143
LI +M GSL +V+H VD S + + + +A G+ +LH+ + H
Sbjct: 85 TLITHWMPYGSLYNVLHEGTNFVVDQS-----QAVKFALDMARGMAFLHTLEPLIPRHA- 138
Query: 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT-- 201
+ ++++D D A +S M DV S S ++APE + T
Sbjct: 139 LNSRSVMIDEDMTARIS------MADV---KFSFQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 202 -KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVS 260
D++SF +++ E +T+ P D N +E + + G+R P +
Sbjct: 190 RSADMWSFAVLLWELVTREVPFA-DLSN----------MEIGMKVALEGLRPTIPPGISP 238
Query: 261 SIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ KL +C + +P RP + ++
Sbjct: 239 HVS-------------KLMKICMNEDPAKRPKFDMIV 262
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 53 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 113 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 162
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 163 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 214 EFLTKR 219
E + +
Sbjct: 218 EMVRHK 223
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 36/232 (15%)
Query: 7 IENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-----RE 60
+ N + F +++G V + GEIVA+KK+ DK + RE
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE------PFDKPLFALRTLRE 59
Query: 61 AKTLKELKHRNLVKVLGY----AWESGKLKALILEYMENGSLESVIHGPGV--DHSRWTL 114
K LK KH N++ + ++E+ +I E M+ L VI + DH ++
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-- 116
Query: 115 PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
+ + LH ++H D+KPSN+L++ + + V DFG +R++D D
Sbjct: 117 -----FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 175 LSSLS------TAFQGTIGYLAPEFAYMRIVTTK-VDVFSFGIVVMEFLTKR 219
S + F T Y APE ++ +DV+S G ++ E +R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG + V R + G VAVK ++ + + + + E +++ +H N+V++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYK- 109
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G+ +++E+++ G+L + V R + V +V L YLH+
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDI-----VSQVRLNEEQIATVCEAVLQALAYLHAQ---G 161
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K +ILL D +SDFG + + L GT ++APE +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV----GTPYWMAPEVISRSL 217
Query: 199 VTTKVDVFSFGIVVMEFLTKRRP 221
T+VD++S GI+V+E + P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/218 (24%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 17 NNIIGNSNLSTVYKGRLEDGEI---VAVKKLNFHQFSAESD-KSFYREAKTLKELKHR-N 71
++IG N V K R++ + A+K++ +++++ D + F E + L +L H N
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPN 84
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRID 119
++ +LG G L L +EY +G+L + V S + + +
Sbjct: 85 IINLLGACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
VA G+DYL +H ++ NIL+ ++ A ++DFG SR +V+++
Sbjct: 144 FAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVK-----K 195
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
T + + ++A E + TT DV+S+G+++ E ++
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 27/230 (11%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYR 59
EI + F E +G VYKG L E + VA+K L + + F
Sbjct: 22 EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRH 78
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLES--VIHGPGVD--------- 108
EA L+H N+V +LG + L ++I Y +G L V+ P D
Sbjct: 79 EAMLRARLQHPNVVCLLGVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 109 -HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
S P + ++ +A G++YL S + +VH D+ N+L+ +SD G R
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFR- 193
Query: 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+V+ D L I ++APE + D++S+G+V+ E +
Sbjct: 194 -EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 90 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 150 D-ANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 199
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 200 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 214 EFLTKR 219
E + +
Sbjct: 255 EMVRHK 260
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLSQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 68/292 (23%), Positives = 127/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++ + TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 24 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 82
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 83 NPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 135
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 136 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 190
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 241
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 242 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 278
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 68/292 (23%), Positives = 127/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+ +L S +++K EA + +
Sbjct: 51 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELR-EATSPKANKEILDEAYVMASVD 109
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 110 NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 162
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 163 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 217
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 268
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 269 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 305
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TG+FSE V G++ AVK + + + S E L+++KH
Sbjct: 31 GTGAFSE----------VVLAEEKATGKLFAVKCIPKKALKGK-ESSIENEIAVLRKIKH 79
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
N+V L +ES L+++ + G L I V+ +T ++ V + +
Sbjct: 80 ENIV-ALEDIYESPNHLYLVMQLVSGGELFDRI----VEKGFYTEKDASTLIRQVLDAVY 134
Query: 130 YLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRML---DVHLQDLSSLSTAFQ 183
YLH + IVH D+KP N+L D + + +SDFG S+M DV +STA
Sbjct: 135 YLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV-------MSTAC- 183
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT GY+APE + + VD +S G++ L P
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLG 77
IG V++G+ GE VAVK FS+ ++S++REA+ + L+H N +LG
Sbjct: 12 IGKGRFGEVWRGKWR-GEEVAVKI-----FSSREERSWFREAEIYQTVMLRHEN---ILG 62
Query: 78 YAWESGKLKA------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+ K L+ +Y E+GSL ++ V T+ I + +S A+GL +L
Sbjct: 63 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHL 117
Query: 132 H-----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
H + I H D+K NIL+ ++ ++D G + D + GT
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 187 GYLAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
Y+APE I + D+++ G+V E + G+ E+ L
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 227
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLG 77
IG V++G+ GE VAVK FS+ ++S++REA+ + L+H N +LG
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKI-----FSSREERSWFREAEIYQTVMLRHEN---ILG 61
Query: 78 YAWESGKLKA------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+ K L+ +Y E+GSL ++ V T+ I + +S A+GL +L
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHL 116
Query: 132 H-----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
H + I H D+K NIL+ ++ ++D G + D + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 187 GYLAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
Y+APE I + D+++ G+V E + G+ E+ L
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V G+ VA+K + + + S+ F EAK + L H LV++ G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYM NG L + + + H R+ + +++ V ++YL S
Sbjct: 89 TKQRPI-FIITEYMANGCLLNYLR--EMRH-RFQTQQLLEMCKDVCEAMEYLESK---QF 141
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D+ N L++ VSDFG SR + L D + S + + + PE
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 200 TTKVDVFSFGIVVMEFLT 217
++K D+++FG+++ E +
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V G+ VA+K + + + S+ F EAK + L H LV++ G
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYM NG L + + R+ + +++ V ++YL S
Sbjct: 74 TKQRPI-FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QF 126
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D+ N L++ VSDFG SR + L D + S + + + PE
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 200 TTKVDVFSFGIVVMEFLT 217
++K D+++FG+++ E +
Sbjct: 184 SSKSDIWAFGVLMWEIYS 201
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V G+ VA+K + + + S+ F EAK + L H LV++ G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYM NG L + + R+ + +++ V ++YL S
Sbjct: 69 TKQRPI-FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QF 121
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D+ N L++ VSDFG SR + L D + S + + + PE
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 200 TTKVDVFSFGIVVMEFLT 217
++K D+++FG+++ E +
Sbjct: 179 SSKSDIWAFGVLMWEIYS 196
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 27/230 (11%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYR 59
EI + F E +G VYKG L E + VA+K L + + F
Sbjct: 5 EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRH 61
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLES--VIHGPGVD--------- 108
EA L+H N+V +LG + L ++I Y +G L V+ P D
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 109 -HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
S P + ++ +A G++YL S + +VH D+ N+L+ +SD G R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFR- 176
Query: 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+V+ D L I ++APE + D++S+G+V+ E +
Sbjct: 177 -EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLG 77
IG V++G+ GE VAVK FS+ ++S++REA+ + L+H N +LG
Sbjct: 14 IGKGRFGEVWRGKWR-GEEVAVKI-----FSSREERSWFREAEIYQTVMLRHEN---ILG 64
Query: 78 YAWESGKLKA------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+ K L+ +Y E+GSL ++ V T+ I + +S A+GL +L
Sbjct: 65 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHL 119
Query: 132 H-----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
H + I H D+K NIL+ ++ ++D G + D + GT
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 187 GYLAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
Y+APE I + D+++ G+V E + G+ E+ L
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 229
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V G+ VA+K + + + S+ F EAK + L H LV++ G
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYM NG L + + R+ + +++ V ++YL S
Sbjct: 73 TKQRPI-FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QF 125
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D+ N L++ VSDFG SR + L D + S + + + PE
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 200 TTKVDVFSFGIVVMEFLT 217
++K D+++FG+++ E +
Sbjct: 183 SSKSDIWAFGVLMWEIYS 200
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V G+ VA+K + + + S+ F EAK + L H LV++ G
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYM NG L + + R+ + +++ V ++YL S
Sbjct: 80 TKQRPI-FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QF 132
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D+ N L++ VSDFG SR + L D + S + + + PE
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 200 TTKVDVFSFGIVVMEFLT 217
++K D+++FG+++ E +
Sbjct: 190 SSKSDIWAFGVLMWEIYS 207
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 68/292 (23%), Positives = 127/292 (43%), Gaps = 44/292 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++ + TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 17 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 75
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVAN 126
+ ++ ++LG S LI + M G L + H + S++ L + + +A
Sbjct: 76 NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIG-SQYLL----NWCVQIAK 128
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
G++YL D +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPI 183
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK----- 234
Query: 247 INGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLI 298
G R P +Y + + C + + RP EL+I
Sbjct: 235 --GERLPQPPICTIDVYM-------------IMVKCWMIDADSRPKFRELII 271
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLG 77
IG V++G+ GE VAVK FS+ ++S++REA+ + L+H N +LG
Sbjct: 50 IGKGRFGEVWRGKWR-GEEVAVKI-----FSSREERSWFREAEIYQTVMLRHEN---ILG 100
Query: 78 YAWESGKLKA------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+ K L+ +Y E+GSL ++ V T+ I + +S A+GL +L
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHL 155
Query: 132 H-----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
H + I H D+K NIL+ ++ ++D G + D + GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 187 GYLAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
Y+APE I + D+++ G+V E + G+ E+ L
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 52 ESDKSFYR-EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHS 110
ESDK R E +T+ L+H LV L A+E +I E+M G L + +H+
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVN-LHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHN 250
Query: 111 RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL--DRDFEAHVSDFGTSRML 168
+ + + ++ + V GL ++H VH D+KP NI+ R E + DFG L
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFG----L 303
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTG 223
HL S+ GT + APE A + V D++S G++ L+ P G
Sbjct: 304 TAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLSQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DATLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + +L H+N+V+
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 99 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 212
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLSQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DATLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLG 77
IG V++G+ GE VAVK FS+ ++S++REA+ + L+H N +LG
Sbjct: 17 IGKGRFGEVWRGKWR-GEEVAVKI-----FSSREERSWFREAEIYQTVMLRHEN---ILG 67
Query: 78 YAWESGKLKA------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+ K L+ +Y E+GSL ++ V T+ I + +S A+GL +L
Sbjct: 68 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHL 122
Query: 132 H-----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
H + I H D+K NIL+ ++ ++D G + D + GT
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 187 GYLAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
Y+APE I + D+++ G+V E + G+ E+ L
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 232
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 52 ESDKSFYR-EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHS 110
ESDK R E +T+ L+H LV L A+E +I E+M G L + +H+
Sbjct: 89 ESDKETVRKEIQTMSVLRHPTLVN-LHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHN 144
Query: 111 RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL--DRDFEAHVSDFGTSRML 168
+ + + ++ + V GL ++H VH D+KP NI+ R E + DFG L
Sbjct: 145 KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFG----L 197
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTG 223
HL S+ GT + APE A + V D++S G++ L+ P G
Sbjct: 198 TAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 251
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + +L H+N+V+
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 113 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 226
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLG 77
IG V++G+ GE VAVK FS+ ++S++REA+ + L+H N +LG
Sbjct: 37 IGKGRFGEVWRGKWR-GEEVAVKI-----FSSREERSWFREAEIYQTVMLRHEN---ILG 87
Query: 78 YAWESGKLKA------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+ K L+ +Y E+GSL ++ V T+ I + +S A+GL +L
Sbjct: 88 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHL 142
Query: 132 H-----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
H + I H D+K NIL+ ++ ++D G + D + GT
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 187 GYLAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
Y+APE I + D+++ G+V E + G+ E+ L
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 252
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 58.2 bits (139), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V G+ VA+K + + + S+ F EAK + L H LV++ G
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYM NG L + + R+ + +++ V ++YL S
Sbjct: 74 TKQRPI-FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QF 126
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D+ N L++ VSDFG SR + L D + S + + + PE
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 200 TTKVDVFSFGIVVMEFLT 217
++K D+++FG+++ E +
Sbjct: 184 SSKSDIWAFGVLMWEIYS 201
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 39/230 (16%)
Query: 14 FSENNIIGNSNLSTVY--KGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
F +G V+ K +++D A+K++ +K RE K L +L+H
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCN-YAIKRIRLPNRELAREKVM-REVKALAKLEHPG 64
Query: 72 LVKVLGYAW-----------ESGKLKALI-LEYMENGSLESVIHGPGVDHSRWTLPKR-- 117
+V+ AW S K+ I ++ +L+ ++G R T+ +R
Sbjct: 65 IVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG------RCTIEERER 117
Query: 118 ---IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
+ + + +A +++LHS ++H D+KPSNI D V DFG +D ++
Sbjct: 118 SVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 175 LSSLS--------TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
+ L+ T GT Y++PE + + KVD+FS G+++ E L
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 33 LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK---ALI 89
L DG A+K++ H+ + + REA + H N+++++ Y K L+
Sbjct: 51 LHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108
Query: 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSN 148
L + + G+L + I + T + + +L+ + GL+ +H+ GY H D+KP+N
Sbjct: 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY----AHRDLKPTN 164
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHL----QDLSSLSTAFQ-GTIGYLAPEFAYMR---IVT 200
ILL + + + D G+ +H+ Q L+ A Q TI Y APE ++ ++
Sbjct: 165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224
Query: 201 TKVDVFSFGIVVMEFLTKRRPTGLDEENG 229
+ DV+S G V+ + P + + G
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 55 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 114 TDLYKLLKCQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 163 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 222 LAEMLSNR 229
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 29/197 (14%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA----------- 87
VA+KK+ +S K RE K ++ L H N+VKV SG
Sbjct: 39 VAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS 96
Query: 88 --LILEYMENGSLESVIHGPGV-DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
++ EYME + GP + +H+R + + GL Y+HS ++H D+
Sbjct: 97 VYIVQEYMETDLANVLEQGPLLEEHARL-------FMYQLLRGLKYIHSAN---VLHRDL 146
Query: 145 KPSNILLD-RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK- 202
KP+N+ ++ D + DFG +R++D H LS T Y +P TK
Sbjct: 147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKA 205
Query: 203 VDVFSFGIVVMEFLTKR 219
+D+++ G + E LT +
Sbjct: 206 IDMWAAGCIFAEMLTGK 222
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 53 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 113 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 162
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 163 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 214 EFL 216
E +
Sbjct: 218 EMI 220
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 57.8 bits (138), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLSQVIQM-ELDHERMSY-----LLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DATLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 56 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 114
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 115 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 163
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 164 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 222
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 223 LAEMLSNR 230
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 57 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 115
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 116 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 164
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 165 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 223
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 224 LAEMLSNR 231
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 48 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 106
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 107 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 155
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 156 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 214
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 215 LAEMLSNR 222
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 55 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 114 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 163 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 222 LAEMLSNR 229
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 25/229 (10%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL-- 76
IG V+K R + G+ VA+KK+ + RE K L+ LKH N+V ++
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 77 --GYAWESGKLKA---LILEYMEN---GSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
A + KA L+ ++ E+ G L +V+ ++TL + V+ + NGL
Sbjct: 86 CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQMLLNGL 138
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
Y+H I+H DMK +N+L+ RD ++DFG +R + + T+ Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 189 LAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPIS 234
PE R +D++ G ++ E T R P G E++ L+ IS
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 19 IIGN-SNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IIG + VYK + ++ ++A K+ S E + + E L H N+VK+L
Sbjct: 16 IIGELGDFGKVYKAQNKETSVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNIVKLLD 74
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYD 136
+ L LI E+ G++++V+ ++ R +I V+ + L+YLH D
Sbjct: 75 AFYYENNLWILI-EFCAGGAVDAVM----LELERPLTESQIQVVCKQTLDALNYLH---D 126
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
I+H D+K NIL D + ++DFG S + + +F GT ++APE
Sbjct: 127 NKIIHRDLKAGNILFTLDGDIKLADFGVSAK---NTRTXIQRRDSFIGTPYWMAPEVVMC 183
Query: 197 -----RIVTTKVDVFSFGIVVMEFLTKRRP 221
R K DV+S GI ++E P
Sbjct: 184 ETSKDRPYDYKADVWSLGITLIEMAEIEPP 213
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 49 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 107
Query: 95 NGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L ++ + DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 108 T-DLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 156
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 157 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 215
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 216 LAEMLSNR 223
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 51 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 110 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 158
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 159 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 218 LAEMLSNR 225
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 49 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 107
Query: 95 NGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L ++ + DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 108 T-DLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 156
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 157 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 215
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 216 LAEMLSNR 223
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G VYK E VA+K++ + RE LKEL+HRN++++
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ +L LI EY EN + + P V ++ L + NG+++ HS
Sbjct: 102 IHHNHRLH-LIFEYAENDLKKYMDKNPDV-----SMRVIKSFLYQLINGVNFCHSRR--- 152
Query: 139 IVHCDMKPSNILLDRDFEAH-----VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
+H D+KP N+LL + + DFG +R + ++ + T+ Y PE
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII----TLWYRPPEI 208
Query: 194 AY-MRIVTTKVDVFSFGIVVMEFLTK 218
R +T VD++S + E L K
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMK 234
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 36/232 (15%)
Query: 7 IENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-----RE 60
+ N + F +++G V + GEIVA+KK+ DK + RE
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE------PFDKPLFALRTLRE 59
Query: 61 AKTLKELKHRNLVKVLGY----AWESGKLKALILEYMENGSLESVIHGPGV--DHSRWTL 114
K LK KH N++ + ++E+ +I E M+ L VI + DH ++
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-- 116
Query: 115 PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
+ + LH ++H D+KPSN+L++ + + V DFG +R++D D
Sbjct: 117 -----FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 175 LSSLS------TAFQGTIGYLAPEFAYMRIVTTK-VDVFSFGIVVMEFLTKR 219
S + T T Y APE ++ +DV+S G ++ E +R
Sbjct: 169 NSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 51 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 110 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 158
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 159 TTXDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 218 LAEMLSNR 225
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 51 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 110 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 158
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 159 TTXDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 218 LAEMLSNR 225
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 55 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 114 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 163 TTXDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 222 LAEMLSNR 229
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 53 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 112 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 160
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 161 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 219
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 220 LAEMLSNR 227
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 54 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 114 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 163
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + F T Y APE VD++S G ++
Sbjct: 164 DCTLKILDFGLARTAGT-----SFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 218
Query: 214 EFL 216
E +
Sbjct: 219 EMI 221
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 71 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 129
Query: 95 NGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L ++ + DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 130 T-DLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 178
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 179 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 237
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 238 LAEMLSNR 245
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 57 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 117 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 166
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 167 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 221
Query: 214 EFLTKR 219
E + +
Sbjct: 222 EMVCHK 227
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 57.4 bits (137), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 59 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 117
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 118 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 166
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 167 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 225
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 226 LAEMLSNR 233
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 57.4 bits (137), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 51 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 110 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 158
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 159 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 218 LAEMLSNR 225
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 57.4 bits (137), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 46 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 106 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 155
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 156 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMG 210
Query: 214 EFLTKR 219
E + +
Sbjct: 211 EMVCHK 216
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 57.4 bits (137), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 19/188 (10%)
Query: 40 AVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL- 98
A+K + S S+ E LK L H N++K+ + +E + L++E + G L
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGGELF 124
Query: 99 ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDF 155
+ +IH + + ++ V +G+ YLH IVH D+KP N+LL ++D
Sbjct: 125 DEIIHRMKFNEVDAAV-----IIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDA 176
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+ DFG S + + + L TA+ Y+APE + K DV+S G+++
Sbjct: 177 LIKIVDFGLSAVFENQKKMKERLGTAY-----YIAPE-VLRKKYDEKCDVWSIGVILFIL 230
Query: 216 LTKRRPTG 223
L P G
Sbjct: 231 LAGYPPFG 238
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 57.4 bits (137), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 57.4 bits (137), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 53 VAIKKISPFEHQTYCQRTL-REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 112 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 160
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 161 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 219
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 220 LAEMLSNR 227
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 55 VAIKKISPFEHQTYXQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 114 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 163 TTXDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 222 LAEMLSNR 229
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 51 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 95 NG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L H DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 110 TDLYKLLKTQHLSN-DHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 158
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 159 TTXDLKIXDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 217
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 218 LAEMLSNR 225
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 20 IGNSNLSTVYKG--RLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G N +V +G R+ +I VA+K L A++++ REA+ + +L + +V+++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRLI 76
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP--KRIDVLISVANGLDYLHSG 134
G + L++E G L + G R +P ++L V+ G+ YL
Sbjct: 77 GVC--QAEALMLVMEMAGGGPLHKFLVG-----KREEIPVSNVAELLHQVSMGMKYLE-- 127
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ VH D+ N+LL A +SDFG S+ L + +A + + + APE
Sbjct: 128 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECI 185
Query: 195 YMRIVTTKVDVFSFGIVVMEFLT 217
R +++ DV+S+G+ + E L+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 67/293 (22%), Positives = 120/293 (40%), Gaps = 49/293 (16%)
Query: 20 IGNSNLSTVYKGRLEDGE------IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G+ VY+G++ VAVK L +S + + F EA + + H+N+V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDY 130
+ +G + +S + ++LE M G L+S + S+ + +D+L +A G Y
Sbjct: 112 RCIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
L + +H D+ N LL A + DFG +R D++ +
Sbjct: 171 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVK 225
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI---SLRQLVEKALA 244
++ PE I T+K D +SFG+++ E + G P S ++++E +
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----------GYMPYPSKSNQEVLEFVTS 275
Query: 245 NGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
G ++ PK +++ C PEDRPN +L
Sbjct: 276 GG-----RMDPPKNCPG------------PVYRIMTQCWQHQPEDRPNFAIIL 311
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 62 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 116
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 170
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 171 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 33/233 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG V+K R + G+ VA+KK+ + RE K L+ LKH N+V ++
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI-- 83
Query: 79 AWESGKLKA-----------LILEYMEN---GSLESVIHGPGVDHSRWTLPKRIDVLISV 124
E + KA L+ ++ E+ G L +V+ ++TL + V+ +
Sbjct: 84 --EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQML 134
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
NGL Y+H I+H DMK +N+L+ RD ++DFG +R + +
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 185 TIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPIS 234
T+ Y PE R +D++ G ++ E T R P G E++ L+ IS
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 98 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 211
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 99 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 212
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 33/233 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG V+K R + G+ VA+KK+ + RE K L+ LKH N+V ++
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI-- 83
Query: 79 AWESGKLKA-----------LILEYMEN---GSLESVIHGPGVDHSRWTLPKRIDVLISV 124
E + KA L+ ++ E+ G L +V+ ++TL + V+ +
Sbjct: 84 --EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQML 134
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
NGL Y+H I+H DMK +N+L+ RD ++DFG +R + +
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 185 TIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPIS 234
T+ Y PE R +D++ G ++ E T R P G E++ L+ IS
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA++K++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 55 VAIRKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 95 NGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L ++ + DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 114 T-DLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 163 TTCDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 222 LAEMLSNR 229
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 90 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 149 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 203
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYRE 60
D + + + G F ++GN VYKGR ++ G++ A+K ++ + + ++ +E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV---TGDEEEEIKQE 70
Query: 61 AKTLKELKH-RNLVKVLGYAWESGKLKA-----LILEYMENGSLESVIHGPGVDHSRWTL 114
LK+ H RN+ G + L++E+ GS+ +I + TL
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TL 126
Query: 115 PKRIDVLIS--VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
+ I + GL +LH ++H D+K N+LL + E + DFG S LD +
Sbjct: 127 KEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEF 215
F GT ++APE K D++S GI +E
Sbjct: 184 ----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 33/233 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG V+K R + G+ VA+KK+ + RE K L+ LKH N+V ++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI-- 82
Query: 79 AWESGKLKA-----------LILEYMEN---GSLESVIHGPGVDHSRWTLPKRIDVLISV 124
E + KA L+ ++ E+ G L +V+ ++TL + V+ +
Sbjct: 83 --EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQML 133
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
NGL Y+H I+H DMK +N+L+ RD ++DFG +R + +
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 185 TIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPIS 234
T+ Y PE R +D++ G ++ E T R P G E++ L+ IS
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 242
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 62 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 116
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 170
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 171 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 105 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 164 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 218
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 115 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 174 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 228
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G S V + ++ G+ A K +N + SA + REA+ + LKH N+V++
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
E G L+ + + G L I V ++ + + +++ H
Sbjct: 72 ISEEG-FHYLVFDLVTGGELFEDI----VAREYYSEADASHCIQQILESVNHCHLN---G 123
Query: 139 IVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
IVH D+KP N+LL + ++DFG L + +Q F GT GYL+PE
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFG----LAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
VD+++ G+++ L P ++++ L
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL 214
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 116 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 175 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKW 229
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G S V + ++ G+ A K +N + SA + REA+ + LKH N+V++
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
E G L+ + + G L I V ++ + + +++ H
Sbjct: 72 ISEEG-FHYLVFDLVTGGELFEDI----VAREYYSEADASHCIQQILESVNHCHLN---G 123
Query: 139 IVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
IVH D+KP N+LL + ++DFG L + +Q F GT GYL+PE
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFG----LAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRP 221
VD+++ G+++ L P
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 139 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 198 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKW 252
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 30/225 (13%)
Query: 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESDKSFYRE 60
R E+ AT +G + V+ R+ED G AVKK+ F AE E
Sbjct: 89 REEVHWATHQLR----LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-------E 135
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP--KRI 118
L +V + G E G + +E +E GSL ++ G LP + +
Sbjct: 136 LMACAGLTSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLVKEQGC------LPEDRAL 188
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSS 177
L GL+YLHS I+H D+K N+LL D A + DFG + L S
Sbjct: 189 YYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSL 245
Query: 178 LSTAF-QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
L+ + GT ++APE R KVDV+S +++ L P
Sbjct: 246 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 41/231 (17%)
Query: 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F E ++G V K R D A+KK+ + + E + E L L H+ +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVXLLASLNHQYV 64
Query: 73 VKVLGYAW----------ESGKLKALIL---EYMENGSLESVIHGPGVDHSR---WTLPK 116
V+ AW + K K+ + EY EN +L +IH ++ R W L +
Sbjct: 65 VRYYA-AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS----RMLDVHL 172
+I L Y+HS I+H ++KP NI +D + DFG + R LD+
Sbjct: 124 QI------LEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 173 QDLSSLS------TAFQGTIGYLAPE-FAYMRIVTTKVDVFSFGIVVMEFL 216
D +L T+ GT Y+A E K+D +S GI+ E +
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 125 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 184 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 238
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 53 VAIKKISPFEHQTYCQRTL-REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 95 NGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L ++ + DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 112 T-DLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 160
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T + T Y APE + T +D++S G +
Sbjct: 161 TTSDLKICDFGLARVADPD-HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 219
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 220 LAEMLSNR 227
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 27/224 (12%)
Query: 36 GEIVAVKKLNFHQFSAESDKS--FYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
G+ VA+K +N + A+SD RE L+ L+H +++K+ ++ +++EY
Sbjct: 38 GQKVALKIIN-KKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI-IMVIEYA 95
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
N + + V + + + + + ++Y H IVH D+KP N+LLD
Sbjct: 96 GNELFDYI-----VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDE 147
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVV 212
++DFG S + + D + L T+ G+ Y APE ++ +VDV+S G+++
Sbjct: 148 HLNVKIADFGLSNI----MTDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVIL 202
Query: 213 MEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
L +R P D+E+ P+ K ++NG+ + + P
Sbjct: 203 YVMLCRRLP--FDDES--IPVLF-----KNISNGVYTLPKFLSP 237
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R + T + Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGTSFMMTPEVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LILE + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 27/224 (12%)
Query: 36 GEIVAVKKLNFHQFSAESDKS--FYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
G+ VA+K +N + A+SD RE L+ L+H +++K+ ++ +++EY
Sbjct: 33 GQKVALKIIN-KKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI-IMVIEYA 90
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
N + + V + + + + + ++Y H IVH D+KP N+LLD
Sbjct: 91 GNELFDYI-----VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDE 142
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVV 212
++DFG S + + D + L T+ G+ Y APE ++ +VDV+S G+++
Sbjct: 143 HLNVKIADFGLSNI----MTDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVIL 197
Query: 213 MEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
L +R P D+E+ P+ K ++NG+ + + P
Sbjct: 198 YVMLCRRLP--FDDES--IPVLF-----KNISNGVYTLPKFLSP 232
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 27/224 (12%)
Query: 36 GEIVAVKKLNFHQFSAESDKS--FYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
G+ VA+K +N + A+SD RE L+ L+H +++K+ ++ +++EY
Sbjct: 39 GQKVALKIIN-KKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI-IMVIEYA 96
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
N + + V + + + + + ++Y H IVH D+KP N+LLD
Sbjct: 97 GNELFDYI-----VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDE 148
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVV 212
++DFG S + + D + L T+ G+ Y APE ++ +VDV+S G+++
Sbjct: 149 HLNVKIADFGLSNI----MTDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVIL 203
Query: 213 MEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
L +R P D+E+ P+ K ++NG+ + + P
Sbjct: 204 YVMLCRRLP--FDDES--IPVLF-----KNISNGVYTLPKFLSP 238
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 64/292 (21%), Positives = 119/292 (40%), Gaps = 47/292 (16%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + +++E M G L+S + S+ + +D+L +A G YL
Sbjct: 113 CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 172 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 226
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI---SLRQLVEKALAN 245
+ PE I T+K D +SFG+++ E + G P S ++++E +
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----------GYMPYPSKSNQEVLEFVTSG 276
Query: 246 GINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
G ++ PK +++ C PEDRPN +L
Sbjct: 277 G-----RMDPPKNCPG------------PVYRIMTQCWQHQPEDRPNFAIIL 311
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 27/224 (12%)
Query: 36 GEIVAVKKLNFHQFSAESDKS--FYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
G+ VA+K +N + A+SD RE L+ L+H +++K+ ++ +++EY
Sbjct: 29 GQKVALKIIN-KKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI-IMVIEYA 86
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
N + + V + + + + + ++Y H IVH D+KP N+LLD
Sbjct: 87 GNELFDYI-----VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDE 138
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVV 212
++DFG S + + D + L T+ G+ Y APE ++ +VDV+S G+++
Sbjct: 139 HLNVKIADFGLSNI----MTDGNFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVIL 193
Query: 213 MEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
L +R P D+E+ P+ K ++NG+ + + P
Sbjct: 194 YVMLCRRLP--FDDES--IPVLF-----KNISNGVYTLPKFLSP 228
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHS-RWTLPKRI 118
E + +L H NL+++ A+ES L++EY++ G L I +D S T I
Sbjct: 136 EISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRI----IDESYNLTELDTI 190
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNIL-LDRDF-EAHVSDFGTSRMLDVHLQDLS 176
+ + G+ ++H Y I+H D+KP NIL ++RD + + DFG +R +
Sbjct: 191 LFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR----RYKPRE 243
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
L F GT +LAPE V+ D++S G++ L+ P
Sbjct: 244 KLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + +++E M G L+S + S+ + +D+L +A G YL
Sbjct: 98 CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG +R D++ + +
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 211
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 15/194 (7%)
Query: 40 AVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLE 99
A K +N + SA + REA+ + LKH N+V++ E G L+ + + G L
Sbjct: 60 AAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-FHYLVFDLVTGGELF 118
Query: 100 SVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA-- 157
I V ++ + + ++++H +D IVH D+KP N+LL +
Sbjct: 119 EDI----VAREYYSEADASHCIHQILESVNHIHQ-HD--IVHRDLKPENLLLASKCKGAA 171
Query: 158 -HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
++DFG L + +Q F GT GYL+PE VD+++ G+++ L
Sbjct: 172 VKLADFG----LAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILL 227
Query: 217 TKRRPTGLDEENGL 230
P ++++ L
Sbjct: 228 VGYPPFWDEDQHKL 241
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 19/189 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
V ++L+ Q E ++ RE L+++ + L ++ES L+ + M G L
Sbjct: 129 VTAERLSPEQLE-EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 99 ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158
+ + + + ++ S+ + +LH+ IVH D+KP NILLD + +
Sbjct: 188 FDYL----TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240
Query: 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT------KVDVFSFGIVV 212
+SDFG S HL+ L GT GYLAPE + T +VD+++ G+++
Sbjct: 241 LSDFGFS----CHLEPGEKLRE-LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 213 MEFLTKRRP 221
L P
Sbjct: 296 FTLLAGSPP 304
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 45/182 (24%), Positives = 87/182 (47%), Gaps = 8/182 (4%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VA+KK++ + ++ RE + L +H N++ + + L+A+ Y+ +
Sbjct: 71 VAIKKISPFEHQTYCQRTL-REIQILLRFRHENVIGIRD-ILRASTLEAMRDVYIVQDLM 128
Query: 99 ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158
E+ ++ + + + L + GL Y+HS ++H D+KPSN+L++ +
Sbjct: 129 ETDLYK-LLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLK 184
Query: 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLT 217
+ DFG +R+ D D + T T Y APE + T +D++S G ++ E L+
Sbjct: 185 ICDFGLARIADPE-HDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243
Query: 218 KR 219
R
Sbjct: 244 NR 245
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFY--REAKTLKELKH 69
GSF G L+T YK + + VA+K ++ Q +SD RE LK L+H
Sbjct: 20 GSF------GKVKLATHYKTQ----QKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRH 68
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+++K+ + +++EY G L I V+ R T + + ++
Sbjct: 69 PHIIKLYDVITTPTDI-VMVIEYA-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIE 122
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
Y H IVH D+KP N+LLD + ++DFG S + + D + L T+ G+ Y
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI----MTDGNFLKTSC-GSPNYA 174
Query: 190 APEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRP 221
APE ++ +VDV+S GIV+ L R P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R + T + Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFLTKR 219
E + +
Sbjct: 217 EMVCHK 222
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F + ++ Y ++ E++ K H + E + L+ +H
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---------ENRVLQNSRHPF 209
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGL 128
L L Y++++ ++EY G L + V D +R+ + + L
Sbjct: 210 LT-ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 261
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
DYLHS ++ V+ D+K N++LD+D ++DFG + ++D +++ T F GT Y
Sbjct: 262 DYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFG---LCKEGIKDGATMKT-FCGTPEY 315
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
LAPE VD + G+V+ E + R P
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F + ++ Y ++ E++ K H + E + L+ +H
Sbjct: 162 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---------ENRVLQNSRHPF 212
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGL 128
L L Y++++ ++EY G L + V D +R+ + + L
Sbjct: 213 LT-ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 264
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
DYLHS ++ V+ D+K N++LD+D ++DFG + ++D +++ T F GT Y
Sbjct: 265 DYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFG---LCKEGIKDGATMKT-FCGTPEY 318
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
LAPE VD + G+V+ E + R P
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 15/185 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKALILEYME 94
GE+VAVK L + + RE + L+ L H ++VK G + G K L++EY+
Sbjct: 38 GEMVAVKALK-EGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 95 NGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
GSL + H G L + + + G+ YLH+ + +H + N+LLD
Sbjct: 97 LGSLRDYLPRHCVG-------LAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLD 146
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
D + DFG ++ + + + + + APE DV+SFG+ +
Sbjct: 147 NDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 205
Query: 213 MEFLT 217
E LT
Sbjct: 206 YELLT 210
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 20 IGNSNLSTVYKG--RLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G N +V +G R+ +I VA+K L A++++ REA+ + +L + +V+++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLI 402
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP--KRIDVLISVANGLDYLHSG 134
G + L++E G L + G R +P ++L V+ G+ YL
Sbjct: 403 GVCQAEALM--LVMEMAGGGPLHKFLVG-----KREEIPVSNVAELLHQVSMGMKYLE-- 453
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ VH ++ N+LL A +SDFG S+ L + +A + + + APE
Sbjct: 454 -EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECI 511
Query: 195 YMRIVTTKVDVFSFGIVVMEFLT 217
R +++ DV+S+G+ + E L+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 15/185 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKALILEYME 94
GE+VAVK L + + RE + L+ L H ++VK G + G K L++EY+
Sbjct: 37 GEMVAVKALK-EGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 95 NGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
GSL + H G L + + + G+ YLH+ + +H + N+LLD
Sbjct: 96 LGSLRDYLPRHCVG-------LAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLD 145
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
D + DFG ++ + + + + + APE DV+SFG+ +
Sbjct: 146 NDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 204
Query: 213 MEFLT 217
E LT
Sbjct: 205 YELLT 209
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 13/182 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E + L+ ++ + L YA+++ LIL+Y+ G L + + R+T +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQI 163
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ + L++LH + I++ D+K NILLD + ++DFG S+ + D + +
Sbjct: 164 YVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF---VADETERA 217
Query: 180 TAFQGTIGYLAPEFAYMRIV--TTKVDVFSFGIVVMEFLTKRRPTGLD-EENGLSPISLR 236
F GTI Y+AP+ VD +S G+++ E LT P +D E+N + IS R
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
Query: 237 QL 238
L
Sbjct: 278 IL 279
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 12 GSFSEN-NII---GNSNLSTVYKG--RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
G+F+E NI+ G + V K R+ E AVK +N + + RE + LK
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLK 76
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
+L H N++K+ +S ++ E G L I + R++ ++ V
Sbjct: 77 KLDHPNIMKLFEILEDSSSF-YIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVF 131
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+G+ Y+H IVH D+KP NILL ++D + + DFG S + + + TA+
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE K DV+S G+++ L+ P
Sbjct: 189 -----YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 22/147 (14%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWT--LPKRI--DVLISVANGLDYLHSGYDIPIVHCD 143
+I EYMEN S+ V +T +P ++ ++ SV N Y+H+ +I H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRD 177
Query: 144 MKPSNILLDRDFEAHVSDFGTSR-MLDVHLQDLSSLSTAFQGTIGYLAPEF-----AYMR 197
+KPSNIL+D++ +SDFG S M+D ++ +GT ++ PEF +Y
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDKKIK-------GSRGTYEFMPPEFFSNESSYN- 229
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRPTGL 224
KVD++S GI + P L
Sbjct: 230 --GAKVDIWSLGICLYVMFYNVVPFSL 254
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVL 76
+G V++G L GE VAVK FS+ ++S++RE + L+H N++ +
Sbjct: 15 CVGKGRYGEVWRG-LWHGESVAVKI-----FSSRDEQSWFRETEIYNTVLLRHDNILGFI 68
Query: 77 G---YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
+ S LI Y E+GSL + R TL + + +S A GL +L
Sbjct: 69 ASDMTSRNSSTQLWLITHYHEHGSLYDFLQ-------RQTLEPHLALRLAVSAACGLAHL 121
Query: 132 H-----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
H + I H D K N+L+ + + ++D G + M L + GT
Sbjct: 122 HVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTK 181
Query: 187 GYLAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGLDEE 227
Y+APE +I T D+++FG+V+ E + G+ E+
Sbjct: 182 RYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVED 228
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 12 GSFSEN-NII---GNSNLSTVYK--GRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
G+F+E NI+ G + V K R+ E AVK +N + + RE + LK
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLK 76
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
+L H N++K+ +S ++ E G L I + R++ ++ V
Sbjct: 77 KLDHPNIMKLFEILEDSSSF-YIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVF 131
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+G+ Y+H IVH D+KP NILL ++D + + DFG S + + + TA+
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE K DV+S G+++ L+ P
Sbjct: 189 -----YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 67/263 (25%), Positives = 108/263 (41%), Gaps = 55/263 (20%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFY--REAKTLKELKH 69
GS I V+K +L + + VAVK F + +S+ RE + +KH
Sbjct: 15 GSLQLLEIKARGRFGCVWKAQLMN-DFVAVKI-----FPLQDKQSWQSEREIFSTPGMKH 68
Query: 70 RNLVKVLGYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN 126
NL++ + L+ LI + + GSL + G + T + V +++
Sbjct: 69 ENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNII-----TWNELCHVAETMSR 123
Query: 127 GLDYLHS--------GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML-------DVH 171
GL YLH G+ I H D K N+LL D A ++DFG + D H
Sbjct: 124 GLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH 183
Query: 172 LQDLSSLSTAFQGTIGYLAPE-----FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTG--- 223
Q GT Y+APE + R ++D+++ G+V+ E +++ +
Sbjct: 184 GQ---------VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPV 234
Query: 224 ------LDEENGLSPISLRQLVE 240
+EE G P SL +L E
Sbjct: 235 DEYMLPFEEEIGQHP-SLEELQE 256
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 12 GSFSEN-NII---GNSNLSTVYKG--RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
G+F+E NI+ G + V K R+ E AVK +N + + RE + LK
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLK 76
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
+L H N++K+ +S ++ E G L I + R++ ++ V
Sbjct: 77 KLDHPNIMKLFEILEDSSSF-YIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVF 131
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+G+ Y+H IVH D+KP NILL ++D + + DFG S + + + TA+
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE K DV+S G+++ L+ P
Sbjct: 189 -----YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 20 IGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG- 77
+G+ V+K R + G ++AVK++ E+ + LK +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGY 135
+ + A+ L L+ + GP +P+RI + +++ L YL +
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGP--------IPERILGKMTVAIVKALYYLKEKH 144
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTS-RMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ +H D+KPSNILLD + + DFG S R++D +D S+ G Y+APE
Sbjct: 145 GV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA------GCAAYMAPE-- 194
Query: 195 YMRI---------VTTKVDVFSFGIVVMEFLTKRRP 221
RI + DV+S GI ++E T + P
Sbjct: 195 --RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ VY+G++ D + V + +E D+ F EA + + H+N+V+
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYL 131
+G + +S + ++LE M G L+S + S+ + +D+L +A G YL
Sbjct: 99 CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ +H D+ N LL A + DFG ++ D++ + +
Sbjct: 158 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ--DIYRASYYRKGGCAMLPVKW 212
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ PE I T+K D +SFG+++ E +
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 15/185 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKALILEYME 94
GE+VAVK L + + +E L+ L H +++K G + G K L++EY+
Sbjct: 43 GEMVAVKALKA-DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 95 NGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
GSL + H G L + + + G+ YLHS + +H ++ N+LLD
Sbjct: 102 LGSLRDYLPRHSIG-------LAQLLLFAQQICEGMAYLHSQH---YIHRNLAARNVLLD 151
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
D + DFG ++ + + + + + APE DV+SFG+ +
Sbjct: 152 NDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 213 MEFLT 217
E LT
Sbjct: 211 YELLT 215
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 67/226 (29%), Positives = 96/226 (42%), Gaps = 32/226 (14%)
Query: 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESDKSFYRE 60
R E+ AT +G + V+ R+ED G AVKK+ F AE E
Sbjct: 70 REEVHWATHQLR----LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-------E 116
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP--KRI 118
L +V + G A G + +E +E GSL ++ G LP + +
Sbjct: 117 LMACAGLTSPRIVPLYG-AVREGPWVNIFMELLEGGSLGQLVKEQGC------LPEDRAL 169
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRML--DVHLQDL 175
L GL+YLHS I+H D+K N+LL D A + DFG + L D +DL
Sbjct: 170 YYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL 226
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ GT ++APE R KVDV+S +++ L P
Sbjct: 227 LT-GDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 -DANLCQVIQM-ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R + T + Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAPEVILGMGYKENVDLWSVGCIMG 216
Query: 214 EFLTKR 219
E + +
Sbjct: 217 EMVCHK 222
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 15/185 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYME 94
GE+VAVK L + + +E L+ L H +++K G ++G L++EY+
Sbjct: 60 GEMVAVKALKA-DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 95 NGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
GSL + H G L + + + G+ YLH+ + +H D+ N+LLD
Sbjct: 119 LGSLRDYLPRHSIG-------LAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLD 168
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
D + DFG ++ + + + + + APE DV+SFG+ +
Sbjct: 169 NDRLVKIGDFGLAKAVP-EGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 213 MEFLT 217
E LT
Sbjct: 228 YELLT 232
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 21/221 (9%)
Query: 9 NATGSFSEN----NIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKT 63
NA+ FS+N +G S V + G A K +N + SA + REA+
Sbjct: 22 NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 81
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
++L+H N+V++ E L+ + + G L I V ++ +
Sbjct: 82 CRKLQHPNIVRLHDSIQEES-FHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQ 136
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ + Y HS IVH ++KP N+LL + ++DFG L + + D S
Sbjct: 137 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG----LAIEVND-SEAWH 188
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
F GT GYL+PE + VD+++ G+++ L P
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKA-LILEYMENGSLESVIHGPGVDHSRWTLPKR 117
+E + L+ L+H+N+++++ + K K +++EY G E + V R+ + +
Sbjct: 55 KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQA 111
Query: 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177
+ +GL+YLHS IVH D+KP N+LL +S G + L D +
Sbjct: 112 HGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 178 LSTAFQGTIGYLAPEFA--YMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++ QG+ + PE A KVD++S G+ + T P
Sbjct: 169 RTS--QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 13 SFSENNIIGNSNLST-VYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHR 70
SF +++G+ T VY+G D VAVK++ FS RE + L+E +H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 71 NLVKVLG------YAWESGKLKALIL-EYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
N+++ + + + +L A L EY+E + P I +L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP------------ITLLQQ 126
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDR-----DFEAHVSDFGTSRMLDVHLQDLSSL 178
+GL +LHS + IVH D+KP NIL+ +A +SDFG + L V S
Sbjct: 127 TTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 179 STAFQGTIGYLAPEFAYMRI---VTTKVDVFSFGIV 211
S GT G++APE T VD+FS G V
Sbjct: 184 S-GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 25/202 (12%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
GE+VA+K ++ + ++ + E + LK L+H+++ + L + E+ ++LEY
Sbjct: 35 GEMVAIKIMDKNTLGSDLPR-IKTEIEALKNLRHQHICQ-LYHVLETANKIFMVLEYCPG 92
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRD 154
G L I + R + + V + + + Y+HS GY H D+KP N+L D
Sbjct: 93 GELFDYI----ISQDRLSEEETRVVFRQIVSAVAYVHSQGY----AHRDLKPENLLFDEY 144
Query: 155 FEAHVSDFGTSRM----LDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFG 209
+ + DFG D HLQ G++ Y APE + + ++ DV+S G
Sbjct: 145 HKLKLIDFGLCAKPKGNKDYHLQTCC-------GSLAYAAPELIQGKSYLGSEADVWSMG 197
Query: 210 IVVMEFLTKRRPTGLDEENGLS 231
I++ + P D++N ++
Sbjct: 198 ILLYVLMCGFLP--FDDDNVMA 217
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 14 FSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN- 71
FS + IIG VY R D G++ A+K L+ + + ++ + + L
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 72 --LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN--- 126
+ + YA+ + + IL+ M G L + GV D+ A
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAAEIIL 303
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGT 185
GL+++H+ + +V+ D+KP+NILLD +SD G + D S A GT
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGT 353
Query: 186 IGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRP 221
GY+APE + + D FS G ++ + L P
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 14 FSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN- 71
FS + IIG VY R D G++ A+K L+ + + ++ + + L
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 72 --LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN--- 126
+ + YA+ + + IL+ M G L + GV D+ A
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAAEIIL 303
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGT 185
GL+++H+ + +V+ D+KP+NILLD +SD G + D S A GT
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGT 353
Query: 186 IGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRP 221
GY+APE + + D FS G ++ + L P
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 14 FSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN- 71
FS + IIG VY R D G++ A+K L+ + + ++ + + L
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 72 --LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN--- 126
+ + YA+ + + IL+ M G L + GV D+ A
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAAEIIL 302
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGT 185
GL+++H+ + +V+ D+KP+NILLD +SD G + D S A GT
Sbjct: 303 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGT 352
Query: 186 IGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRP 221
GY+APE + + D FS G ++ + L P
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 14 FSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN- 71
FS + IIG VY R D G++ A+K L+ + + ++ + + L
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 72 --LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN--- 126
+ + YA+ + + IL+ M G L + GV D+ A
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAAEIIL 303
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGT 185
GL+++H+ + +V+ D+KP+NILLD +SD G + D S A GT
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGT 353
Query: 186 IGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRP 221
GY+APE + + D FS G ++ + L P
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 37/107 (34%), Positives = 53/107 (49%), Gaps = 11/107 (10%)
Query: 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF---EAHVSDFGTSRMLDVHLQD 174
I ++ + G+ YLH IVH D+KP NILL + + + DFG SR + H +
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACE 189
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
L + GT YLAPE +TT D+++ GI+ LT P
Sbjct: 190 LREI----MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E++ L+ +H + L YA+++ ++EY G L H + R +R
Sbjct: 58 ESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH---LSRERVFTEERAR 111
Query: 120 VL-ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
+ + L+YLHS +V+ D+K N++LD+D ++DFG + + D +++
Sbjct: 112 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATM 165
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T F GT YLAPE VD + G+V+ E + R P
Sbjct: 166 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E++ L+ +H L L YA+++ ++EY G L H + R +R
Sbjct: 55 ESRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH---LSRERVFTEERAR 108
Query: 120 VL-ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
+ + L+YLHS +V+ D+K N++LD+D ++DFG + + D +++
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATM 162
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T F GT YLAPE VD + G+V+ E + R P
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E++ L+ +H + L YA+++ ++EY G L H + R +R
Sbjct: 55 ESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH---LSRERVFTEERAR 108
Query: 120 VL-ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
+ + L+YLHS +V+ D+K N++LD+D ++DFG + + D +++
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATM 162
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T F GT YLAPE VD + G+V+ E + R P
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 54.3 bits (129), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 76 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + + DFG SR +++D S+ A +G I ++APE
Sbjct: 131 R---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED-STXXKASKGKLPIKWMAPE 182
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 231
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 232 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 262
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 54.3 bits (129), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 16/215 (7%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G S V + ++ G+ A K +N + SA + REA+ + LKH N+V++
Sbjct: 30 LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
E G LI + + G L I V ++ D + L+ + + +
Sbjct: 90 ISEEGH-HYLIFDLVTGGELFEDI----VAREYYS---EADASHCIQQILEAVLHCHQMG 141
Query: 139 IVHCDMKPSNILLDRDFEA---HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+VH D+KP N+LL + ++DFG L + ++ F GT GYL+PE
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFG----LAIEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
VD+++ G+++ L P ++++ L
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 232
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 54.3 bits (129), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 38/268 (14%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 60 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 98 LESVIHG------PGVDHSR--WTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
L + + P D + TL I VA G+++L S I H D+ NI
Sbjct: 119 LSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXI---HRDLAARNI 175
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFG 209
LL + DFG +R D++ + + ++APE + R+ T + DV+SFG
Sbjct: 176 LLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 233
Query: 210 IVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXX 269
+++ E + G SP ++ E+ G R +Y
Sbjct: 234 VLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY------ 277
Query: 270 XXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 278 -------QTMLDCWHGEPSQRPTFSELV 298
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 54.3 bits (129), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P DE PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADE-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 38/268 (14%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 60 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 98 LESVIHG------PGVDHSR--WTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
L + + P D + TL I VA G+++L S I H D+ NI
Sbjct: 119 LSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXI---HRDLAARNI 175
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFG 209
LL + DFG +R D++ + + ++APE + R+ T + DV+SFG
Sbjct: 176 LLSEKNVVKIXDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 233
Query: 210 IVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXX 269
+++ E + G SP ++ E+ G R +Y
Sbjct: 234 VLLWEIFSL----------GASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMY------ 277
Query: 270 XXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 278 -------QTMLDCWHGEPSQRPTFSELV 298
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 45 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 104 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 158
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + + DFG SR +++D S+ A +G I ++APE
Sbjct: 159 R---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED-STYYKASKGKLPIKWMAPE 210
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 211 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 259
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 260 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 290
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 81 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + + DFG SR +++D S+ A +G I ++APE
Sbjct: 136 R---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED-STYYKASKGKLPIKWMAPE 187
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 236
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 237 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 267
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E LK+L H N++K+ + +E + L++E G L I + +++
Sbjct: 71 EVAVLKQLDHPNIMKLYEF-FEDKRNYYLVMEVYRGGELFDEI----ILRQKFSEVDAAV 125
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFGTSRMLDVHLQDLS 176
++ V +G YLH IVH D+KP N+LL+ RD + DFG S +V +
Sbjct: 126 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 182
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTG 223
L TA+ Y+APE + K DV+S G+++ L P G
Sbjct: 183 RLGTAY-----YIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFG 223
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 76 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + + DFG SR +++D S+ A +G I ++APE
Sbjct: 131 R---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED-STYYKASKGKLPIKWMAPE 182
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 231
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 232 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 262
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 19 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 78 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 132
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + + DFG SR +++D S+ A +G I ++APE
Sbjct: 133 R---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED-STYYKASKGKLPIKWMAPE 184
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 185 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 233
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 234 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 264
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 76 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + + DFG SR +++D S+ A +G I ++APE
Sbjct: 131 R---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED-STYYKASKGKLPIKWMAPE 182
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 231
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 232 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 262
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 15/185 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKALILEYME 94
GE+VAVK L + + +E L+ L H +++K G + G K L++EY+
Sbjct: 43 GEMVAVKALKA-DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 95 NGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
GSL + H G L + + + G+ YLH+ + +H ++ N+LLD
Sbjct: 102 LGSLRDYLPRHSIG-------LAQLLLFAQQICEGMAYLHAQH---YIHRNLAARNVLLD 151
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
D + DFG ++ + + + + + APE DV+SFG+ +
Sbjct: 152 NDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 210
Query: 213 MEFLT 217
E LT
Sbjct: 211 YELLT 215
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 20 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 79 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 133
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + + DFG SR +++D S+ A +G I ++APE
Sbjct: 134 R---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED-STYYKASKGKLPIKWMAPE 185
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 186 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 234
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 235 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 265
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE LKE++H N++ L +E+ LI E + G L + + T +
Sbjct: 63 REVSILKEIQHPNVI-TLHEVYENKTDVILIGELVAGGELFDFL----AEKESLTEEEAT 117
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQD 174
+ L + NG+ YLHS + I H D+KP NI LLDR+ + DFG + +D
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ F GT ++APE + + D++S G++ L+ P
Sbjct: 172 -NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E LK+L H N++K+ + +E + L++E G L I + +++
Sbjct: 54 EVAVLKQLDHPNIMKLYEF-FEDKRNYYLVMEVYRGGELFDEI----ILRQKFSEVDAAV 108
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFGTSRMLDVHLQDLS 176
++ V +G YLH IVH D+KP N+LL+ RD + DFG S +V +
Sbjct: 109 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE 165
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTG 223
L TA+ Y+APE + K DV+S G+++ L P G
Sbjct: 166 RLGTAY-----YIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFG 206
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 73 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + + DFG SR +++D S+ A +G I ++APE
Sbjct: 128 R---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED-STYYKASKGKLPIKWMAPE 179
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 228
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 229 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 259
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 55 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 95 NGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L ++ + DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 114 T-DLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T Y APE + T +D++S G +
Sbjct: 163 TTCDLKICDFGLARVADPD-HDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 222 LAEMLSNR 229
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 20/188 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV----LGYAWESGKLKALILEYME 94
VA+KK++ + ++ RE K L +H N++ + E K ++ + ME
Sbjct: 56 VAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 114
Query: 95 NGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L ++ + DH + L + GL Y+HS ++H D+KPSN+LL+
Sbjct: 115 T-DLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 163
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIV 211
+ + DFG +R+ D D + T Y APE + T +D++S G +
Sbjct: 164 TTCDLKICDFGLARVADPD-HDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 222
Query: 212 VMEFLTKR 219
+ E L+ R
Sbjct: 223 LAEMLSNR 230
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 11/143 (7%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
++EY+ G L I G ++ P+ + ++ GL +LH I++ D+K
Sbjct: 97 FVMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISIGLFFLHKR---GIIYRDLKLD 149
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N++LD + ++DFG M H+ D + F GT Y+APE + VD ++
Sbjct: 150 NVMLDSEGHIKIADFG---MCKEHMMD-GVTTREFCGTPDYIAPEIIAYQPYGKSVDWWA 205
Query: 208 FGIVVMEFLTKRRPTGLDEENGL 230
+G+++ E L + P ++E+ L
Sbjct: 206 YGVLLYEMLAGQPPFDGEDEDEL 228
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 108/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L+
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLA---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177
+ + I +A +++LHS ++H D+KPSNI D V DFG +D ++ +
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 178 LS-----TAFQGTIG---YLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
L+ G +G Y++PE + + KVD+FS G+++ E L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F + ++ Y ++ E++ K H + E + L+ +H
Sbjct: 21 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---------ENRVLQNSRHPF 71
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGL 128
L L Y++++ ++EY G L + V D +R+ + + L
Sbjct: 72 LT-ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 123
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
DYLHS ++ V+ D+K N++LD+D ++DFG + ++D +++ F GT Y
Sbjct: 124 DYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMK-XFCGTPEY 177
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
LAPE VD + G+V+ E + R P
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F + ++ Y ++ E++ K H + E + L+ +H
Sbjct: 20 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---------ENRVLQNSRHPF 70
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGL 128
L L Y++++ ++EY G L + V D +R+ + + L
Sbjct: 71 LT-ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 122
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
DYLHS + +V+ D+K N++LD+D ++DFG + ++D +++ F GT Y
Sbjct: 123 DYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKX-FCGTPEY 176
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
LAPE VD + G+V+ E + R P
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F + ++ Y ++ E++ K H + E + L+ +H
Sbjct: 19 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---------ENRVLQNSRHPF 69
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGL 128
L L Y++++ ++EY G L + V D +R+ + + L
Sbjct: 70 LT-ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSAL 121
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
DYLHS ++ V+ D+K N++LD+D ++DFG + ++D +++ F GT Y
Sbjct: 122 DYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMK-XFCGTPEY 175
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
LAPE VD + G+V+ E + R P
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK--TLKELKHRNLVKVL 76
+ V+K +L + E VAVK F + +S+ E + +L +KH N+++ +
Sbjct: 31 VKARGRFGCVWKAQLLN-EYVAVKI-----FPIQDKQSWQNEYEVYSLPGMKHENILQFI 84
Query: 77 GYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
G + LI + E GSL + V W + + ++A GL YLH
Sbjct: 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS---WN--ELCHIAETMARGLAYLHE 139
Query: 134 -------GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ-GT 185
G+ I H D+K N+LL + A ++DFG + + S+ T Q GT
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA---GKSAGDTHGQVGT 196
Query: 186 IGYLAPE-----FAYMRIVTTKVDVFSFGIVVMEFLTK 218
Y+APE + R ++D+++ G+V+ E ++
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EYM G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
++EY+ G L I G R+ P + +A GL +L S I++ D+K
Sbjct: 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLD 150
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N++LD + ++DFG M ++ D + F GT Y+APE + VD ++
Sbjct: 151 NVMLDSEGHIKIADFG---MCKENIWD-GVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 206
Query: 208 FGIVVMEFLTKRRPTGLDEENGL 230
FG+++ E L + P ++E+ L
Sbjct: 207 FGVLLYEMLAGQAPFEGEDEDEL 229
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EYM G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
++EY+ G L I G R+ P + +A GL +L S I++ D+K
Sbjct: 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLD 471
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N++LD + ++DFG M ++ D + F GT Y+APE + VD ++
Sbjct: 472 NVMLDSEGHIKIADFG---MCKENIWD-GVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 208 FGIVVMEFLTKRRPTGLDEENGL 230
FG+++ E L + P ++E+ L
Sbjct: 528 FGVLLYEMLAGQAPFEGEDEDEL 550
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G F++ I +++ V+ G++ ++ L HQ S E + L H++
Sbjct: 28 GGFAKCFEISDADTKEVFAGKIVPKSLL----LKPHQREKMS-----MEISIHRSLAHQH 78
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSR---WTLPKRIDVLISVANGL 128
+V G+ +E ++LE SL + H R T P+ L + G
Sbjct: 79 VVGFHGF-FEDNDFVFVVLELCRRRSLLEL-------HKRRKALTEPEARYYLRQIVLGC 130
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YLH ++H D+K N+ L+ D E + DFG + ++ + +L GT Y
Sbjct: 131 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC----GTPNY 183
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+APE + + +VDV+S G ++ L + P
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G F++ I +++ V+ G++ ++ L HQ S E + L H++
Sbjct: 32 GGFAKCFEISDADTKEVFAGKIVPKSLL----LKPHQREKMS-----MEISIHRSLAHQH 82
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSR---WTLPKRIDVLISVANGL 128
+V G+ +E ++LE SL + H R T P+ L + G
Sbjct: 83 VVGFHGF-FEDNDFVFVVLELCRRRSLLEL-------HKRRKALTEPEARYYLRQIVLGC 134
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YLH ++H D+K N+ L+ D E + DFG + ++ + +L GT Y
Sbjct: 135 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC----GTPNY 187
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+APE + + +VDV+S G ++ L + P
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G F++ I +++ V+ G++ ++ L HQ S E + L H++
Sbjct: 28 GGFAKCFEISDADTKEVFAGKIVPKSLL----LKPHQREKMS-----MEISIHRSLAHQH 78
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSR---WTLPKRIDVLISVANGL 128
+V G+ +E ++LE SL + H R T P+ L + G
Sbjct: 79 VVGFHGF-FEDNDFVFVVLELCRRRSLLEL-------HKRRKALTEPEARYYLRQIVLGC 130
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YLH ++H D+K N+ L+ D E + DFG + ++ + +L GT Y
Sbjct: 131 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC----GTPNY 183
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+APE + + +VDV+S G ++ L + P
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 39/244 (15%)
Query: 55 KSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTL 114
+ F +EA T+++ H ++VK++G E+ +I+E G L S + V L
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQ---VRKFSLDL 490
Query: 115 PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
I ++ L YL S VH D+ N+L+ + + DFG SR +++D
Sbjct: 491 ASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR----YMED 543
Query: 175 LSSLSTAFQGT--IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
S+ A +G I ++APE R T+ DV+ FG+ + E L G+ G+
Sbjct: 544 -STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKN 598
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPN 292
+ +E NG R P ++Y L C + +P RP
Sbjct: 599 NDVIGRIE-------NGERLPMPPNCPPTLY-------------SLMTKCWAYDPSRRPR 638
Query: 293 MNEL 296
EL
Sbjct: 639 FTEL 642
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 16/170 (9%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKA-LILEYMENGSLESVI---HGPGVDHSRWTL 114
RE L+ELKH N++ + K L+ +Y E+ L +I + L
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 115 PKRI--DVLISVANGLDYLHSGYDIPIVHCDMKPSNILL----DRDFEAHVSDFGTSRML 168
P+ + +L + +G+ YLH+ + ++H D+KP+NIL+ ++D G +R+
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLT 217
+ L+ L+ L T Y APE R T +D+++ G + E LT
Sbjct: 183 NSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 63/271 (23%), Positives = 108/271 (39%), Gaps = 41/271 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 61 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 119
Query: 98 LESVIHGPGVDHSRWTLPKRI--DVL---------ISVANGLDYLHSGYDIPIVHCDMKP 146
L + + + + P+ + D L VA G+++L S +H D+
Sbjct: 120 LSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176
Query: 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVF 206
NILL + DFG +R D+ + + ++APE + R+ T + DV+
Sbjct: 177 RNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 207 SFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXX 266
SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 235 SFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY--- 281
Query: 267 XXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 282 ----------QTMLDCWHGEPSQRPTFSELV 302
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 43 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 92
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 93 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 147
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 201 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 249
Query: 241 KALANGI 247
K ++ +
Sbjct: 250 KIVSGKV 256
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 21/212 (9%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYR-EAKTLKELKHRNL 72
F + +G S VY+ + + + K DK R E L L H N+
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQ----KPYALKVLKKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+K L +E+ +L+LE + G L I V+ ++ D + + + YLH
Sbjct: 111 IK-LKEIFETPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLH 165
Query: 133 SGYDIPIVHCDMKPSNILLDR---DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
IVH D+KP N+L D ++DFG S++++ + L GT GY
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-----LMKTVCGTPGYC 217
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
APE +VD++S GI+ L P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 23 SNLSTVYKGRLEDGEIVAVKKL--NFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYA 79
S+ + V++G + G VAVK++ +F + E K L E H N+++ Y
Sbjct: 45 SSGTVVFQGSFQ-GRPVAVKRMLIDFCDIAL-------MEIKLLTESDDHPNVIRY--YC 94
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR---IDVLISVANGLDYLHSGYD 136
E+ I + N +L+ ++ V L K I +L +A+G+ +LHS
Sbjct: 95 SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 151
Query: 137 IPIVHCDMKPSNILLD-------------RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ I+H D+KP NIL+ + +SDFG + LD
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 211
Query: 184 GTIGYLAPEF---AYMRIVTTKVDVFSFGIVVMEFLTK-RRPTG 223
GT G+ APE + R +T +D+FS G V L+K + P G
Sbjct: 212 GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 57/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + +
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-------VKGRTW 196
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 197 XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 67/270 (24%), Positives = 108/270 (40%), Gaps = 40/270 (14%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 62 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 120
Query: 98 L---------ESVIHGPGVDHSRW-TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
L E V + P + + TL I VA G+++L S I H D+
Sbjct: 121 LSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXI---HRDLAAR 177
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
NILL + DFG +R D+ + + ++APE + R+ T + DV+S
Sbjct: 178 NILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 208 FGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXX 267
FG+++ E + G SP ++ E+ G R +Y
Sbjct: 236 FGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY---- 281
Query: 268 XXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 282 ---------QTMLDCWHGEPSQRPTFSELV 302
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 57/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 63 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 112
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 113 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 167
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + +
Sbjct: 168 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-------VKGATW 217
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 218 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 269
Query: 241 KALANGI 247
K ++ +
Sbjct: 270 KIVSGKV 276
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E + L+ + LVK L Y+++ +++EY+ G + S + G R++ P
Sbjct: 91 EKRILQAVNFPFLVK-LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARF 145
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
GT YLAPE + VD ++ G+++ E P D+ PI Q+
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIY 247
Query: 240 EKALANGI 247
EK ++ +
Sbjct: 248 EKIVSGKV 255
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E + L+ + LVK L Y+++ +++EY+ G + S + G R++ P
Sbjct: 91 EKRILQAVNFPFLVK-LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARF 145
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
GT YLAPE + VD ++ G+++ E P D+ PI Q+
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIY 247
Query: 240 EKALANGI 247
EK ++ +
Sbjct: 248 EKIVSGKV 255
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E + L+ + LVK L Y+++ +++EY+ G + S + G R++ P
Sbjct: 91 EKRILQAVNFPFLVK-LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARF 145
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
GT YLAPE + VD ++ G+++ E P D+ PI Q+
Sbjct: 200 ----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIY 247
Query: 240 EKALANGI 247
EK ++ +
Sbjct: 248 EKIVSGKV 255
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 71/284 (25%), Positives = 113/284 (39%), Gaps = 44/284 (15%)
Query: 19 IIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E VA+K + S + F +EA T+++ H ++VK
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + V L I ++ L YL S
Sbjct: 76 LIGVITENPVW--IIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAPE 192
VH D+ N+L+ + DFG SR +++D S+ A +G I ++APE
Sbjct: 131 R---FVHRDIAARNVLVSATDCVKLGDFGLSR----YMED-STYYKASKGKLPIKWMAPE 182
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R T+ DV+ FG+ + E L G+ G+ + +E NG R
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKNNDVIGRIE-------NGERL 231
Query: 253 ITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
P ++Y L C + +P RP EL
Sbjct: 232 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTEL 262
>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
pdb|2VD5|B Chain B, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
Length = 412
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTL 64
E+ F +IG S V ++ + G++ A+K +N + S +RE + +
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 65 KELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID--VLI 122
R + L +A++ L++EY G L +++ G +P + L
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLA 169
Query: 123 SVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ +D +H GY VH D+KP NILLDR ++DFG+ L D + S
Sbjct: 170 EIVMAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRA---DGTVRSLV 222
Query: 182 FQGTIGYLAPEF-------AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT YL+PE + D ++ G+ E + P
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 23 SNLSTVYKGRLEDGEIVAVKKL--NFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYA 79
S+ + V++G + G VAVK++ +F + E K L E H N+++ Y
Sbjct: 45 SSGTVVFQGSFQ-GRPVAVKRMLIDFCDIAL-------MEIKLLTESDDHPNVIRY--YC 94
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR---IDVLISVANGLDYLHSGYD 136
E+ I + N +L+ ++ V L K I +L +A+G+ +LHS
Sbjct: 95 SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 151
Query: 137 IPIVHCDMKPSNILLD-------------RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ I+H D+KP NIL+ + +SDFG + LD
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPS 211
Query: 184 GTIGYLAPEF---AYMRIVTTKVDVFSFGIVVMEFLTK-RRPTG 223
GT G+ APE + R +T +D+FS G V L+K + P G
Sbjct: 212 GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 43 GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 93
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 94 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 148
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 198
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 248
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 16/194 (8%)
Query: 40 AVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLE 99
A K +N + SA + REA+ ++L+H N+V+ L + + L+ + + G L
Sbjct: 34 AAKIINTKKLSARDFQKLEREARICRKLQHPNIVR-LHDSIQEESFHYLVFDLVTGGELF 92
Query: 100 SVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFE 156
I V ++ + + + Y HS IVH ++KP N+LL +
Sbjct: 93 EDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 145
Query: 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
++DFG L + + D S F GT GYL+PE + VD+++ G+++ L
Sbjct: 146 VKLADFG----LAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 200
Query: 217 TKRRPTGLDEENGL 230
P ++++ L
Sbjct: 201 VGYPPFWDEDQHRL 214
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 107/272 (39%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 60 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D++ + + ++APE + R+ T + DV
Sbjct: 176 ARNILLSEKNVVKICDFGLAR--DIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 234 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 281
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 282 -----------QTMLDCWHGEPSQRPTFSELV 302
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 16/194 (8%)
Query: 40 AVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLE 99
A K +N + SA + REA+ ++L+H N+V+ L + + L+ + + G L
Sbjct: 35 AAKIINTKKLSARDFQKLEREARICRKLQHPNIVR-LHDSIQEESFHYLVFDLVTGGELF 93
Query: 100 SVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFE 156
I V ++ + + + Y HS IVH ++KP N+LL +
Sbjct: 94 EDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146
Query: 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
++DFG L + + D S F GT GYL+PE + VD+++ G+++ L
Sbjct: 147 VKLADFG----LAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 217 TKRRPTGLDEENGL 230
P ++++ L
Sbjct: 202 VGYPPFWDEDQHRL 215
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 63 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 112
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R+ P
Sbjct: 113 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFY 167
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 168 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 221 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 269
Query: 241 KALANGI 247
K ++ +
Sbjct: 270 KIVSGKV 276
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R+ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFAEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 37 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 86
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R+ P
Sbjct: 87 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFY 141
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 142 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 194
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 195 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 243
Query: 241 KALANGI 247
K ++ +
Sbjct: 244 KIVSGKV 250
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 51 GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 101
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 102 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 156
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 206
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 16/194 (8%)
Query: 40 AVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLE 99
A K +N + SA + REA+ ++L+H N+V+ L + + L+ + + G L
Sbjct: 35 AAKIINTKKLSARDFQKLEREARICRKLQHPNIVR-LHDSIQEESFHYLVFDLVTGGELF 93
Query: 100 SVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFE 156
I V ++ + + + Y HS IVH ++KP N+LL +
Sbjct: 94 EDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146
Query: 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
++DFG L + + D S F GT GYL+PE + VD+++ G+++ L
Sbjct: 147 VKLADFG----LAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 217 TKRRPTGLDEENGL 230
P ++++ L
Sbjct: 202 VGYPPFWDEDQHRL 215
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E++ L+ +H L L YA+++ ++EY G L H + R +R
Sbjct: 60 ESRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH---LSRERVFTEERAR 113
Query: 120 VL-ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
+ + L+YLHS +V+ D+K N++LD+D ++DFG + + +S
Sbjct: 114 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDG 164
Query: 179 ST--AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+T F GT YLAPE VD + G+V+ E + R P
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 51 GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 101
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 102 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 156
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 206
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E++ L+ +H L L YA+++ ++EY G L H + R +R
Sbjct: 55 ESRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH---LSRERVFTEERAR 108
Query: 120 VL-ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
+ + L+YLHS +V+ D+K N++LD+D ++DFG + + +S
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDG 159
Query: 179 ST--AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+T F GT YLAPE VD + G+V+ E + R P
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E++ L+ +H L L YA+++ ++EY G L H + R +R
Sbjct: 55 ESRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGEL--FFH---LSRERVFTEERAR 108
Query: 120 VL-ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
+ + L+YLHS +V+ D+K N++LD+D ++DFG + + +S
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDG 159
Query: 179 ST--AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+T F GT YLAPE VD + G+V+ E + R P
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R+ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 107/272 (39%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 97 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 155
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 156 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D++ + + ++APE + R+ T + DV
Sbjct: 213 ARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 271 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 318
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 319 -----------QTMLDCWHGEPSQRPTFSELV 339
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 51 GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 101
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 102 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 156
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 206
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 72/289 (24%), Positives = 117/289 (40%), Gaps = 44/289 (15%)
Query: 17 NNIIGNSNLSTVYKGRLED--GEI--VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N I+G VY+G + GE VAVK + ++ + F EA +K L H ++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDY 130
VK++G E +I+E G L G ++ ++ +L VL S + + Y
Sbjct: 76 VKLIGIIEEEPTW--IIMELYPYGEL-----GHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
L S I VH D+ NIL+ + DFG SR ++ +D S + I +++
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVT-RLPIKWMS 182
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
PE R TT DV+ F + + E L+ + EN K + +
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN------------KDVIGVLEKG 230
Query: 251 RQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLIT 299
++ P L + + L C +P DRP EL+ +
Sbjct: 231 DRLPKPDLCPPV------------LYTLMTRCWDYDPSDRPRFTELVCS 267
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 29 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 78
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 79 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 133
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D V+DFG ++ + L
Sbjct: 134 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC---- 186
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 187 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 235
Query: 241 KALANGI 247
K ++ +
Sbjct: 236 KIVSGKV 242
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E++ L+ +H + L YA+++ ++EY G L H + R +R
Sbjct: 55 ESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANGGEL--FFH---LSRERVFTEERAR 108
Query: 120 VL-ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
+ + L+YLHS +V+ D+K N++LD+D ++DFG + + +S
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDG 159
Query: 179 ST--AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+T F GT YLAPE VD + G+V+ E + R P
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 72/289 (24%), Positives = 117/289 (40%), Gaps = 44/289 (15%)
Query: 17 NNIIGNSNLSTVYKGRLED--GEI--VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N I+G VY+G + GE VAVK + ++ + F EA +K L H ++
Sbjct: 13 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDY 130
VK++G E +I+E G L G ++ ++ +L VL S + + Y
Sbjct: 72 VKLIGIIEEEPTW--IIMELYPYGEL-----GHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
L S I VH D+ NIL+ + DFG SR ++ +D S + I +++
Sbjct: 125 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVT-RLPIKWMS 178
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
PE R TT DV+ F + + E L+ + EN K + +
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN------------KDVIGVLEKG 226
Query: 251 RQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLIT 299
++ P L + + L C +P DRP EL+ +
Sbjct: 227 DRLPKPDLCPPV------------LYTLMTRCWDYDPSDRPRFTELVCS 263
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 72/289 (24%), Positives = 117/289 (40%), Gaps = 44/289 (15%)
Query: 17 NNIIGNSNLSTVYKGRLED--GEI--VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N I+G VY+G + GE VAVK + ++ + F EA +K L H ++
Sbjct: 29 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDY 130
VK++G E +I+E G L G ++ ++ +L VL S + + Y
Sbjct: 88 VKLIGIIEEEPTW--IIMELYPYGEL-----GHYLERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
L S I VH D+ NIL+ + DFG SR ++ +D S + I +++
Sbjct: 141 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVT-RLPIKWMS 194
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
PE R TT DV+ F + + E L+ + EN K + +
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN------------KDVIGVLEKG 242
Query: 251 RQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELLIT 299
++ P L + + L C +P DRP EL+ +
Sbjct: 243 DRLPKPDLCPPV------------LYTLMTRCWDYDPSDRPRFTELVCS 279
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R+ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 107/272 (39%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 60 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D++ + + ++APE + R+ T + DV
Sbjct: 176 ARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 234 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 281
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 282 -----------QTMLDCWHGEPSQRPTFSELV 302
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R+ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 107/272 (39%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 62 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 120
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 121 LSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 177
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D++ + + ++APE + R+ T + DV
Sbjct: 178 ARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 235
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 236 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 283
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 284 -----------QTMLDCWHGEPSQRPTFSELV 304
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 71 GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 121
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 122 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 176
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 226
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE 226
APE + VD ++ G+++ E P D+
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 263
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 45/185 (24%), Positives = 78/185 (42%), Gaps = 28/185 (15%)
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
T+ I VA G+++L S +H D+ NILL + + DFG +R D++
Sbjct: 197 TMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLAR--DIYK 251
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ + ++APE + +I +TK DV+S+G+++ E + G SP
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSL----------GGSP 301
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPN 292
Q+ E + G+R IY ++ L C +P++RP
Sbjct: 302 YPGVQMDEDFCSRLREGMRMRAPEYSTPEIY-------------QIMLDCWHRDPKERPR 348
Query: 293 MNELL 297
EL+
Sbjct: 349 FAELV 353
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 62/244 (25%), Positives = 100/244 (40%), Gaps = 39/244 (15%)
Query: 55 KSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTL 114
+ F +EA T+++ H ++VK++G E+ +I+E G L S + V L
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQ---VRKFSLDL 490
Query: 115 PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
I ++ L YL S VH D+ N+L+ + DFG SR +++D
Sbjct: 491 ASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSR----YMED 543
Query: 175 LSSLSTAFQGT--IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
S+ A +G I ++APE R T+ DV+ FG+ + E L G+ G+
Sbjct: 544 -STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH----GVKPFQGVKN 598
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPN 292
+ +E NG R P ++Y L C + +P RP
Sbjct: 599 NDVIGRIE-------NGERLPMPPNCPPTLY-------------SLMTKCWAYDPSRRPR 638
Query: 293 MNEL 296
EL
Sbjct: 639 FTEL 642
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 57/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+++D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 59/186 (31%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 49 FSAESDKSFYREAKTLKELK-------HRNLVKVLGYAWESGKLKALILEYMENGSLESV 101
FSAE + REA TLKE+ H N+++ L +E+ L+ + M+ G L
Sbjct: 58 FSAEEVQEL-REA-TLKEVDILRKVSGHPNIIQ-LKDTYETNTFFFLVFDLMKKGELFDY 114
Query: 102 IHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161
+ V S K + L+ V L L+ IVH D+KP NILLD D ++D
Sbjct: 115 L-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTD 167
Query: 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI------VTTKVDVFSFGIVVMEF 215
FG S LD + L S+ GT YLAPE + +VD++S G+++
Sbjct: 168 FGFSCQLDPG-EKLRSVC----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222
Query: 216 LTKRRP 221
L P
Sbjct: 223 LAGSPP 228
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G F++ I +++ V+ G++ ++ L HQ S E + L H++
Sbjct: 50 GGFAKCFEISDADTKEVFAGKIVPKSLL----LKPHQREKMS-----MEISIHRSLAHQH 100
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSR---WTLPKRIDVLISVANGL 128
+V G+ +E ++LE SL + H R T P+ L + G
Sbjct: 101 VVGFHGF-FEDNDFVFVVLELCRRRSLLEL-------HKRRKALTEPEARYYLRQIVLGC 152
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YLH ++H D+K N+ L+ D E + DFG + ++ + L GT Y
Sbjct: 153 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNY 205
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+APE + + +VDV+S G ++ L + P
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 36 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 86
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 87 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 141
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-------GTPEYL 191
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 241
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 26 STVYKGRLEDGEIVAVKKL--NFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWES 82
+ V++G + G VAVK++ +F + E K L E H N+++ Y E+
Sbjct: 30 TVVFQGSFQ-GRPVAVKRMLIDFCDIAL-------MEIKLLTESDDHPNVIRY--YCSET 79
Query: 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR---IDVLISVANGLDYLHSGYDIPI 139
I + N +L+ ++ V L K I +L +A+G+ +LHS + I
Sbjct: 80 TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKI 136
Query: 140 VHCDMKPSNILLD-------------RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
+H D+KP NIL+ + +SDFG + LD + GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 187 GYLAPE-------FAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTG 223
G+ APE R +T +D+FS G V L+K + P G
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G F++ I +++ V+ G++ ++ L HQ S E + L H++
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVPKSLL----LKPHQREKMS-----MEISIHRSLAHQH 102
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSR---WTLPKRIDVLISVANGL 128
+V G+ +E ++LE SL + H R T P+ L + G
Sbjct: 103 VVGFHGF-FEDNDFVFVVLELCRRRSLLEL-------HKRRKALTEPEARYYLRQIVLGC 154
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YLH ++H D+K N+ L+ D E + DFG + ++ + L GT Y
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNY 207
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+APE + + +VDV+S G ++ L + P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 57/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAPE + VD ++ G+++ + P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 51 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 101
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 102 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 156
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 206
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 51 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 101
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 102 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 156
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-------GTPEYL 206
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 43 GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 93
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R+ P + +
Sbjct: 94 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFE 148
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 198
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 248
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G F++ I +++ V+ G++ ++ L HQ S E + L H++
Sbjct: 26 GGFAKCFEISDADTKEVFAGKIVPKSLL----LKPHQREKMS-----MEISIHRSLAHQH 76
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSR---WTLPKRIDVLISVANGL 128
+V G+ +E ++LE SL + H R T P+ L + G
Sbjct: 77 VVGFHGF-FEDNDFVFVVLELCRRRSLLEL-------HKRRKALTEPEARYYLRQIVLGC 128
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YLH ++H D+K N+ L+ D E + DFG + ++ + L GT Y
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNY 181
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+APE + + +VDV+S G ++ L + P
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 38/239 (15%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIVAVK--------KLNFHQFSAESDKSFYREAKTLKELK 68
++G+ TV+KG + +GE + + K F A +D + L
Sbjct: 37 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML-----AIGSLD 91
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTL----PKRI-DVLIS 123
H ++V++LG G L+ +Y+ GSL +DH R P+ + + +
Sbjct: 92 HAHIVRLLGLC--PGSSLQLVTQYLPLGSL--------LDHVRQHRGALGPQLLLNWGVQ 141
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+A G+ YL + +VH ++ N+LL + V+DFG + +L D L + +
Sbjct: 142 IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAK 196
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
I ++A E + T + DV+S+G+ V E +T G + GL + L+EK
Sbjct: 197 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT----FGAEPYAGLRLAEVPDLLEKG 251
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 38/239 (15%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIVAVK--------KLNFHQFSAESDKSFYREAKTLKELK 68
++G+ TV+KG + +GE + + K F A +D + L
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML-----AIGSLD 73
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTL----PKRI-DVLIS 123
H ++V++LG G L+ +Y+ GSL +DH R P+ + + +
Sbjct: 74 HAHIVRLLGLC--PGSSLQLVTQYLPLGSL--------LDHVRQHRGALGPQLLLNWGVQ 123
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+A G+ YL + +VH ++ N+LL + V+DFG + +L D L + +
Sbjct: 124 IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAK 178
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
I ++A E + T + DV+S+G+ V E +T G + GL + L+EK
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT----FGAEPYAGLRLAEVPDLLEKG 233
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I E+ + G+
Sbjct: 51 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 166
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D++ + + ++APE + R+ T + DV
Sbjct: 167 ARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 225 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 272
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 273 -----------QTMLDCWHGEPSQRPTFSELV 293
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I E+ + G+
Sbjct: 51 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 166
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D++ + + ++APE + R+ T + DV
Sbjct: 167 ARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 225 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 272
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 273 -----------QTMLDCWHGEPSQRPTFSELV 293
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 60 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D+ + + ++APE + R+ T + DV
Sbjct: 176 ARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 234 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 281
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 282 -----------QTMLDCWHGEPSQRPTFSELV 302
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I+E+ + G+
Sbjct: 51 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 109
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 166
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D+ + + ++APE + R+ T + DV
Sbjct: 167 ARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 225 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 272
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 273 -----------QTMLDCWHGEPSQRPTFSELV 293
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 51.2 bits (121), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 51.2 bits (121), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 110/230 (47%), Gaps = 23/230 (10%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G V K R + G+I+AVK++ S E + +++ + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYD 136
+ G + + +E M+ SL+ + +D + T+P+ I + +S+ L++LHS
Sbjct: 75 LFREGDV-WICMELMDT-SLDK-FYKQVIDKGQ-TIPEDILGKIAVSIVKALEHLHS--K 128
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTS-RMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+ ++H D+KPSN+L++ + + DFG S ++D +D+ + G Y+APE
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA------GCKPYMAPERIN 182
Query: 196 MRI----VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+ + K D++S GI ++E R P + G L+Q+VE+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPY---DSWGTPFQQLKQVVEE 229
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 13 SFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL---- 67
SF + +G+ + V+K R EDG + AVK+ + F D+ A+ L E+
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDR-----ARKLAEVGSHE 111
Query: 68 ---KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVL 121
+H V+ L AWE G + L E + SL+ G + W + D L
Sbjct: 112 KVGQHPCCVR-LEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLR--DTL 167
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+++A +LHS +VH D+KP+NI L + DFG L L TA
Sbjct: 168 LALA----HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL----------LVELGTA 210
Query: 182 FQGTIG-----YLAPEFAYMRIVTTKVDVFSFGIVVME 214
G + Y+APE T DVFS G+ ++E
Sbjct: 211 GAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLTILE 247
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G V K R + G+I+AVK++ S E + +++ + V G
Sbjct: 59 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYD 136
+ G + + +E M+ SL+ + +D + T+P+ I + +S+ L++LHS
Sbjct: 119 LFREGDV-WICMELMDT-SLDK-FYKQVIDKGQ-TIPEDILGKIAVSIVKALEHLHS--K 172
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
+ ++H D+KPSN+L++ + + DFG S +L D S T G Y+APE
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGISG----YLVD-SVAKTIDAGCKPYMAPERINP 227
Query: 197 RI----VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+ + K D++S GI ++E R P + G L+Q+VE+
Sbjct: 228 ELNQKGYSVKSDIWSLGITMIELAILRFPY---DSWGTPFQQLKQVVEE 273
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R+ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 51 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 101
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R+ P + +
Sbjct: 102 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFE 156
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 206
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY+ G + S + G R+ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+L+D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE 226
APE + VD ++ G+++ E P D+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 50.8 bits (120), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 40/225 (17%)
Query: 26 STVYKGRLEDGEIVAVKKL--NFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWES 82
+ V++G + G VAVK++ +F + E K L E H N+++ Y E+
Sbjct: 30 TVVFQGSFQ-GRPVAVKRMLIDFCDIAL-------MEIKLLTESDDHPNVIRY--YCSET 79
Query: 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR---IDVLISVANGLDYLHSGYDIPI 139
I + N +L+ ++ V L K I +L +A+G+ +LHS + I
Sbjct: 80 TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKI 136
Query: 140 VHCDMKPSNILLD-------------RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
+H D+KP NIL+ + +SDFG + LD GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTS 196
Query: 187 GYLAPE-------FAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTG 223
G+ APE R +T +D+FS G V L+K + P G
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 50.8 bits (120), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 20 IGNSNLSTVYKGR--LEDGEIVAVKKLNF-HQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G +TVYKG+ L D +VA+K++ H+ A + RE LK+LKH N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPC--TAIREVSLLKDLKHANIV-TL 65
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPG--VDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ K L+ EY++ L+ + G ++ L L + GL Y H
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL-----FLFQLLRGLAYCHRQ 119
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
++H D+KP N+L++ E ++DFG +R + + + T+ Y P+
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPPDIL 172
Query: 195 YMRI-VTTKVDVFSFGIVVMEFLTKR 219
+T++D++ G + E T R
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 22/160 (13%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
++LEY G + S + G R++ P + +YLHS + +++ D+KP
Sbjct: 119 MVLEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N+L+D+ V+DFG ++ + L GT YLAPE + VD ++
Sbjct: 172 NLLIDQQGYIKVADFGFAKRVKGRTWXLC-------GTPEYLAPEIILSKGYNKAVDWWA 224
Query: 208 FGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
G+++ E P D+ PI Q+ EK ++ +
Sbjct: 225 LGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 58/186 (31%), Positives = 84/186 (45%), Gaps = 28/186 (15%)
Query: 49 FSAESDKSFYREAKTLKELK-------HRNLVKVLGYAWESGKLKALILEYMENGSLESV 101
FSAE + REA TLKE+ H N+++ L +E+ L+ + M+ G L
Sbjct: 45 FSAEEVQEL-REA-TLKEVDILRKVSGHPNIIQ-LKDTYETNTFFFLVFDLMKKGELFDY 101
Query: 102 IHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161
+ V S K + L+ V L L+ IVH D+KP NILLD D ++D
Sbjct: 102 L-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTD 154
Query: 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI------VTTKVDVFSFGIVVMEF 215
FG S LD + L + GT YLAPE + +VD++S G+++
Sbjct: 155 FGFSCQLDPG-EKLREVC----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 209
Query: 216 LTKRRP 221
L P
Sbjct: 210 LAGSPP 215
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT YLAP + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 63/272 (23%), Positives = 105/272 (38%), Gaps = 42/272 (15%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L +E ++ E K L + H N+V +LG + G +I E+ + G+
Sbjct: 51 VAVKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 98 LESVIHGPGVDHSRW------------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L + + + + TL I VA G+++L S +H D+
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 166
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILL + DFG +R D+ + + ++APE + R+ T + DV
Sbjct: 167 ARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXX 265
+SFG+++ E + G SP ++ E+ G R +Y
Sbjct: 225 WSFGVLLWEIFSL----------GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-- 272
Query: 266 XXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ L C P RP +EL+
Sbjct: 273 -----------QTMLDCWHGEPSQRPTFSELV 293
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 27/201 (13%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVD-------HSRW 112
E L ++H N++KVL +E+ L++E HG G+D H R
Sbjct: 79 EIAILSRVEHANIIKVLD-IFENQGFFQLVMEK----------HGSGLDLFAFIDRHPRL 127
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
P + + + + YL I+H D+K NI++ DF + DFG++ L
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---- 180
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRPTGLDEENGLS 231
+ L F GTI Y APE +++++S G+ + + + P EE +
Sbjct: 181 -ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239
Query: 232 PISLRQLVEKALANGINGVRQ 252
I LV K L + ++G+ Q
Sbjct: 240 AIHPPYLVSKELMSLVSGLLQ 260
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/238 (22%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+++D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/238 (22%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 51 GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 101
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY G + S + G R++ P + +
Sbjct: 102 PFLVK-LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 156
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+++D+ V+DFG ++ + L GT YL
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GTPEYL 206
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/186 (31%), Positives = 84/186 (45%), Gaps = 28/186 (15%)
Query: 49 FSAESDKSFYREAKTLKELK-------HRNLVKVLGYAWESGKLKALILEYMENGSLESV 101
FSAE + REA TLKE+ H N+++ L +E+ L+ + M+ G L
Sbjct: 58 FSAEEVQEL-REA-TLKEVDILRKVSGHPNIIQ-LKDTYETNTFFFLVFDLMKKGELFDY 114
Query: 102 IHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161
+ V S K + L+ V L L+ IVH D+KP NILLD D ++D
Sbjct: 115 L-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTD 167
Query: 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI------VTTKVDVFSFGIVVMEF 215
FG S LD + L + GT YLAPE + +VD++S G+++
Sbjct: 168 FGFSCQLDPG-EKLREVC----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222
Query: 216 LTKRRP 221
L P
Sbjct: 223 LAGSPP 228
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 18/216 (8%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G S V + ++ G+ A +N + SA + REA+ + LKH N+V++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 79 AWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E G LI + + G L E ++ + D + L+ + + +
Sbjct: 79 ISEEGH-HYLIFDLVTGGELFEDIVAREYYSEA--------DASHCIQQILEAVLHCHQM 129
Query: 138 PIVHCDMKPSNILLDRDFEA---HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+VH ++KP N+LL + ++DFG L + ++ F GT GYL+PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFG----LAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
VD+++ G+++ L P ++++ L
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAE---SDKSFYREAKTLKELKHRNLV 73
+IG S V + E G+ AVK ++ +F++ S + REA LKH ++V
Sbjct: 30 EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++L + S + ++ E+M+ L I ++ + + L Y H
Sbjct: 90 ELLE-TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH- 147
Query: 134 GYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
D I+H D+KP N+LL + + DFG + + L + ++ GT ++A
Sbjct: 148 --DNNIIHRDVKPENVLLASKENSAPVKLGDFGVA----IQLGESGLVAGGRVGTPHFMA 201
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE VDV+ G+++ L+ P
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+++D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE 226
APE + VD ++ G+++ E P D+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 20 IGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G + V+ R++D G AVKK+ F E E L +V +
Sbjct: 66 VGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP--KRIDVLISVANGLDYLHSG 134
G A G + +E +E GSL +I G LP + + L GL+YLH+
Sbjct: 117 G-AVREGPWVNIFMELLEGGSLGQLIKQMGC------LPEDRALYYLGQALEGLEYLHTR 169
Query: 135 YDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLSTAF-QGTIGYLAPE 192
I+H D+K N+LL D A + DFG + L S L+ + GT ++APE
Sbjct: 170 R---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ KVD++S +++ L P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAE----SDKSFYREAKTLKELKHRNLVK 74
+G+ + V K R + G+ A K + + S+ S + RE L+E++H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII- 71
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
L +E+ LILE + G L + + T + L + +G+ YLHS
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 135 YDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
I H D+KP NI LLD++ + DFG + ++ + F GT ++A
Sbjct: 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG----NEFKNIF-GTPEFVA 179
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPIS 234
PE + + D++S G++ L+ P G ++ L+ IS
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 20 IGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G + V+ R++D G AVKK+ F E E L +V +
Sbjct: 82 VGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 132
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP--KRIDVLISVANGLDYLHSG 134
G A G + +E +E GSL +I G LP + + L GL+YLH+
Sbjct: 133 G-AVREGPWVNIFMELLEGGSLGQLIKQMGC------LPEDRALYYLGQALEGLEYLHTR 185
Query: 135 YDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLSTAF-QGTIGYLAPE 192
I+H D+K N+LL D A + DFG + L S L+ + GT ++APE
Sbjct: 186 R---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ KVD++S +++ L P
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAE----SDKSFYREAKTLKELKHRNLVK 74
+G+ + V K R + G+ A K + + S+ S + RE L+E++H N++
Sbjct: 20 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII- 78
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
L +E+ LILE + G L + + T + L + +G+ YLHS
Sbjct: 79 TLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSK 134
Query: 135 YDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
I H D+KP NI LLD++ + DFG + ++ + F GT ++A
Sbjct: 135 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG----NEFKNIF-GTPEFVA 186
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPIS 234
PE + + D++S G++ L+ P G ++ L+ IS
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS 231
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/238 (22%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+++D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 76 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 128
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL VH D+ N+LL A +SDFG S+ L ++
Sbjct: 129 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 184
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 185 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 56 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 108
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL VH D+ N+LL A +SDFG S+ L ++
Sbjct: 109 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 164
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 165 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 78 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 130
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL VH D+ N+LL A +SDFG S+ L ++
Sbjct: 131 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 186
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 78 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 130
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL VH D+ N+LL A +SDFG S+ L ++
Sbjct: 131 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 186
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 58 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 110
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL VH D+ N+LL A +SDFG S+ L ++
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 166
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 68 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 120
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL VH D+ N+LL A +SDFG S+ L ++
Sbjct: 121 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 176
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 62 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 114
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL VH D+ N+LL A +SDFG S+ L ++
Sbjct: 115 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 170
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 20 IGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G + V+ R++D G AVKK+ F E E L +V +
Sbjct: 80 LGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 130
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP--KRIDVLISVANGLDYLHSG 134
G A G + +E +E GSL +I G LP + + L GL+YLH+
Sbjct: 131 G-AVREGPWVNIFMELLEGGSLGQLIKQMGC------LPEDRALYYLGQALEGLEYLHTR 183
Query: 135 YDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLSTAF-QGTIGYLAPE 192
I+H D+K N+LL D A + DFG + L S L+ + GT ++APE
Sbjct: 184 R---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 240
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ KVD++S +++ L P
Sbjct: 241 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 62 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 114
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL VH D+ N+LL A +SDFG S+ L ++
Sbjct: 115 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENXYKA 170
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 420 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 472
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL + VH D+ N+LL A +SDFG S+ L ++
Sbjct: 473 ELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 528
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
T + + + APE ++K DV+SFG+++ E +
Sbjct: 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/238 (22%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY G + S + G R++ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+++D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA +++L + +V+++G + L++E E G L + +R K I
Sbjct: 421 EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNII 473
Query: 120 VLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
L+ V+ G+ YL + VH D+ N+LL A +SDFG S+ L ++
Sbjct: 474 ELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKA 529
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME-FLTKRRP 221
T + + + APE ++K DV+SFG+++ E F ++P
Sbjct: 530 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+FDR + TGSF ++ + Y ++ D + V K H + E
Sbjct: 42 QFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---------E 91
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ L+ + LVK L ++++ +++EY+ G + S + G R++ P
Sbjct: 92 KRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFY 146
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ + L
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT LAPE + VD ++ G+++ E P D+ PI Q+ E
Sbjct: 200 ---GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYE 248
Query: 241 KALANGI 247
K ++ +
Sbjct: 249 KIVSGKV 255
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 39/114 (34%), Positives = 56/114 (49%), Gaps = 11/114 (9%)
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS-RMLDVH 171
+P+ I I++A H ++ I+H D+KPSNILLDR + DFG S +++D
Sbjct: 121 VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-- 178
Query: 172 LQDLSSLSTAFQGTIGYLAPE----FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
S T G Y+APE A + + DV+S GI + E T R P
Sbjct: 179 ----SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 19 IIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+IG V +L++ + + A+K LN + ++ + +RE + + + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWT--LPKRID--VLISVANGLDYLHS 133
YA++ L+++Y G L +++ S++ LP+ + L + +D +H
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLL-------SKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
+ VH D+KP NIL+D + ++DFG+ L ++D + S+ GT Y++PE
Sbjct: 194 ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---MEDGTVQSSVAVGTPDYISPEI 247
Query: 194 AYMR-----IVTTKVDVFSFGIVVMEFLTKRRP 221
+ D +S G+ + E L P
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 18/187 (9%)
Query: 53 SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112
S + RE L+E++H N++ L +E+ LILE + G L + +
Sbjct: 72 SREEIEREVNILREIRHPNII-TLHDIFENKTDVVLILELVSGGELFDFL----AEKESL 126
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDF---EAHVSDFGTSRML 168
T + L + +G+ YLHS I H D+KP NI LLD++ + DFG + +
Sbjct: 127 TEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 183
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEE 227
+ + F GT ++APE + + D++S G++ L+ P G ++
Sbjct: 184 EAG----NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 238
Query: 228 NGLSPIS 234
L+ IS
Sbjct: 239 ETLTNIS 245
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/238 (22%), Positives = 100/238 (42%), Gaps = 32/238 (13%)
Query: 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
TGSF ++ + Y ++ D + V K H + E + L+ +
Sbjct: 50 GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN---------EKRILQAVNF 100
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
LVK L ++++ +++EY G + S + G R+ P + +
Sbjct: 101 PFLVK-LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFE 155
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS + +++ D+KP N+++D+ V+DFG ++ + L GT YL
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GTPEYL 205
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
APE + VD ++ G+++ E P D+ PI Q+ EK ++ +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 255
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 22/160 (13%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++EY G + S + G R++ P + +YLHS + +++ D+KP
Sbjct: 119 MVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N+++D+ V+DFG ++ + L GT YLAPE + VD ++
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GTPEYLAPEIILSKGYNKAVDWWA 224
Query: 208 FGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
G+++ E P D+ PI Q+ EK ++ +
Sbjct: 225 LGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 22/160 (13%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++EY G + S + G R++ P + +YLHS + +++ D+KP
Sbjct: 119 MVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N+++D+ V+DFG ++ + L GT YLAPE + VD ++
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GTPEYLAPEIILSKGYNKAVDWWA 224
Query: 208 FGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
G+++ E P D+ PI Q+ EK ++ +
Sbjct: 225 LGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 36/200 (18%)
Query: 39 VAVKKLNFHQFSA----ESDKSF--YREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92
VA+K ++ +F+ E+D + E + LK+L H ++K+ + + ++LE
Sbjct: 38 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLEL 95
Query: 93 MENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151
ME G L + V+ + + L + + YLH I+H D+KP N+LL
Sbjct: 96 MEGGELFDKVVGNKRLKEATCKL-----YFYQMLLAVQYLHEN---GIIHRDLKPENVLL 147
Query: 152 ---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-------AYMRIVTT 201
+ D ++DFG S++L +SL GT YLAPE Y R
Sbjct: 148 SSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNR---- 198
Query: 202 KVDVFSFGIVVMEFLTKRRP 221
VD +S G+++ L+ P
Sbjct: 199 AVDCWSLGVILFICLSGYPP 218
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 20/170 (11%)
Query: 58 YREAKTLKELKHRNLVKVLGYAWESGKLKA-LILEYMENGSLESV--IHGPGVDHSRWTL 114
Y+E LK+L H N+VK++ + + ++ E + G + V + D +R+
Sbjct: 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF 143
Query: 115 PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
I G++YLH I+H D+KPSN+L+ D ++DFG S +
Sbjct: 144 QDLI-------KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN----EFKG 189
Query: 175 LSSLSTAFQGTIGYLAPE--FAYMRIVTTK-VDVFSFGIVVMEFLTKRRP 221
+L + GT ++APE +I + K +DV++ G+ + F+ + P
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 36/200 (18%)
Query: 39 VAVKKLNFHQFSA----ESDKSF--YREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92
VA+K ++ +F+ E+D + E + LK+L H ++K+ + + ++LE
Sbjct: 38 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLEL 95
Query: 93 MENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151
ME G L + V+ + + L + + YLH I+H D+KP N+LL
Sbjct: 96 MEGGELFDKVVGNKRLKEATCKL-----YFYQMLLAVQYLHEN---GIIHRDLKPENVLL 147
Query: 152 ---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-------AYMRIVTT 201
+ D ++DFG S++L +SL GT YLAPE Y R
Sbjct: 148 SSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNR---- 198
Query: 202 KVDVFSFGIVVMEFLTKRRP 221
VD +S G+++ L+ P
Sbjct: 199 AVDCWSLGVILFICLSGYPP 218
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 36/200 (18%)
Query: 39 VAVKKLNFHQFSA----ESDKSF--YREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92
VA+K ++ +F+ E+D + E + LK+L H ++K+ + + ++LE
Sbjct: 37 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLEL 94
Query: 93 MENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151
ME G L + V+ + + L + + YLH I+H D+KP N+LL
Sbjct: 95 MEGGELFDKVVGNKRLKEATCKL-----YFYQMLLAVQYLHEN---GIIHRDLKPENVLL 146
Query: 152 ---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-------AYMRIVTT 201
+ D ++DFG S++L +SL GT YLAPE Y R
Sbjct: 147 SSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNR---- 197
Query: 202 KVDVFSFGIVVMEFLTKRRP 221
VD +S G+++ L+ P
Sbjct: 198 AVDCWSLGVILFICLSGYPP 217
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 36/200 (18%)
Query: 39 VAVKKLNFHQFSA----ESDKSF--YREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92
VA+K ++ +F+ E+D + E + LK+L H ++K+ + + ++LE
Sbjct: 38 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLEL 95
Query: 93 MENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151
ME G L + V+ + + L + + YLH I+H D+KP N+LL
Sbjct: 96 MEGGELFDKVVGNKRLKEATCKL-----YFYQMLLAVQYLHEN---GIIHRDLKPENVLL 147
Query: 152 ---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-------AYMRIVTT 201
+ D ++DFG S++L +SL GT YLAPE Y R
Sbjct: 148 SSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNR---- 198
Query: 202 KVDVFSFGIVVMEFLTKRRP 221
VD +S G+++ L+ P
Sbjct: 199 AVDCWSLGVILFICLSGYPP 218
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 11 TGSFSENNIIGNSNLSTVYK--GRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL- 67
T F E IG+ +V+K RL DG I A+K+ + +++ RE L
Sbjct: 6 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 64
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H ++V+ AW + EY GSL I S + + D+L+ V G
Sbjct: 65 QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDR 153
L Y+HS + +VH D+KPSNI + R
Sbjct: 124 LRYIHS---MSLVHMDIKPSNIFISR 146
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 11 TGSFSENNIIGNSNLSTVYKG--RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL- 67
T F E IG+ +V+K RL DG I A+K+ + +++ RE L
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 66
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H ++V+ AW + EY GSL I S + + D+L+ V G
Sbjct: 67 QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDR 153
L Y+HS + +VH D+KPSNI + R
Sbjct: 126 LRYIHS---MSLVHMDIKPSNIFISR 148
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 36/200 (18%)
Query: 39 VAVKKLNFHQFSA----ESDKSF--YREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92
VA+K ++ +F+ E+D + E + LK+L H ++K+ + + ++LE
Sbjct: 44 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLEL 101
Query: 93 MENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151
ME G L + V+ + + L + + YLH I+H D+KP N+LL
Sbjct: 102 MEGGELFDKVVGNKRLKEATCKL-----YFYQMLLAVQYLHEN---GIIHRDLKPENVLL 153
Query: 152 ---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-------AYMRIVTT 201
+ D ++DFG S++L +SL GT YLAPE Y R
Sbjct: 154 SSQEEDCLIKITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNR---- 204
Query: 202 KVDVFSFGIVVMEFLTKRRP 221
VD +S G+++ L+ P
Sbjct: 205 AVDCWSLGVILFICLSGYPP 224
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 11 TGSFSENNIIGNSNLSTVYKG--RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL- 67
T F E IG+ +V+K RL DG I A+K+ + +++ RE L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H ++V+ AW + EY GSL I S + + D+L+ V G
Sbjct: 69 QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDR 153
L Y+HS + +VH D+KPSNI + R
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISR 150
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 11 TGSFSENNIIGNSNLSTVYKG--RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL- 67
T F E IG+ +V+K RL DG I A+K+ + +++ RE L
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 66
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+H ++V+ AW + EY GSL I S + + D+L+ V G
Sbjct: 67 QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDR 153
L Y+HS + +VH D+KPSNI + R
Sbjct: 126 LRYIHS---MSLVHMDIKPSNIFISR 148
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 39/160 (24%), Positives = 71/160 (44%), Gaps = 22/160 (13%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++EY G + S + G R+ P + +YLHS + +++ D+KP
Sbjct: 119 MVMEYAPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 171
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N+++D+ V+DFG ++ + L GT YLAPE + VD ++
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLC-------GTPEYLAPEIILSKGYNKAVDWWA 224
Query: 208 FGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
G+++ E P D+ PI Q+ EK ++ +
Sbjct: 225 LGVLIYEMAAGYPPFFADQ-----PI---QIYEKIVSGKV 256
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 61/277 (22%), Positives = 107/277 (38%), Gaps = 47/277 (16%)
Query: 28 VYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW-ESGKLK 86
++KGR + +IV VK L +S + F E L+ H N++ VLG
Sbjct: 26 LWKGRWQGNDIV-VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 87 ALILEYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143
LI + GSL +V+H VD S + + + A G +LH+ + H
Sbjct: 85 TLITHWXPYGSLYNVLHEGTNFVVDQS-----QAVKFALDXARGXAFLHTLEPLIPRHA- 138
Query: 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK- 202
+ ++ +D D A +S DV S S ++APE + T
Sbjct: 139 LNSRSVXIDEDXTARIS------XADV---KFSFQSPGRXYAPAWVAPEALQKKPEDTNR 189
Query: 203 --VDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVS 260
D +SF +++ E +T+ P + +S ++ K + G+R P +
Sbjct: 190 RSADXWSFAVLLWELVTREVP--------FADLSNXEIGXKV---ALEGLRPTIPPGISP 238
Query: 261 SIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ KL +C + +P RP + ++
Sbjct: 239 HVS-------------KLXKICXNEDPAKRPKFDXIV 262
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 30/173 (17%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRI 118
E + LK+L H ++K+ + + ++LE ME G L + V+ + + L
Sbjct: 204 EIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---- 257
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDL 175
+ + YLH I+H D+KP N+LL + D ++DFG S++L
Sbjct: 258 -YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE----- 308
Query: 176 SSLSTAFQGTIGYLAPEF-------AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+SL GT YLAPE Y R VD +S G+++ L+ P
Sbjct: 309 TSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPP 357
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 30/173 (17%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRI 118
E + LK+L H ++K+ + + ++LE ME G L + V+ + + L
Sbjct: 190 EIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---- 243
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDL 175
+ + YLH I+H D+KP N+LL + D ++DFG S++L
Sbjct: 244 -YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE----- 294
Query: 176 SSLSTAFQGTIGYLAPEF-------AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+SL GT YLAPE Y R VD +S G+++ L+ P
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSGYPP 343
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 20/215 (9%)
Query: 17 NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+IG VY GR GE VA++ ++ + + + K+F RE ++ +H N+V +
Sbjct: 38 GELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
G L A+I + +L SV+ + + K + + G+ YLH+
Sbjct: 96 GACMSPPHL-AIITSLCKGRTLYSVVRDAKIVLD---VNKTRQIAQEIVKGMGYLHAK-- 149
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ-GTIGYLAPEFAY 195
I+H D+K N+ D + + ++DFG + V Q G + +LAPE
Sbjct: 150 -GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 196 MRIVTTK---------VDVFSFGIVVMEFLTKRRP 221
T+ DVF+ G + E + P
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 48.1 bits (113), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 19 IIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVL 76
++G + V R+ E G++ AVK L + D + E + L ++ + L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS-VANGLDYLHSGY 135
+++ ++E++ G L + H + SR R + + + L +LH
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDL--MFH---IQKSRRFDEARARFYAAEIISALMFLH--- 141
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA-FQGTIGYLAPEFA 194
D I++ D+K N+LLD + ++DFG + + ++TA F GT Y+APE
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-----GICNGVTTATFCGTPDYIAPEIL 196
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
+ VD ++ G+++ E L P + E+ L
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 48.1 bits (113), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 75/311 (24%), Positives = 122/311 (39%), Gaps = 53/311 (17%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+F +T A G E G V K VAVK L A+ ++ E
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLK--------VAVKMLK-STAHADEKEALMSE 99
Query: 61 AKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIH---GPGVDHS------ 110
K + L +H N+V +LG G + +I EY G L + + PG+++S
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPV-LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 111 -RWTLPKRIDVL---ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166
L R D+L VA G+ +L S +H D+ N+LL A + DFG +R
Sbjct: 159 PEEQLSSR-DLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR 214
Query: 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE 226
D+ + + + ++APE + + T + DV+S+GI++ E + GL+
Sbjct: 215 --DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNP 268
Query: 227 ENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSN 286
G I + K + +G + PK + SI C +
Sbjct: 269 YPG---ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ----------------ACWALE 309
Query: 287 PEDRPNMNELL 297
P RP ++
Sbjct: 310 PTHRPTFQQIC 320
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 48.1 bits (113), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 74/308 (24%), Positives = 119/308 (38%), Gaps = 51/308 (16%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+F +T A G E G V K VAVK L A+ ++ E
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLK--------VAVKMLK-STAHADEKEALMSE 99
Query: 61 AKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIH--------GPGVDHSR 111
K + L +H N+V +LG G + +I EY G L + + P +
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 112 WTLPKRIDVL---ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168
TL R D+L VA G+ +L S +H D+ N+LL A + DFG +R
Sbjct: 159 STLSTR-DLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR-- 212
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN 228
D+ + + + ++APE + + T + DV+S+GI++ E + GL+
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNPYP 268
Query: 229 GLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPE 288
G I + K + +G + PK + SI C + P
Sbjct: 269 G---ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ----------------ACWALEPT 309
Query: 289 DRPNMNEL 296
RP ++
Sbjct: 310 HRPTFQQI 317
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 47.8 bits (112), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 66/282 (23%), Positives = 103/282 (36%), Gaps = 37/282 (13%)
Query: 20 IGNSNLSTVYKGRLE--DGEIV--AVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVK 74
+G+ + V +G + G+ V AVK L S E+ F RE + L HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G L + E L S++ + L + VA G+ YL S
Sbjct: 86 LYGVV-----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+H D+ N+LL + DFG R L + D + + + APE
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWCAPESL 196
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R + D + FG+ + E T G + GL+ + ++K G R
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDK------EGERLPR 246
Query: 255 DPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
IY + + C + PEDRP L
Sbjct: 247 PEDCPQDIY-------------NVMVQCWAHKPEDRPTFVAL 275
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 47.8 bits (112), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 66/282 (23%), Positives = 103/282 (36%), Gaps = 37/282 (13%)
Query: 20 IGNSNLSTVYKGRLE--DGEIV--AVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVK 74
+G+ + V +G + G+ V AVK L S E+ F RE + L HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G L + E L S++ + L + VA G+ YL S
Sbjct: 76 LYGVV-----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+H D+ N+LL + DFG R L + D + + + APE
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWCAPESL 186
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R + D + FG+ + E T G + GL+ + ++K G R
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDK------EGERLPR 236
Query: 255 DPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
IY + + C + PEDRP L
Sbjct: 237 PEDCPQDIY-------------NVMVQCWAHKPEDRPTFVAL 265
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 47.8 bits (112), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 66/282 (23%), Positives = 103/282 (36%), Gaps = 37/282 (13%)
Query: 20 IGNSNLSTVYKGRLE--DGEIV--AVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVK 74
+G+ + V +G + G+ V AVK L S E+ F RE + L HRNL++
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G L + E L S++ + L + VA G+ YL S
Sbjct: 80 LYGVV-----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 134
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+H D+ N+LL + DFG R L + D + + + APE
Sbjct: 135 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESL 190
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R + D + FG+ + E T G + GL+ + ++K G R
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDK------EGERLPR 240
Query: 255 DPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
IY + + C + PEDRP L
Sbjct: 241 PEDCPQDIY-------------NVMVQCWAHKPEDRPTFVAL 269
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 47.4 bits (111), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 66/282 (23%), Positives = 103/282 (36%), Gaps = 37/282 (13%)
Query: 20 IGNSNLSTVYKGRLE--DGEIV--AVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVK 74
+G+ + V +G + G+ V AVK L S E+ F RE + L HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G L + E L S++ + L + VA G+ YL S
Sbjct: 86 LYGVV-----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+H D+ N+LL + DFG R L + D + + + APE
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESL 196
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R + D + FG+ + E T G + GL+ + ++K G R
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDK------EGERLPR 246
Query: 255 DPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
IY + + C + PEDRP L
Sbjct: 247 PEDCPQDIY-------------NVMVQCWAHKPEDRPTFVAL 275
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 66/282 (23%), Positives = 103/282 (36%), Gaps = 37/282 (13%)
Query: 20 IGNSNLSTVYKGRLE--DGEIV--AVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVK 74
+G+ + V +G + G+ V AVK L S E+ F RE + L HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G L + E L S++ + L + VA G+ YL S
Sbjct: 76 LYGVV-----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+H D+ N+LL + DFG R L + D + + + APE
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESL 186
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R + D + FG+ + E T G + GL+ + ++K G R
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDK------EGERLPR 236
Query: 255 DPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
IY + + C + PEDRP L
Sbjct: 237 PEDCPQDIY-------------NVMVQCWAHKPEDRPTFVAL 265
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 72/301 (23%), Positives = 107/301 (35%), Gaps = 48/301 (15%)
Query: 12 GSFSENNIIGNSNLSTVYK------GRLEDGEI---------VAVKKLNFHQFS-AESDK 55
GS S +IG +L + K G + GE VAVK L S E+
Sbjct: 1 GSQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 60
Query: 56 SFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP 115
F RE + L HRNL+++ G L + E L S++ + L
Sbjct: 61 DFIREVNAMHSLDHRNLIRLYGVV-----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 115
Query: 116 KRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ VA G+ YL S +H D+ N+LL + DFG R L + D
Sbjct: 116 TLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDH 171
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+ + + APE R + D + FG+ + E T G + GL+ +
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQI 227
Query: 236 RQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNE 295
++K G R IY + + C + PEDRP
Sbjct: 228 LHKIDK------EGERLPRPEDCPQDIY-------------NVMVQCWAHKPEDRPTFVA 268
Query: 296 L 296
L
Sbjct: 269 L 269
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 18/136 (13%)
Query: 113 TLPKRI--DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS-RMLD 169
T+P+ I + +S+ L++LHS + ++H D+KPSN+L++ + DFG S ++D
Sbjct: 132 TIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVD 189
Query: 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRI----VTTKVDVFSFGIVVMEFLTKRRPTGLD 225
+D+ + G Y APE + + K D++S GI +E R P
Sbjct: 190 DVAKDIDA------GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPY--- 240
Query: 226 EENGLSPISLRQLVEK 241
+ G L+Q+VE+
Sbjct: 241 DSWGTPFQQLKQVVEE 256
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/185 (23%), Positives = 72/185 (38%), Gaps = 28/185 (15%)
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
TL I VA G+++L S +H D+ NILL + DFG +R D++
Sbjct: 189 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--DIYK 243
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ + ++APE + R+ T + DV+SFG+++ E + G SP
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----------GASP 293
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPN 292
++ E+ G R +Y + L C P RP
Sbjct: 294 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-------------QTMLDCWHGEPSQRPT 340
Query: 293 MNELL 297
+EL+
Sbjct: 341 FSELV 345
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 66/282 (23%), Positives = 103/282 (36%), Gaps = 37/282 (13%)
Query: 20 IGNSNLSTVYKGRLE--DGEIV--AVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVK 74
+G+ + V +G + G+ V AVK L S E+ F RE + L HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G L + E L S++ + L + VA G+ YL S
Sbjct: 76 LYGVV-----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+H D+ N+LL + DFG R L + D + + + APE
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESL 186
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R + D + FG+ + E T G + GL+ + ++K G R
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDK------EGERLPR 236
Query: 255 DPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
IY + + C + PEDRP L
Sbjct: 237 PEDCPQDIY-------------NVMVQCWAHKPEDRPTFVAL 265
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/217 (22%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ N +Y A+K LN + ++ + +RE + +
Sbjct: 85 GAFGEVAVVKMKNTERIY----------AMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW--TLPKRIDVLISVANGLD 129
+ L YA++ L+++Y G L +++ S++ LP+ + + +
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLL-------SKFEDKLPEDM-ARFYIGEMVL 186
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ S + + VH D+KP N+LLD + ++DFG+ ++ D + S+ GT Y+
Sbjct: 187 AIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMN---DDGTVQSSVAVGTPDYI 243
Query: 190 APEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRP 221
+PE M + D +S G+ + E L P
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/185 (23%), Positives = 72/185 (38%), Gaps = 28/185 (15%)
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
TL I VA G+++L S +H D+ NILL + DFG +R D++
Sbjct: 196 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--DIYK 250
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ + ++APE + R+ T + DV+SFG+++ E + G SP
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----------GASP 300
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPN 292
++ E+ G R +Y + L C P RP
Sbjct: 301 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-------------QTMLDCWHGEPSQRPT 347
Query: 293 MNELL 297
+EL+
Sbjct: 348 FSELV 352
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/185 (23%), Positives = 72/185 (38%), Gaps = 28/185 (15%)
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
TL I VA G+++L S +H D+ NILL + DFG +R D++
Sbjct: 198 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--DIYK 252
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ + ++APE + R+ T + DV+SFG+++ E + G SP
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----------GASP 302
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPN 292
++ E+ G R +Y + L C P RP
Sbjct: 303 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-------------QTMLDCWHGEPSQRPT 349
Query: 293 MNELL 297
+EL+
Sbjct: 350 FSELV 354
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/185 (23%), Positives = 72/185 (38%), Gaps = 28/185 (15%)
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
TL I VA G+++L S +H D+ NILL + DFG +R D++
Sbjct: 191 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--DIYK 245
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ + ++APE + R+ T + DV+SFG+++ E + G SP
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----------GASP 295
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPN 292
++ E+ G R +Y + L C P RP
Sbjct: 296 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-------------QTMLDCWHGEPSQRPT 342
Query: 293 MNELL 297
+EL+
Sbjct: 343 FSELV 347
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 101/244 (41%), Gaps = 48/244 (19%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESD-KSFYREA 61
DR EI + G+ S ++ + +LE +VA+KK+ F D K RE
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYD-------KLE-KRVVAIKKI-LRVFEDLIDCKRILREI 103
Query: 62 KTLKELKHRNLVKVLGYAWESGKLK----ALILEYMENGSLESVIHGPGVDHSRWTLPKR 117
L L H ++VKVL K ++LE + + + + P +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPV-----YLTELH 157
Query: 118 IDVLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV------ 170
I L+ ++ G+ Y+HS I+H D+KP+N L+++D V DFG +R +D
Sbjct: 158 IKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 171 -----------------HLQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVV 212
H ++L T T Y APE ++ T +DV+S G +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 213 MEFL 216
E L
Sbjct: 275 AELL 278
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/217 (22%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ N +Y A+K LN + ++ + +RE + +
Sbjct: 101 GAFGEVAVVKMKNTERIY----------AMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW--TLPKRIDVLISVANGLD 129
+ L YA++ L+++Y G L +++ S++ LP+ + + +
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLL-------SKFEDKLPEDM-ARFYIGEMVL 202
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ S + + VH D+KP N+LLD + ++DFG+ ++ D + S+ GT Y+
Sbjct: 203 AIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMN---DDGTVQSSVAVGTPDYI 259
Query: 190 APEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRP 221
+PE M + D +S G+ + E L P
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 35/203 (17%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L S+E + + E K + +L H N+V +LG SG + LI EY G
Sbjct: 78 VAVKMLKEKADSSERE-ALMSELKMMTQLGSHENIVNLLGACTLSGPI-YLIFEYCCYGD 135
Query: 98 LESVIHGP----GVDHSRWTLPKRI------------DVLI---SVANGLDYLHSGYDIP 138
L + + D + KR+ D+L VA G+++L
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---S 192
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT----IGYLAPEFA 194
VH D+ N+L+ + DFG +R D+ +S + +G + ++APE
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLAR--DI----MSDSNYVVRGNARLPVKWMAPESL 246
Query: 195 YMRIVTTKVDVFSFGIVVMEFLT 217
+ I T K DV+S+GI++ E +
Sbjct: 247 FEGIYTIKSDVWSYGILLWEIFS 269
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 98/237 (41%), Gaps = 47/237 (19%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLG 77
IG V+ G+ GE VAVK F + S++RE + + ++H N +LG
Sbjct: 45 IGKGRYGEVWMGKWR-GEKVAVK-----VFFTTEEASWFRETEIYQTVLMRHEN---ILG 95
Query: 78 YAWESGKLKA--------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+ + +K LI +Y ENGSL + +D + + S +GL
Sbjct: 96 FI--AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAK-----SMLKLAYSSVSGLC 148
Query: 130 YLH----SGYDIP-IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
+LH S P I H D+K NIL+ ++ ++D G + ++ G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 185 TIGYLAPEF-----------AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
T Y+ PE +Y+ D++SFG+++ E + G+ EE L
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIM-----ADMYSFGLILWEVARRCVSGGIVEEYQL 260
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G+ YLH+ ++H D+K N+ L+ D + + DFG + ++ + +L GT
Sbjct: 153 QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC----GT 205
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE + + +VD++S G ++ L + P
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 53 SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112
S + RE L+++ H N++ L +E+ LILE + G L +
Sbjct: 58 SREEIEREVSILRQVLHHNVI-TLHDVYENRTDVVLILELVSGGELFDFL----AQKESL 112
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDFE-AHVS--DFGTSRML 168
+ + + + +G++YLH+ I H D+KP NI LLD++ H+ DFG +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-- 167
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++D F GT ++APE + + D++S G++ L+ P
Sbjct: 168 --EIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 53 SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112
S + RE L+++ H N++ L +E+ LILE + G L +
Sbjct: 58 SREEIEREVSILRQVLHHNVI-TLHDVYENRTDVVLILELVSGGELFDFL----AQKESL 112
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDFE-AHVS--DFGTSRML 168
+ + + + +G++YLH+ I H D+KP NI LLD++ H+ DFG +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-- 167
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++D F GT ++APE + + D++S G++ L+ P
Sbjct: 168 --EIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 45/303 (14%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+F +T A G E G V K VAVK L A+ ++ E
Sbjct: 41 QFGKTLGAGAFGKVVEATAFGLGKEDAVLK--------VAVKMLK-STAHADEKEALMSE 91
Query: 61 AKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV------DHSRWT 113
K + L +H N+V +LG G + +I EY G L + + D
Sbjct: 92 LKIMSHLGQHENIVNLLGACTHGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 150
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
L + VA G+ +L S +H D+ N+LL A + DFG +R D+
Sbjct: 151 LRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND 205
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233
+ + + ++APE + + T + DV+S+GI++ E + GL+ G I
Sbjct: 206 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNPYPG---I 258
Query: 234 SLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNM 293
+ K + +G + PK + SI C + P RP
Sbjct: 259 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ----------------ACWALEPTHRPTF 302
Query: 294 NEL 296
++
Sbjct: 303 QQI 305
>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex
With An Indirubin Ligand
Length = 429
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 12/97 (12%)
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA--HVSDFGTSRMLDVHLQDLSSLST 180
S+ LD LH I+HCD+KP NILL + + V DFG+S H + + + +
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQS 262
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
F Y APE +D++S G ++ E LT
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLT 294
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 73/309 (23%), Positives = 118/309 (38%), Gaps = 51/309 (16%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+F +T A G E G V K VAVK L A+ ++ E
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLK--------VAVKMLK-STAHADEKEALMSE 99
Query: 61 AKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIH--------GPGVDHSR 111
K + L +H N+V +LG G + +I EY G L + + P +
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 112 WTLPKRIDVL---ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168
T R D+L VA G+ +L S +H D+ N+LL A + DFG +R
Sbjct: 159 STASTR-DLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR-- 212
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN 228
D+ + + + ++APE + + T + DV+S+GI++ E + GL+
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNPYP 268
Query: 229 GLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPE 288
G I + K + +G + PK + SI C + P
Sbjct: 269 G---ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ----------------ACWALEPT 309
Query: 289 DRPNMNELL 297
RP ++
Sbjct: 310 HRPTFQQIC 318
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G+ YLH+ ++H D+K N+ L+ D + + DFG + ++ + L GT
Sbjct: 137 QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC----GT 189
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE + + +VD++S G ++ L + P
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G+ YLH+ ++H D+K N+ L+ D + + DFG + ++ + L GT
Sbjct: 153 QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC----GT 205
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE + + +VD++S G ++ L + P
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 53 SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112
S + RE L+++ H N++ L +E+ LILE + G L +
Sbjct: 58 SREEIEREVSILRQVLHHNVI-TLHDVYENRTDVVLILELVSGGELFDFL----AQKESL 112
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDFE-AHVS--DFGTSRML 168
+ + + + +G++YLH+ I H D+KP NI LLD++ H+ DFG +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-- 167
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++D F GT ++APE + + D++S G++ L+ P
Sbjct: 168 --EIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G+ YLH+ ++H D+K N+ L+ D + + DFG + ++ + L GT
Sbjct: 153 QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC----GT 205
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE + + +VD++S G ++ L + P
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 45/303 (14%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+F +T A G E G V K VAVK L A+ ++ E
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLK--------VAVKMLK-STAHADEKEALMSE 99
Query: 61 AKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV------DHSRWT 113
K + L +H N+V +LG G + +I EY G L + + D
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 158
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
L + VA G+ +L S +H D+ N+LL A + DFG +R D+
Sbjct: 159 LRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND 213
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233
+ + + ++APE + + T + DV+S+GI++ E + GL+ G I
Sbjct: 214 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGLNPYPG---I 266
Query: 234 SLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNM 293
+ K + +G + PK + SI C + P RP
Sbjct: 267 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ----------------ACWALEPTHRPTF 310
Query: 294 NEL 296
++
Sbjct: 311 QQI 313
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 18 NIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKV 75
++IG + VY ++ E VA+KK+N F D K RE L LK ++++
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 76 LGYAWESGKLK----ALILEYMENGSLESVIHGP---GVDHSRWTLPKRIDVLISVANGL 128
LK ++LE + + L+ + P +H + +L ++ G
Sbjct: 91 YDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIK-------TILYNLLLGE 142
Query: 129 DYLH-SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD------------------ 169
+++H SG I+H D+KP+N LL++D V DFG +R ++
Sbjct: 143 NFIHESG----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK-VDVFSFGIVVMEFL 216
H ++L T+ T Y APE ++ TK +D++S G + E L
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 53 SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112
S + RE L+++ H N++ L +E+ LILE + G L +
Sbjct: 58 SREEIEREVSILRQVLHHNVI-TLHDVYENRTDVVLILELVSGGELFDFL----AQKESL 112
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDFE-AHVS--DFGTSRML 168
+ + + + +G++YLH+ I H D+KP NI LLD++ H+ DFG +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-- 167
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++D F GT ++APE + + D++S G++ L+ P
Sbjct: 168 --EIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41
Length = 417
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 12/97 (12%)
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA--HVSDFGTSRMLDVHLQDLSSLST 180
S+ LD LH I+HCD+KP NILL + + V DFG+S H + + + +
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQS 262
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
F Y APE +D++S G ++ E LT
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLT 294
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 53 SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112
S + RE L+++ H N++ L +E+ LILE + G L +
Sbjct: 58 SREEIEREVSILRQVLHHNVI-TLHDVYENRTDVVLILELVSGGELFDFL----AQKESL 112
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDFE-AHVS--DFGTSRML 168
+ + + + +G++YLH+ I H D+KP NI LLD++ H+ DFG +
Sbjct: 113 SEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-- 167
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++D F GT ++APE + + D++S G++ L+ P
Sbjct: 168 --EIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 74/316 (23%), Positives = 120/316 (37%), Gaps = 58/316 (18%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+F +T A G E G V K VAVK L A+ ++ E
Sbjct: 34 QFGKTLGAGAFGKVVEATAFGLGKEDAVLK--------VAVKMLK-STAHADEKEALMSE 84
Query: 61 AKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIH-------GP------- 105
K + L +H N+V +LG G + +I EY G L + + GP
Sbjct: 85 LKIMSHLGQHENIVNLLGACTHGGPV-LVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 106 --GVDHSRWTLPKRIDVL---ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160
G+D + D+L VA G+ +L S +H D+ N+LL A +
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIG 200
Query: 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRR 220
DFG +R D+ + + + ++APE + + T + DV+S+GI++ E +
Sbjct: 201 DFGLAR--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--- 255
Query: 221 PTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLAL 280
GL+ G I + K + +G + PK + SI
Sbjct: 256 -LGLNPYPG---ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ---------------- 295
Query: 281 VCTSSNPEDRPNMNEL 296
C + P RP ++
Sbjct: 296 ACWALEPTHRPTFQQI 311
>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2)
Length = 429
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 12/97 (12%)
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA--HVSDFGTSRMLDVHLQDLSSLST 180
S+ LD LH I+HCD+KP NILL + + V DFG+S H + + +
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQS 262
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
F Y APE +D++S G ++ E LT
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLT 294
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 44.7 bits (104), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 22/177 (12%)
Query: 58 YREAKTLKELK-HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPK 116
+RE + L + + HRN+++++ + E + L+ E M GS+ S IH + +
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFY-LVFEKMRGGSILSHIH----KRRHFNELE 112
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQ 173
V+ VA+ LD+LH+ I H D+KP NIL + + + DFG + ++
Sbjct: 113 ASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN-G 168
Query: 174 DLSSLST----AFQGTIGYLAPEFA-----YMRIVTTKVDVFSFGIVVMEFLTKRRP 221
D S +ST G+ Y+APE I + D++S G+++ L+ P
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 44.7 bits (104), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE L+++ H N++ L +E+ LILE + G L + + +
Sbjct: 64 REVSILRQVLHPNII-TLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEAT 118
Query: 119 DVLISVANGLDYLHSGYDIPIVHCDMKPSNI-LLDRDFE-AHVS--DFGTSRMLDVHLQD 174
+ + +G++YLH+ I H D+KP NI LLD++ H+ DFG L ++D
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG----LAHEIED 171
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
F GT ++APE + + D++S G++ L+ P
Sbjct: 172 GVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 15/211 (7%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAE---SDKSFYREAKTLKELKHRNLV 73
+IG S V + E G+ AVK ++ +F++ S + REA LKH ++V
Sbjct: 32 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++L + S + ++ E+M+ L I ++ + + L Y H
Sbjct: 92 ELL-ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH- 149
Query: 134 GYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
D I+H D+KP +LL + + FG + + L + ++ GT ++A
Sbjct: 150 --DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA----IQLGESGLVAGGRVGTPHFMA 203
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE VDV+ G+++ L+ P
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 234
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 44.3 bits (103), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 15/211 (7%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAE---SDKSFYREAKTLKELKHRNLV 73
+IG S V + E G+ AVK ++ +F++ S + REA LKH ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++L + S + ++ E+M+ L I ++ + + L Y H
Sbjct: 90 ELLE-TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH- 147
Query: 134 GYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
D I+H D+KP +LL + + FG + + L + ++ GT ++A
Sbjct: 148 --DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA----IQLGESGLVAGGRVGTPHFMA 201
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE VDV+ G+++ L+ P
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 9/100 (9%)
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
IS+A L+YLH + I++ D+K N+LLD + ++D+G M L+ + ST
Sbjct: 162 ISLA--LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTST- 212
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
F GT Y+APE VD ++ G+++ E + R P
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 27/120 (22%)
Query: 120 VLISVANGLDYLH-SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML----DVHL-- 172
+L ++ G ++H SG I+H D+KP+N LL++D + DFG +R + D+H+
Sbjct: 136 ILYNLLLGEKFIHESG----IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVN 191
Query: 173 ---------------QDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
++L T+ T Y APE ++ T +D++S G + E L
Sbjct: 192 DLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+ +H N++ L ++ GK ++ E M+ G L I + ++ + VL +
Sbjct: 70 LRYGQHPNII-TLKDVYDDGKYVYVVTELMKGGELLDKI----LRQKFFSEREASAVLFT 124
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNIL-LDRDFEA---HVSDFGTSRMLDVHLQDLSSLS 179
+ ++YLH+ +VH D+KPSNIL +D + DFG ++ L + L
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE----NGLL 177
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T ++APE + D++S G+++ LT P
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
IS+A L+YLH + I++ D+K N+LLD + ++D+G M L+ ++
Sbjct: 130 ISLA--LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRP-GDTTSX 180
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
F GT Y+APE VD ++ G+++ E + R P
Sbjct: 181 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 220
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 58 YREAKTLKELK-HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPK 116
+RE + L + + HRN+++++ + E + L+ E M GS+ S IH + +
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFY-LVFEKMRGGSILSHIH----KRRHFNELE 112
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQ 173
V+ VA+ LD+LH+ I H D+KP NIL + + + DF + ++
Sbjct: 113 ASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN-G 168
Query: 174 DLSSLST----AFQGTIGYLAPEFA-----YMRIVTTKVDVFSFGIVVMEFLTKRRP 221
D S +ST G+ Y+APE I + D++S G+++ L+ P
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 135 YDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+D+ +VH D+KP N+L + + E + DFG +R+ Q L + F T+ Y AP
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCF--TLHYAAP 178
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E D++S G+++ L+ + P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2
pdb|1KWP|B Chain B, Crystal Structure Of Mapkap2
pdb|1NY3|A Chain A, Crystal Structure Of Adp Bound To Map Kap Kinase 2
Length = 400
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 136 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 245
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISP 273
>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
Length = 406
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 142 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 196
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 251
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 252 MWSLGVIMYILLCGYPPFYSNHGLAISP 279
>pdb|2OZA|A Chain A, Structure Of P38alpha Complex
Length = 356
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 92 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 201
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 202 MWSLGVIMYILLCGYPPFYSNHGLAISP 229
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 106 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 160
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 215
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 216 MWSLGVIMYILLCGYPPFYSNHGLAISP 243
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 33 LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALILE 91
L++G+ AVK + + + S +RE +TL + + ++N+++++ + +E L+ E
Sbjct: 35 LQNGKEYAVKIIE--KQAGHSRSRVFREVETLYQCQGNKNILELIEF-FEDDTRFYLVFE 91
Query: 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151
++ GS+ + I + + V+ VA LD+LH+ I H D+KP NIL
Sbjct: 92 KLQGGSILAHIQ----KQKHFNEREASRVVRDVAAALDFLHTK---GIAHRDLKPENILC 144
Query: 152 ---DRDFEAHVSDF--GTSRMLDVHLQDLSSLS-TAFQGTIGYLAPEFAYM-----RIVT 200
++ + DF G+ L+ +++ T G+ Y+APE +
Sbjct: 145 ESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYD 204
Query: 201 TKVDVFSFGIVVMEFLTKRRP 221
+ D++S G+V+ L+ P
Sbjct: 205 KRCDLWSLGVVLYIMLSGYPP 225
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
IS+A L+YLH + I++ D+K N+LLD + ++D+G M L+ ++
Sbjct: 115 ISLA--LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRP-GDTTSX 165
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
F GT Y+APE VD ++ G+++ E + R P
Sbjct: 166 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 205
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 96 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 150
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 205
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 206 MWSLGVIMYILLCGYPPFYSNHGLAISP 233
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 14 FSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---H 69
F + G TV G+ + G VA+KK+ + + RE + +++L H
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNRELQIMQDLAVLHH 78
Query: 70 RNLVKVLGYAWESGKLKA------LILEYMENGSLESVIHGPGVDHSRWTL---PKRIDV 120
N+V++ Y + G+ +++EY+ + +H ++ R + P I V
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-----TLHRCCRNYYRRQVAPPPILIKV 133
Query: 121 -LISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLDVHLQDLSSL 178
L + + LH + + H D+KP N+L++ D + DFG+++ L S
Sbjct: 134 FLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP-----SEP 187
Query: 179 STAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFL 216
+ A+ + Y APE + + TT VD++S G + E +
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 92 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 201
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 202 MWSLGVIMYILLCGYPPFYSNHGLAISP 229
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 5/87 (5%)
Query: 141 HCDMKPSNILLDRDFEAHVSDFG-TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
H D+KP NIL+ D A++ DFG S D L L + GT+ Y APE
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV----GTLYYXAPERFSESHA 212
Query: 200 TTKVDVFSFGIVVMEFLTKRRPTGLDE 226
T + D+++ V+ E LT P D+
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQ 239
>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|B Chain B, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|C Chain C, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|D Chain D, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|E Chain E, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|F Chain F, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|G Chain G, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|H Chain H, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|I Chain I, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|J Chain J, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|K Chain K, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|L Chain L, Mk2 Kinase Bound To Compound 5b
Length = 318
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 90 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 199
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 200 MWSLGVIMYILLCGYPPFYSNHGLAISP 227
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 97 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 151
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 206
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 207 MWSLGVIMYILLCGYPPFYSNHGLAISP 234
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 25/177 (14%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E + +L H L+ L A+E LILE++ G L I + + + + I+
Sbjct: 98 EISIMNQLHHPKLIN-LHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVIN 153
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS--DFGTSRMLDVHLQDLSS 177
+ GL ++H IVH D+KP NI+ + + V DFG + L+ ++
Sbjct: 154 YMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVK 208
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234
++TA T + APE V D+++ G++ L+ GLSP +
Sbjct: 209 VTTA---TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-----------GLSPFA 251
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 91 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 145
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 200
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 201 MWSLGVIMYILLCGYPPFYSNHGLAISP 228
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
IS+A L+YLH + I++ D+K N+LLD + ++D+G M L+ ++
Sbjct: 119 ISLA--LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRP-GDTTSX 169
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
F GT Y+APE VD ++ G+++ E + R P
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 98 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 152
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H +SL+T T Y+APE D
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCY-TPYYVAPEVLGPEKYDKSCD 207
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 208 MWSLGVIMYILLCGYPPFYSNHGLAISP 235
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + + Y
Sbjct: 20 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVA---NGLDYLHSGY 135
+E I ME G+ +D + W K+ ID + N L+ +H+ +
Sbjct: 80 YEI--TDQYIYMVMECGN---------IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 128
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ-GTIGYLAPE 192
IVH D+KP+N L+ D + DFG + + D +S+ Q GT+ Y+ PE
Sbjct: 129 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPE 182
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + + Y
Sbjct: 16 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVA---NGLDYLHSGY 135
+E I ME G+ +D + W K+ ID + N L+ +H+ +
Sbjct: 76 YEI--TDQYIYMVMECGN---------IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 124
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ-GTIGYLAPE 192
IVH D+KP+N L+ D + DFG + + D +S+ Q GT+ Y+ PE
Sbjct: 125 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPE 178
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 40.8 bits (94), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + + Y
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVA---NGLDYLHSGY 135
+E I ME G+ +D + W K+ ID + N L+ +H+ +
Sbjct: 96 YEI--TDQYIYMVMECGN---------IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ-GTIGYLAPE 192
IVH D+KP+N L+ D + DFG + + D +S+ Q GT+ Y+ PE
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPE 198
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + + Y
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVA---NGLDYLHSGY 135
+E I ME G+ +D + W K+ ID + N L+ +H+ +
Sbjct: 77 YEI--TDQYIYMVMECGN---------IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ-GTIGYLAPE 192
IVH D+KP+N L+ D + DFG + + D +S+ Q GT+ Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPE 179
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + + Y
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVA---NGLDYLHSGY 135
+E I ME G+ +D + W K+ ID + N L+ +H+ +
Sbjct: 124 YEI--TDQYIYMVMECGN---------IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ-GTIGYLAPE 192
IVH D+KP+N L+ D + DFG + + D +S+ Q GT+ Y+ PE
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPE 226
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 54/234 (23%), Positives = 91/234 (38%), Gaps = 36/234 (15%)
Query: 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESD---------- 54
E+ ++ I + + V G +G VA+K++ F+ SD
Sbjct: 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV----FNTVSDGRTVNILSDS 70
Query: 55 ---KSFYREAKTLKELKHRNLV---KVLGYAWESGKLKALILEYMENGSLESVIHGPGVD 108
K RE + L H N++ + + E K ++ + L VIH D
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH----D 126
Query: 109 HSRWTLPKRIDVLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
P+ I + + GL LH +VH D+ P NILL + + + DF +R
Sbjct: 127 QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR- 182
Query: 168 LDVHLQDLSSLS-TAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
+D + + T + Y APE + T VD++S G V+ E ++
Sbjct: 183 -----EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 54/234 (23%), Positives = 91/234 (38%), Gaps = 36/234 (15%)
Query: 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESD---------- 54
E+ ++ I + + V G +G VA+K++ F+ SD
Sbjct: 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV----FNTVSDGRTVNILSDS 70
Query: 55 ---KSFYREAKTLKELKHRNLV---KVLGYAWESGKLKALILEYMENGSLESVIHGPGVD 108
K RE + L H N++ + + E K ++ + L VIH D
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH----D 126
Query: 109 HSRWTLPKRIDVLI-SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
P+ I + + GL LH +VH D+ P NILL + + + DF +R
Sbjct: 127 QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR- 182
Query: 168 LDVHLQDLSSLS-TAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
+D + + T + Y APE + T VD++S G V+ E ++
Sbjct: 183 -----EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 20/178 (11%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + + Y
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVA---NGLDYLHSGY 135
+E I ME G+ +D + W K+ ID + N L+ +H+ +
Sbjct: 124 YEI--TDQYIYMVMECGN---------IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ-GTIGYLAPE 192
IVH D+KP+N L+ D + DFG + + D +S+ Q GT+ Y+ PE
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ---PDTTSVVKDSQVGTVNYMPPE 226
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 16/162 (9%)
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+ +H N++ L ++ GK L+ E M G L I + ++ + VL +
Sbjct: 75 LRYGQHPNII-TLKDVYDDGKHVYLVTELMRGGELLDKI----LRQKFFSEREASFVLHT 129
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNIL-LDRDFEAH---VSDFGTSRMLDVHLQDLSSLS 179
+ ++YLHS +VH D+KPSNIL +D + DFG ++ L + L
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE----NGLL 182
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T ++APE + D++S GI++ L P
Sbjct: 183 MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 16/162 (9%)
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+ +H N++ L ++ GK L+ E M G L I + ++ + VL +
Sbjct: 75 LRYGQHPNII-TLKDVYDDGKHVYLVTELMRGGELLDKI----LRQKFFSEREASFVLHT 129
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNIL-LDRDFEA---HVSDFGTSRMLDVHLQDLSSLS 179
+ ++YLHS +VH D+KPSNIL +D + DFG ++ L + L
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE----NGLL 182
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T ++APE + D++S GI++ L P
Sbjct: 183 MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
L+ +H N++ L ++ GK ++ E + G L I + ++ + VL +
Sbjct: 70 LRYGQHPNII-TLKDVYDDGKYVYVVTELXKGGELLDKI----LRQKFFSEREASAVLFT 124
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNIL-LDRDFEA---HVSDFGTSRMLDVHLQDLSSLS 179
+ ++YLH+ +VH D+KPSNIL +D + DFG ++ L + L
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE----NGLL 177
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T ++APE + D++S G+++ LT P
Sbjct: 178 XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 13/148 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+++E ++ G L S I G D + +T + +++ S+ + YLHS I I H D+KP
Sbjct: 90 IVMECLDGGELFSRIQDRG-DQA-FTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 148 NILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L + +DFG ++ H T + Y+APE D
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY-----YVAPEVLGPEKYDKSCD 199
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP 232
++S G+++ L P + +SP
Sbjct: 200 MWSLGVIMYILLCGYPPFYSNHGLAISP 227
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 220
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 274
>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 220
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 274
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 123 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 176
Query: 187 GYLAPEFA-YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 177 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 230
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 205
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 259
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 177
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 178
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 177
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 193
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 247
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 18/177 (10%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + + Y
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVA---NGLDYLHSGY 135
+E I ME G+ +D + W K+ ID + N L+ +H+ +
Sbjct: 96 YEITD--QYIYMVMECGN---------IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
IVH D+KP+N L+ D + DFG + + + S GT+ Y+ PE
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQV--GTVNYMPPE 198
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 193
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 247
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 192
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 246
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 193
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 247
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 192
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 246
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 173
Query: 187 GYLAPEFA-YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 227
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 8/114 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ + ++ ++H D+K NIL+D + E + DFG+ +L ++ T F GT
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTR 178
Query: 187 GYLAPEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
Y PE+ Y R V+S GI++ + + P DEE + RQ V
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.136 0.389
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 8,516,998
Number of Sequences: 62578
Number of extensions: 346813
Number of successful extensions: 3296
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 713
Number of HSP's successfully gapped in prelim test: 372
Number of HSP's that attempted gapping in prelim test: 1166
Number of HSP's gapped (non-prelim): 1145
length of query: 299
length of database: 14,973,337
effective HSP length: 98
effective length of query: 201
effective length of database: 8,840,693
effective search space: 1776979293
effective search space used: 1776979293
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 51 (24.3 bits)